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ABSTRACT    
     Not only does the DNA sequence encode proteins and drive cellular processes but the base-pair 
stack also exhibits a unique and exquisite property: it facilitates charge transport on ultrafast time 
scales over long distances. A molecular wire, DNA conducts charge with very shallow distance 
dependence, yet mismatches and lesions significantly attenuate this process. It is this characteristic 
that has inspired the research described herein: how might nature exploit DNA CT and perhaps 
more importantly, how can we gauge which biological pathways are governed by DNA-mediated 
CT? 
 
     Here, we have focused on understanding the role of DNA CT in the search for lesions by repair 
proteins. All of the proteins we have examined contain a redox-active [4Fe4S] cluster, thus these 
metalloproteins can “tap into” DNA-mediated CT. We have proposed a model where repair proteins 
send and receive signal over long distances via the DNA base pair stack to efficiently scan the 
genome for damage. As glycosylases bind to DNA, they are activated toward oxidation, triggering 
DNA-mediated CT to a distally bound repair protein that is then reduced, loses its affinity for DNA, 
and dissociates. DNA CT is remarkably sensitive to intervening lesions and mismatches; thus the 
signal is only transmitted between proteins if the DNA is intact. Based on this model, repair 
proteins will reduce the population of sites to search through a relocalization of the proteins in the 
vicinity of lesions that inhibit CT. To test this model, we have employed single-molecule atomic 
force microscopy (AFM) to investigate Endonuclease III (EndoIII), a base excision repair (BER) 
protein that contains a redox-active [4Fe4S] cluster. Notably, there is no simple protocol that has 
been established to generate long DNA strands required for AFM studies, > 3000 bp, containing 
site-specific modifications. To circumvent this, we have designed modular vectors that we 
synthesize by PCR with primers containing a 2ʹ′-O-methyl base to generate ~ 2000 bp duplexes with 
14 base single-strand overhangs. The vectors are then pieced together to yield a site-specific lesion 
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in the middle of a ~ 4000 bp DNA duplex. With these DNA samples, we find a redistribution of 
EndoIII onto the long DNA strands containing a C:A mismatch, which is not a specific substrate of 
EndoIII but inhibits CT.  When both long and short strands are matched, accumulation of EndoIII 
on longer strands is not observed. These results demonstrate the link between DNA CT and the 
ability of a BER protein that contains a redox-active [4Fe4S] cluster to find damage in DNA. 
Importantly, we recognize that interrogation times for BER proteins depend on DNA CT over long 
distances as well as the percentage of proteins oxidized. AFM measurements taken as a function of 
oxidation of proteins bound to DNA, using peroxide as an oxidant, reveal an additional increase in 
the ratio of EndoIII bound to strands containing a mismatch.  
 
     We then identified residues in EndoIII, specifically aromatic; that we thought may be involved in 
the CT pathway between the [4Fe4S] cluster and DNA. Subsequently, we have prepared and 
examined a variety of EndoIII mutants using electrochemical, AFM, and in vivo methods. The 
residues targeted for mutation are either conserved aromatic amino acids near the [4Fe4S] cluster or 
are located close to the DNA binding site. All of the EndoIII mutants display glycolytic activity 
within error of wild-type protein. Y75A EndoIII, protein with a single mutation making it deficient 
in DNA-mediated CT, does not redistribute onto strands containing a C:A mismatch.  Y75F and 
W178A EndoIII, proteins shown to perform charge transfer within error or even more efficiently 
than wild-type, do show redistribution onto the mismatched DNA strands. Thus, consistently, we 
find a correlation between the ability of mutants to carry out DNA/protein CT and their ability to 
relocate near a single base mismatch.  
 
     As another test of the search model, we employed genetic methods to investigate the interactions 
of proteins that may cooperate with each other in vivo to find damage. MutY, a BER protein also 
containing a redox-active [4Fe4S] cluster, displays a DNA-bound potential similar to that of 
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EndoIII. We have performed assays to monitor MutY, a protein that removes adenine from 8-oxo-
G:A mismatches, in E. coli and asked whether changes in EndoIII might affect MutY activity. We 
find that inactivating EndoIII in vivo leads to a decrease in MutY activity, evidenced by an increase 
in unrepaired MutY lesions. Additionally, we introduced oxidative stress into in vivo experiments to 
further increase the number of lesions that are specific substrates for MutY. By increasing the 
overall signal of MutY activity, we ultimately reduce the standard error of the measurements. 
Previously, we found that a mutant of EndoIII that is glycolytically inactive yet contains an intact 
[4Fe4S] cluster restores MutY activity; however, Y82A, a mutant of EndoIII that is deficient in its 
ability to perform CT, cannot aid MutY in fixing damage. Notably, mutations at the analogous 82 
position in the human homologue of MutY, MutYH, have been shown to lead to a predisposal 
toward colorectal cancer. Significantly, AFM studies with Y82A provide further evidence that this 
mutant cannot perform DNA-mediated CT, as the protein does not redistribute in the vicinity of a 
lesion.  
 
     Various DNA-binding proteins, such as those involved in repair and other pathways that 
maintain the integrity of DNA, have already been found to contain FeS domains and other redox 
cofactors. We are discovering proteins from alternate repair pathways that may also utilize DNA 
CT to find damage in the genome. XPD, a 5ʹ′-3ʹ′ helicase involved in nucleotide excision repair from 
archaea, contains a conserved [4Fe4S] cluster and exhibits a DNA-bound redox potential that 
indicates it is able to carry out DNA CT. In AFM studies, we observe the redistribution of XPD 
onto long DNA strands containing a single base mismatch. Importantly, in XPD from archaea, 
L325V aligns with mutated residues in human XPD and Schizosaccharomyces pombe Rad 15 that 
are associated with diseases including Trichothiodystrophy and Xeroderma Pigmentosum. On the 
basis of electrochemical and AFM experiments, we have demonstrated this mutant is not only 
defective in carrying out DNA CT but also does not redistribute to find lesions in DNA strands.  
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Further, we recognize that we can apply AFM techniques to probe DNA-mediated signaling 
between two distinct repair proteins bound to DNA. When XPD and EndoIII are mixed together at 
equal concentrations, they coordinate in relocalizing onto the mismatched strand. However, when a 
CT-deficient mutant of either repair protein (Y82A or L325V) is combined with the CT-proficient 
repair partner, no relocalization occurs. When wild-type protein is titrated into the DNA/mutant 
protein solution at increasing concentrations, it substitutes for the protein that could not perform 
CT; thereby restoring redistribution. These data not only indicate a general link between the ability 
of a repair protein to carry out DNA CT and its propensity to redistribute onto DNA strands near 
lesions, but also provide evidence for coordinated DNA CT between repair proteins in their search 
for damage in the genome. 
 
     Extending the methodology to examine related systems, we are now employing AFM to 
“visualize” the helicase activity of XPD. Electrochemical studies in our lab have revealed that XPD 
performs DNA CT efficiently in an ATP-dependent manner. Thus, we have added ATP to 
DNA/protein solutions, initiating XPD helicase activity, in an effort to understand whether there is a 
change in redistribution that reflects the ability of XPD to perform DNA CT. Interestingly, at high 
concentrations of ATP, we see an increase in proteins that are bound to the short strands of DNA. 
Though we have introduced complementary strands to block the short-strand overhangs, over time, 
rather than determining the redistribution of XPD, we have instead directly observed the helicase 
activity of the protein. Now, we are using this knowledge to our advantage in developing new 
protocols to explore links between the biochemical activity of XPD and its ability to perform DNA-
mediated CT. 
 
      We have also probed DNA CT using time-resolved IR (TRIR) spectroscopy. In the first step of 
the search model, a reduced metalloprotein binds DNA, and consequently, gets oxidized. Since the 
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guanine base is the most susceptible to oxidation, we have considered that guanine oxidation may 
indeed trigger the metalloprotein to bind DNA, initiating the search process. To investigate this, we 
have developed a metal-based photooxidant: [Re(CO)3(dppz)(pyʹ′-OR)]+ (dppz=dipyrido[3,2-a:2ʹ′,3ʹ′-
c]phenazine; pyʹ′-OR=4-functionalized pyridine] that can be tethered to DNA duplexes via the 
pyridine moiety to examine the photophysical and electronic properties of DNA CT. Importantly, 
the (C≡O) stretching vibrations allow us to utilize TRIR to monitor DNA CT on pico and 
microsecond time scales. Charge injection, the motions of DNA bases, and back electron transfer 
rates dictate the efficiency of CT and, thereby, the response we detect. In conjunction with these 
studies, we have employed biochemical methods to directly observe long-range guanine oxidation 
of DNA by the excited state complex.  
 
     The results presented here establish a link between the ability of a metalloprotein to perform CT 
and its ability to find lesions in the genome. Atomic force microscopy studies have provided us with 
snapshots of proteins bound to DNA containing a single mismatch, unveiling the first step in the 
search for damage. In these experiments, we observe on average only two proteins bound to long  
(~ 4000 bp) strands of DNA, which supports the model that these metalloproteins may be mediating 
charge over very long molecular distances. By employing electrochemical, in vivo, and AFM 
techniques, we have identified residues that may be integral to the CT pathway between the [4Fe4S] 
cluster and the DNA. Excitingly, we have found that, regardless of the organism or the repair 
pathway from which they originate, repair proteins that are able to mediate charge transport can 
redistribute to find lesions. A potential trigger of this search process, guanine oxidation has been 
probed with a metal-based photooxidant. Here, we have identified and explored the properties that 
are required for a protein to participate in a DNA-mediated search and gained valuable insight as to 
how this might occur in a biological context. 
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CHAPTER 1 
DNA-mediated Charge Transport in a Biological Context 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Barton, J. K., Olmon, E. D., Sontz, P. S. (2011) Coordination Chemistry Reviews 
255, 619−634, and Sontz, P. S., Muren, N. B., Barton, J. K. (2012) Accounts of Chemical Research, 
submitted.  
  
2 
 INTRODUCTION 
     The DNA π-stack facilitates charge transport (CT) over long distances, and these reactions are 
sensitive to perturbations in base pair stacking, such as single base mismatches and lesions (1-3). In 
vitro and electrochemical studies have established that remarkably, DNA CT proceeds over 
molecular distances as large as 340 Å (4), but how might DNA CT be exploited within a cellular 
context? We have considered several ways in which DNA-mediated CT could act as a conduit to 
funnel damage to distant sites, trigger transcription of genes to activate cellular defense pathways, 
or even provide a platform for bound repair proteins to signal one another in their search for lesions. 
Indeed, we are now discovering that within the cell, redox-active proteins may utilize the same 
chemistry as that of synthetic metal complexes and electrochemical redox probes in vitro, and these 
proteins may harness DNA-mediated CT to reduce damage to the genome and regulate cellular 
processes. 
 
DNA Damage Over Long Ranges in the Cell 
     We have employed flash-quench and electrochemical techniques to characterize DNA CT (i.e., 
rate, distance dependence, sensitivity to structural changes), though an outstanding question still 
remains: could this process occur in a physiological context? In an effort to examine this question, 
we have probed hole migration in the nucleus of the cell (5). HeLa cell nuclei were isolated and 
mixed with a metal-based photooxidant, Rh(phi)2DMB3+ (DMB: 4,4ʹ′-dimethyl-2,2ʹ′-bipyridine). We 
found that, upon irradiation, the complex generated strand breaks at intercalation sites that were 
distinct from sites of guanine oxidation. Moreover, even when constitutively bound proteins 
prevented Rh(phi)2DMB3+from intercalating in the DNA, guanine doublet oxidation patterns (5ʹ′-G 
of 5ʹ′-GG-3ʹ′) were still observed at these sites (5). These results indicate that long-range CT, 
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mediated via π-stacking of the base pairs, can proceed across regions of DNA that would 
otherwise be inaccessible, generating damage at remote points.  
     What, then, are elements in the cell that modulate DNA CT? Methylases (i.e., M. Hha1), for 
example, extrude cytosines from their target sites to expose them for methylation (6, 7). Since this 
activity disrupts base pair stacking, methylases inhibit DNA CT. Similarly; TATA-binding proteins 
kink DNA duplexes by 90° at their recognition sites, thus attenuating CT (7, 8). On the other hand, 
there are examples of proteins that do not hinder CT when they bind; rather they facilitate electron 
transfer by stabilizing the duplex (9). Importantly, in eukaryotic cells, DNA is packed in 
nucleosome core particles (10). Strands of DNA (~ 150 bp), which have negative backbones, are 
wrapped around positively charged octamer histone proteins. We thought this DNA structure might 
confer resistance to reactive oxygen species (ROS) (10). To determine the effects of packing on 
long-range CT in DNA, we utilized rhodium photooxidants to generate guanine oxidation products 
in reconstituted nucleosomes (10). Although the complex could not access the DNA as efficiently, 
studies with noncovalently bound Rh(phi)2DMB3+ revealed damage at the 5ʹ′-G of 5ʹ′-GG-3ʹ′, similar 
patterns found within HeLa cells (5, 10). Remarkably, when Rh(phi)2(bpy)3+ was tethered to the 5ʹ′ 
end of the DNA, the complex both intercalated and produced damage at distant sites up to 24 bp 
away (10) (Figure 1.1). Long-range CT within DNA in the nucleosome was confirmed in a similar 
study that employed a different yet comparable photooxidant, anthraquinone (11). We then 
considered whether DNA CT over long ranges could transmit damage to distant sites that either 
absorb and mitigate damage or, alternatively, propagate further downstream mutations. Notably, 
analysis of genomic DNA has revealed that introns and exons contain different numbers of sites 
with low oxidation potential (12). It is possible then, that DNA-mediated CT funnels damage away 
from specific protein coding regions, clustering it elsewhere, and thereby protecting these sites from 
oxidation. 
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Figure 1.1. DNA in cells is wrapped around a histone core. Photooxidation of a metal complex 
tethered to DNA generates oxidative damage (Gox) at distant guanine sites in the nucleosome core 
particle (pdb ID: 1aoi).  
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Funneling Damage to Specific Regions of DNA 
      Mitochondria, cellular sites of respiration, accumulate ROS resulting from oxidative 
phosphorylation (13, 14). These organelles also contain their own DNA, making them particularly 
interesting systems to examine with respect to DNA CT. Photoactivation of [Rh(phi)2(bpy)]3+ at 
long wavelengths (365 nm) in the presence of DNA generates base mutations, such as 8-
oxodeoxyguanosine (8-oxodG), identical to naturally occurring oxidative lesions. Irradiation at 
shorter wavelengths (313 nm) results in direct strand cleavage, marking the specific site of complex 
intercalation (15, 16). HeLa cells incubated with [Rh(phi)2(bpy)]3+, which is readily absorbed, and 
irradiated, can also be analyzed for DNA mutations and oxidative damage (17). Rh complex 
binding sites can be directly compared to sites of guanine oxidation with a primer extension assay 
(15). Base oxidation, resulting from DNA CT hole migration in vitro or in HeLa cells, has been 
shown to occur primarily in conserved sequence block II, nucleotides 303-315, of mtDNA (16). 
Furthermore, this sequence is located within the control region of mitochondria, which regulates 
primer formation for mtDNA replication (18, 19). Mutations within this region of mtDNA are 
associated with tumor formation and other diseases (20).  
     Remarkably, sites of DNA oxidation via CT within the mitochondria occur as far as 70 bases 
from the intercalated metal complex, suggesting that DNA CT plays a role in mtDNA oxidative 
damage (16). Conserved sequence block II, which contains seven consecutive guanines, is a site of 
very low oxidation potential, and could, therefore, act as a sink for lesions such as 8-oxodG (21). 
Extensive damage to this region through DNA-mediated funneling would save the cell from further 
error propagation by preventing replication of the damaged mitochondrial genome (Figure 1.2). 
Nevertheless, replication of DNA containing lesions ultimately leads to mutations such as dG to dT 
transversions, and these mutations have been shown also to occur within conserved sequence block 
II. This ultimately reduces the amount of guanine in the regulatory region, eliminating the 
checkpoint and funneling site for oxidative stress, limiting mutant mitochondrial function.  
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Figure 1.2. Multiple copies of mitochondrial DNA (black) are found in mitochondria (green) 
organelles within the cell. Irradiation of Rh(phi)2(bpy)3+ photooxidant results in oxidation of sites 
with low oxidation potential (Gox). Damage in the genome is funneled (green arrows), via DNA-
mediated electron transfer (e-) to the control region (orange), preventing replication of the lesion-
filled plasmid (bottom right). DNA replication of undamaged DNA occurs, aiding in the survival of 
functional error-free mitochondria (bottom left). 
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     Tumor cells, which do not necessarily depend on respiration, could then survive utilizing 
alternative energy pathways independent of mitochondria (17). 
 
DNA CT with Metalloproteins 
     To further our understanding of DNA CT in biology, we have extended our studies to examine 
metalloproteins from repair pathways. Specifically, the proteins from the base excision repair 
(BER) network recognize and repair DNA bases that have been damaged by oxidative stress (22). 
Left unrepaired, these lesions would threaten the integrity of the genome. We first employed 
electrochemical techniques to examine whether DNA damage products found in nature influence 
DNA-mediated signaling (1-3). Just as we established that single base mismatches inhibit DNA CT, 
as they disrupt base pair stacking, common lesions, including O4-methyl-thymine, O6-methyl-
guanine, 8-oxo-guanine, and 5-hydroxy-cytosine have this effect as well (3). Notably, a subset of 
base excision repair (BER) proteins contain [4Fe4S]2+ clusters within a Cys-X6-Cys-X2-Cys-X5-Cys 
loop near the C terminus of the protein that are not required for the protein to fold into a native 
conformation (23). A vast number of DNA repair proteins are known to contain this loop, defined 
by the first two ligating cysteines, a proposed structural element (24-26). Having no clear structural 
role, we wondered: why are the iron-sulfur cofactors present? Crystal structures (with DNA) of two 
BER proteins from E. coli, MutY and Endonuclease III (EndoIII), have revealed the proximity of 
the [4Fe4S] cluster to the DNA backbone (27-40). EndoIII is resistant to reduction in solution, 
having an estimated [4Fe4S]2+/1+ couple midpoint potential of < -600 mV (26, 28). Notably, initial 
measurements of the redox potentials of these proteins were performed in the absence of DNA. We 
then wondered whether the DNA environment would alter the redox properties of the [4Fe4S] 
cluster. Measurements of DNA-bound potentials were then made using DNA-modified electrodes 
to examine this question (Figure 1.3). 
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Figure 1.3. Examples of surfaces used for DNA/protein electrochemistry of BER proteins (left) or 
SoxR (right). DNA duplexes are attached to the gold via a 5ʹ′ thiol linker. Mercaptohexanol (curved 
lines) is used to backfill so that the duplexes are in an upright position. Electrons travel (arrow) 
from the gold surface to the bound protein. EndoIII and MutY are bound when the [4Fe4S] cluster 
is in the 3+ oxidation state and SoxR binds as a dimer. 
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     MutY was probed electrochemically on loosely packed DNA gold electrode films (34). A thiol-
terminated duplex with a non-specific DNA binding site was attached to a gold surface and 
passivated with mercaptohexanol. Cyclic voltammetry of MutY at the DNA-modified surface 
yielded a midpoint potential +90 mV vs. NHE, an appropriate potential for a physiologically active 
redox switch. In the absence of DNA, examination of a surface coated with mercaptohexanol 
yielded no electrochemical signal. Therefore, DNA was required to observe reduction of the 
[4Fe4S] cluster-containing protein. When the electrode was modified with duplex DNA containing 
an abasic site, no signal was observed, establishing that electron transfer occurs through the DNA to 
the bound MutY protein. The redox reaction of MutY is DNA-mediated.  
     Redox potentials of +100 mV vs. NHE are common for high-potential iron proteins, and in the 
case of MutY (+90 mV vs. NHE) indicated a shift in the oxidation state of the [4Fe4S] cluster from 
2+ to 3+ as the protein binds to the DNA (35, 36). EndoIII was also examined bound to a DNA-
modified electrode. As with MutY, for EndoIII when the potential was held at +50 mV, promoting 
oxidation of the cluster, the signal increased. Quite remarkably, both proteins display signals with 
midpoint potentials in the presence of DNA of ~ 100 mV vs. NHE. Both also display a much 
smaller signal when the intervening duplex contains an abasic site. We can then attribute oxidation 
of the cluster to DNA-mediated CT from the electrode through the base pair stack to the bound 
protein. 
     Building upon these studies, EndoIII was then examined bound to DNA versus free using highly 
oriented pyrolytic graphite (HOPG) electrodes (37). In these experiments, graphite electrodes were 
modified with pyrenated DNA, and both cyclic voltammetry and square wave voltammetry data 
were collected. A midpoint potential of ~ 20 mV vs. NHE was observed in the presence of well-
matched DNA and EndoIII. In contrast, in the absence of DNA, oxidative scans of EndoIII yielded 
an irreversible anodic peak at ~ 250 mV and loss of the yellow solution color, an indicator of 
[4Fe4S] cluster degradation (37). Consecutive positive scans showed broad, irregular signals at -80 
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and -710 mV vs. NHE, representative of clusters that have lost an iron to become [3Fe4S]. The 
2+/3+ EndoIII [4Fe4S] cluster redox couple exhibited a positive potential (~ 250 mV). These data 
taken together indicate that EndoIII in the 3+ oxidation state binds DNA at least a thousand fold 
more tightly than the reduced, 2+, form. This characteristic shift in binding affinity between the 
reduced and oxidized forms of MutY and EndoIII has been an important element in our proposed 
mechanism for how these repair proteins scan the genome using DNA CT to find their lesions (35, 
37-39).  
     Another metalloprotein, the SoxR transcription factor, regulates the response to superoxide 
within the cell. SoxR contains two [2Fe2S] clusters (one in each monomer) that are not required for 
protein folding (40-43). The oxidation of SoxR leads to the expression of the SoxS transcription 
factor to control expression of genes involved in protecting the cell from stresses, but interestingly 
the affinities of SoxR for its promoter are equal for the oxidized and reduced form of the protein 
(44). Redox potentials for SoxR without DNA, however, were found to be about -290 mV vs. NHE, 
providing somewhat of a conundrum since that would suggest that at cellular potentials, SoxR was 
already oxidized, not an optimum situation for a sensor of oxidation [42, 45, 46]. Determination of 
the DNA-bound redox potential of SoxR was thought to provide insight to the activation 
mechanism of the protein. Well-matched DNA duplexes, attached to an HOPG electrode via pyrene 
modification, were self-assembled to form loosely packed DNA monolayers. Redmond red was 
used as the redox-active probe in these studies, with a midpoint potential of -160 mV vs. NHE (47). 
A quasi-reversible stable electrochemical signal was found for the [2Fe2S] cluster of SoxR at +200 
mV vs. NHE (44). Differing from MutY and EndoIII signals, SoxR showed asymmetries in 
reduction and oxidation waves, displaying a better resolved anodic peak. Measurements of SoxR 
extracted from different organisms yielded similar potentials. Significantly, then, there was ~ 500 
mV positive shift in redox potential of SoxR upon DNA binding.  It is likely this shift in potential 
that provides the energetics for the torqueing of the DNA by oxidized SoxR to activate 
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transcription. Critically, we see the importance of performing redox measurements in the 
presence of DNA, as the DNA polyanion alters the protein environment and potential. MutY, 
EndoIII, and SoxR show redox activity in a physiologically relevant regime only when bound to 
DNA. These redox-active proteins, then, may use DNA CT as a sensor for oxidative damage and to 
locate lesions awaiting repair. 
     Methods to probe long-range DNA-mediated oxidation of 5ʹ′-GG-3ʹ′ have aided in the study of 
DNA/protein interactions so that we can gain insight into how these metalloproteins might take 
advantage of the unique property of DNA to conduct charge. Experiments harnessing DNA-
mediated CT to generate oxidized guanine, leading to DNA-protein cross-links, have provided a 
more detailed look at the amino acid/DNA interface (48-56). Noncovalent ruthenium intercalators, 
upon photoactivation, have been used to generate guanine radicals, and these radicals can promote 
adducts with histone proteins.  
     DNA/MutY cross-linking experiments were performed using tethered [Rh(phi)2(bpyʹ′)]3+ to 
generate oxidative damage (56). MutY was chosen for initial studies, since base flipping was 
thought to be involved in lesion detection. Worth nothing, lysine 142 in MutY was thought to play a 
large mechanistic role during the repair of 8-oxo-G:A lesions based on early cross-linking and 
NMR investigations (49, 57, 58). In our experiments, interestingly, there was no apparent change in 
distal/proximal guanine ratios upon DNA-mediated guanine oxidation in the presence of up to 200 
nM of protein. This result indicated that MutY binding does not perturb long-range DNA CT, and 
thus might use a mechanism other than base flipping to search for damage. Oligonucleotides with 
an 8-oxo-G:7-deaza-A MutY binding site 20 Å away from the tethered Rh photooxidant were then 
used to probe DNA CT-mediated cross-link formation between MutY and 8-oxo-G (Figure 1.4). A 
covalent cross-link of 8-oxo-G with MutY was identified involving lysine 142. This provided an 
example of long-range DNA-mediated CT providing a route to a protein/DNA redox reaction (56).  
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Figure 1.4. Upon irradiation at 365 nm (1) of [Rh(phi)2(bpyʹ′)]3+ intercalator (2), electrons are 
pulled from the site of lowest oxidation potential, guanine (3). Guanine is then oxidized (4) to form 
8-oxo-G, forming a cross-link with bound MutY through lysine 142 contacts (5).  
 
 
 
 
 
 
 
 
 
 
     Having reliable methods to generate oxidative damage and knowing that MutY is redox-active 
from electrochemical studies, we have also been able to show that MutY itself can be activated in a 
DNA-mediated redox dependent manner (38). [Ru(phen)2dppz]2+ binds to DNA by intercalation 
and is excited in the presence of visible light.  This excited state is then quenched by an electron 
acceptor to form a Ru(III) species in situ that can then oxidize guanines from a distance, and then 
the guanine radical, once formed can then oxidize MutY [Scheme 1.1] (48, 59). To test this, 
poly(dGC) and poly(dAT) duplexes were irradiated in the presence of [Ru(phen)2dppz]2+ and 
quencher, [Co(NH3)5Cl]2+, with or without MutY. EPR spectra at 10K revealed a primary g value of 
2.02 which was attributed to the [3Fe4S]1+ cluster, an oxidative degradation product of the 
[4Fe4S]2+ cluster (38). Traces showed an additional signal at g values of 2.08 and 2.06 for both 
poly(dGC) and poly(dAT) duplexes in the presence of MutY, assigned to the oxidized [4Fe4S]3+ 
cluster (38, 60). Notably, with poly(dAT), these signals were significantly lower in intensity than 
with poly(dGC).  Thus the [4Fe4S] cluster of MutY can become oxidized to the 3+ state with or 
without intervening guanine radicals. The guanine radical, owing to its relatively long lifetime, can, 
however, increase the yield of protein oxidation. 
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Scheme 1.1. The flash-quench technique used to generate Ru(III) and subsequently oxidize 
DNA-bound MutY (dark blue). Following photoexcitation, Ru(II)* is quenched forming powerful 
ground-state oxidant Ru(III) which can then proceed to oxidize guanine within the base stack. The 
guanine radical not only forms oxidative products but also oxidizes proteins, such as MutY.  Back 
electron transfer reactions are shown in gray. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
14 
     Investigating oxidation of MutY in a DNA-mediated reaction on a faster time scale was 
carried out using transient absorption measurements in the presence of [Ru(phen)2dppz]2+, 
poly(dGC) DNA, and a [Ru(NH3)6]3+ quencher (38). As the DNA-bound metal complex was 
photoactivated, emission decays were observed at 610 nm. Transient absorption signals fit to a 
biexponential indicated a fast phase guanine radical formation in duplex DNA that decreased in the 
presence of MutY. Also, a new species appeared in the poly(dGC) slow phase spectrum with an 
absorption maximum characteristic of the [4Fe4S]3+/2+ difference spectrum. Importantly, these 
experiments established that guanine radical formation could directly lead to oxidation of bound 
protein. The intervening guanine radicals may allow MutY more time to undergo oxidation. 
     Biochemical studies examining 42-mer DNA duplexes incorporating a 5ʹ′-GG-3ʹ′ doublet 
covalently linked to a ruthenium intercalator also showed inhibition of 5ʹ′-G damage in the presence 
of MutY. This system differs from covalently tethered [Rh(phi)2(bpyʹ′)]3+ used to generate oxidative 
damage in previous experiments, owing to its ability to generate guanine radicals through the 
flash/quench pathway. Guanine has an oxidation potential of -1.29 V vs. NHE, making it easily 
oxidized in the presence of Ru(III) complex, which has a reduction potential of 1.5 V vs. NHE (61, 
62). Importantly, the midpoint potential of DNA-bound MutY [4Fe4S]2+/3+ is +0.1 V vs. NHE. 
Thus, instead of generating oxidative DNA damage, MutY can intercept the guanine radicals, 
becoming oxidized itself (34). This explains the inhibition of damage in the denaturing PAGE gel 
experiments tracking 5ʹ′-G damage. EPR studies further confirmed this hypothesis, displaying strong 
signals attributed to the oxidized [4Fe4S]3+ cluster in samples of Ru complex tethered to a 5ʹ′-GG-3ʹ′-
containing 42-mer duplex in the presence of MutY. Collectively, transient absorption, EPR, and 
biochemical experiments indicate that MutY can be oxidized in a DNA-mediated fashion. 
Moreover, the implications of these findings for DNA repair by redox-active proteins are critical, 
since within the cell, oxidative stress may lead to this chemistry as a means to activate repair. 
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CT to Trigger Transcription from a Distance 
     Inspired by our findings that DNA-mediated CT can trigger MutY, we have examined yet 
another system that includes a metallo transcription factor, SoxR. As mentioned earlier, SoxR is 
activated in the presence of oxidative stress; however, the specific source for oxidation in the cell is 
unknown. The protein is reversibly inactivated in vitro by reduction of its [2Fe2S] clusters using 
dithionite (42). In vivo studies, using redox-cyclers such as paraquat to induce oxidative stress, 
show that superoxide is not the direct activator of SoxR. Rather, there is depletion of cellular 
NADPH, which is normally required to keep SoxR in a reduced form. The redox-cyclers then 
undergo autooxidation and produce superoxide by losing an electron to dioxygen. Plumbagin and 
phenazine methosulfate, notably, have yielded reversible oxidation of the [2Fe2S] clusters (42). 
Electrochemistry of SoxR in our lab showed a redox-active signal for the [2Fe2S] cluster of SoxR at 
+200 mV vs. NHE, indicating the protein undergoes one electron oxidation bound to DNA (44). 
Due to the shift seen upon binding to DNA, we questioned whether the DNA-bound form of SoxR 
might be the missing oxidative switch. As DNA is subjected to oxidative damage, and guanine 
radicals, capable of migrating through the base pair stack, are generated, these guanine radicals can 
then serve as the oxidant for SoxR. Once oxidized, SoxR can promote transcription under 
conditions when the cell needs it the most. The oxidative signal then would be the guanine radical. 
     We have learned that the coupling properties of photooxidants used to probe DNA-mediated CT 
are important factors in observing this process. Therefore, SoxR studies were recently conducted in 
our lab using a strong DNA intercalator, [Ru(phen)(dppz)(bpyʹ′)]2+, where dppz is the moiety 
interacting with the DNA, to generate guanine radicals resulting in irreversible oxidative damage 
(63). [Co(NH3)5Cl]2+ was used as the quencher in these studies, eliminating back electron transfer, 
so that the major pathway in the reaction yields oxidative damage. Similar to DNA-bound MutY 
experiments described earlier where MutY oxidation reduced guanine damage, 5ʹ′-GG-3ʹ′ oxidation 
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products were measured with and without oxidized or reduced SoxR. Upon reduction of SoxR 
with sodium dithionite in the presence of DNA-bound Ru, quencher, and light, damage at guanine 
sites was attenuated. This indicated that SoxR was able to donate an electron to the oxidized 
guanine, going from a reduced to an oxidized form, filling the radical hole with its own lost 
electron. Conversely, there was no attenuation in damage when oxidized SoxR was used in the 
experiment. These results clearly showed that SoxR is able to interact with the DNA base stack, 
participating in DNA-mediated CT. The SoxR response to guanine radicals generated in DNA 
suggests that oxidative damage can be an initiator of protein activation. 
     Examining the SoxR response to DNA damage in its native cellular environment, E. coli cultures 
were treated with [Rh(phi)2bpy]3+. This intercalator, with photoactivation, was previously shown to 
generate guanine damage in mitochondria and HeLa cells (15-17). Transcription of the soxS 
product, RNA, observed using reverse transcription PCR, reflects activation of SoxR. Bacteria 
irradiated in the presence of the Rh photooxidant showed much greater soxS levels than those 
without. Since the complex strictly induces DNA damage and cannot oxidize SoxR directly without 
DNA, SoxR must be activated by guanine radicals in these experiments. Expression levels of soxS 
in the presence of [Rh(phi)2bpy]3+ were similar to those occurring when methyl viologen, a redox-
cycler, was used, both systems activating SoxR to the same extent. But is SoxR oxidized from a 
distance through DNA-mediated CT (63, 64)? To test this idea, [Rh(phi)2bpy]3+ was tethered to a 
180-mer duplex of DNA containing the SoxR binding site and the -10 and -35 promoter regions of 
soxS (Figure 1.5), irradiated, and gene products were monitored with an anaerobic abortive 
transcription assay (41). The abortive transcription product, a 4-mer, was only observed in samples 
containing reduced SoxR and tethered complex/DNA. Importantly, there was no direct 
photooxidation of SoxR by [Rh(phi)2bpy]3+ without DNA. Remarkably, then, DNA-mediated 
transcriptional activation of SoxR was indeed demonstrated over a 270 Å distance. These data 
establish that guanine radicals are capable of oxidizing SoxR from a distance.  
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Figure 1.5. [Rh(phi)2(bpyʹ′)]3+ is tethered to a duplex of DNA containing the SoxR binding site.  
SoxR is bound in the reduced (+1) state (yellow protein). Photoactivation of the metal complex 
triggers electron transfer, oxidizing SoxR (2+), which may then kink the DNA and recruit 
transcription machinery such as RNA polymerase (green). 
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     Thus, CT over long ranges may play some role in a number of cellular pathways including: 
funneling damage in mitochondria, enhancing fidelity during replication, and activating 
transcription to defend the cell from oxidative stress. It is clear that in a biological context, DNA CT 
may “wear many hats”. 
 
DNA-mediated Signaling for Lesion Detection by Repair Proteins 
     DNA is the main source of genetic information in cells, allowing them to function, store 
information, and evolve. The specific sequence of the bases in DNA ultimately translates into the 
structure and function of proteins (65). Thus, the integrity of the DNA sequence is vital to cells, 
though there are many mutagens that can produce lesions that are difficult to repair, potentially 
blocking DNA replication or producing defective proteins. For example, thymine dimers caused by 
UV light, base modifications such as 7, 8-dihydro-8-oxo-2-deoxyguanosine (8-oxoG) due to 
oxidative damage, or double-strand breaks can all lead to insertions, deletions, and point mutations 
in the DNA sequence, subsequently destroying the genetic code within the cell (66).   
     Damaged bases in DNA are known to lead to the disruption of DNA replication as well as act as 
possible indicators of cancer due to the high frequency of mutations that arise from these lesions 
(22, 35). Thus, the cell must quickly detect and repair lesions.  Examples of endogenous DNA 
repair pathways include direct repair, base-excision repair (BER), and nucleotide-excision repair 
(19). There is much known about the mechanism of base removal by enzymes from these pathways; 
however, precisely how these bases are located by glycosylases remains unknown.  
     We now know that BER proteins, similar to SoxR, are capable of ‘absorbing’ guanine radical 
damage by donating one of their own electrons into the DNA π-stack. We have performed many 
additional in vitro studies to establish that BER proteins can be oxidized and reduced via DNA-
mediated CT (38, 67). The results from these studies led us to wonder whether BER proteins might 
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exploit DNA CT to recognize their lesions. We have thus proposed a mechanism that may be 
activated within cells for repair utilizing DNA CT. Importantly, binding to DNA shifts the potential 
of the EndoIII [4Fe4S] cluster toward oxidation, which could activate it when repair is required 
(37). The BER proteins all have similar DNA-bound redox potentials and contain a reduced 
[4Fe4S]2+ in solution in the absence of oxidative stress (38). Guanine radicals, forming 
endogenously under conditions of oxidative stress, could initiate binding of protein to DNA, 
oxidizing the [4Fe4S] cluster from 2+ to 3+, increasing protein affinity for the duplex. As this 
occurs, an electron is transferred through the DNA to a distally bound BER protein. This distant 
protein is then reduced, loses its affinity for DNA, and is free to relocate onto another site. The 
process continues as a scan of the region of DNA between the proteins as long as CT occurs. In the 
presence of a lesion such as a mismatch or oxidized base, however, known to attenuate charge 
transfer, DNA CT does not proceed between bound proteins and thus the proteins remain in the 
vicinity of the damage, and slowly proceed to the site of damage (Figure 1.6). In this model, 
proteins are expected to redistribute onto regions of DNA that contain lesions. Additionally, the rate 
of this process depends on the distance over which CT can occur (hundreds of base pairs) and the 
percentage of oxidized protein (39). Assuming only facilitated diffusion and instantaneous 
interrogation, the amount of time required for a protein that is in low copy number to search for 
damage within the cell is reduced by at least an order of magnitude when it is able to cooperate with 
other proteins (39).  
Summary 
     Significantly, in vivo studies depend on generation of DNA damage by photooxidants to 
elucidate the role of CT within cells. Utilizing metal complexes as photooxidants, the funneling of 
damage to specific regulatory sites in the mitochondrial genome has been identified. Moreover CT 
can occur not just to generate guanine damage but also to activate repair proteins and transcription.  
Here too we have seen DNA-mediated redox chemistry, but now with metalloproteins.  
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Figure 1.6. Model for a DNA-mediated search by repair proteins. Guanine radicals (yellow) can 
initiate binding of redox-active protein to DNA, oxidizing the [4Fe4S] cluster from 2+ to 3+ (dark 
blue), increasing protein affinity for the duplex. An electron travels through the DNA to a distally 
bound BER protein. This distant protein reduced, loses its affinity for DNA (light blue) and 
relocates to another site. In the presence of a lesion such as a mismatch or oxidized base (bottom), 
DNA CT does not occur, and the proteins remain bound and process to the lesion. 
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     Using reactions with simple coordination complexes to guide our questions, our goal now 
shifts to discovery of various endogenous “metal complex” systems in which a metalloprotein 
couples with DNA using DNA-mediated CT to activate signaling across the genome.  
     The search for damage in the genome is not a process limited to BER glycosylases. Proteins 
from a wide variety of organisms such as archaea are being identified as DNA-binding proteins that 
contain [4Fe4S] clusters with no obvious functional role (68, 69). For example, XPD, an archaeal 
protein, is a 5ʹ′-3ʹ′ helicase that is part of the TFIIH machinery required for nucleotide excision repair 
(NER). XPD contains a conserved [4Fe4S] cluster speculated to be conformationally controlled by 
ATP binding and hydrolysis (68, 70, 71). Mutations in the iron-sulfur cluster domain of XPD can 
lead to TFIIH instability, which results in serious diseases such as trichothiodystrophy (71-73). It is 
then interesting to consider whether XPD is yet another protein with a DNA-bound midpoint 
potential and CT signal conducive to assisting other proteins in their search for damage. We have 
demonstrated that the [4Fe4S] cluster in Sulfolobus acidocaldarious (Sa)XPD is redox-active (70), 
exhibiting a midpoint potential identical to that of BER proteins (~ 80 mV vs. NHE).  We have 
developed the methods needed to investigate whether proteins that contain redox-active moieties 
and bind DNA, from distinct repair pathways (primases, polymerases, etc.), are responsive to DNA-
mediated CT (74). It is then possible that there are many more proteins we have yet to uncover that 
participate in the DNA-mediated search for damage in vivo.  
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CHAPTER 2 
Redox Signaling between DNA Repair Proteins for Efficient Lesion Detection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Boal, A. K., Genereux, J. C., Sontz, P. A., Gralnick, J. A., Newman, D. K., Barton, J. 
K. (2009) Proc. Natl. Acad. Sci. 106, 15237-15242  
P.A.S. constructed DNA substrates and performed AFM studies. A.K.B. performed 
electrochemistry experiments, reversion assays, and characterized wild-type and mutant proteins. 
J.C.G. performed the genome scanning calculations.  
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INTRODUCTION 
      Base excision repair (BER) proteins, from bacteria to man, are challenged with combing the 
genome for DNA base lesions to maintain the integrity of our genetic material (1, 2). This challenge 
is remarkable given the low copy number of these proteins and that they must discriminate among 
small differences between modified and natural bases. For MutY, a BER repair protein in E. coli 
with a human homolog, there are < 30 proteins in the E. coli cell (1) to interrogate 4.6 million bases; 
the ratio of binding affinities for the target lesion, an 8-oxoguanine:adenine mismatch, versus well-
matched native base pairs is < 1000 (3). Endonuclease III (EndoIII) recognizes a less prevalent 
lesion, hydroxylated pyrimidines, with equally low specificity; the copy number of EndoIII within 
E. coli is ~ 500 (1). How these glycosylases fix their substrate lesions, once found, has been well 
characterized (1, 2) as are the structures of MutY and EndoIII bound to DNA (4, 5). Yet how these 
lesions are efficiently detected before excision is not established.  
     Location of damaged bases in the genome is likely the rate limiting step in BER within the cell 
and, hence, a critical step in maintaining genomic integrity (6). Current models for genome scanning 
to detect lesions involve protein sliding along the DNA, squeezing the backbone, slipping bases out to 
allow for interrogation, or finding transiently opened sites (7, 8). However, given the low copy 
number of these proteins and their need to sift through the genome to find often subtle base lesions, 
the time required for this search is long.  
     Ubiquitous to a subset of these BER proteins are [4Fe4S] clusters, common redox cofactors in 
proteins (1, 2). Increasingly, iron-sulfur clusters are found associated with varied DNA-binding proteins 
and located far from the enzymatic active site with no apparent function. For BER proteins, [4Fe4S] 
clusters were first thought to play a structural role. When not bound to DNA, these proteins are found in 
the [4Fe4S]
2+
 state and are not easily oxidized or reduced under physiological conditions (9). However, 
for MutY and EndoIII, we have demonstrated using DNA-modified electrodes that DNA binding shifts 
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the 3+/2+ cluster potential into a physiological range, ~ 100 mV vs. NHE for each BER enzyme 
(10, 11); DNA binding stabilizes the protein in the +3 form.  
     Given the sensitivity of DNA-mediated charge transport (CT) to mismatched and damaged 
bases, we have proposed that DNA repair glycosylases containing a redox-active [4Fe4S] cluster 
including EndoIII and MutY, use DNA CT as the first step in substrate detection by signaling one 
another to search cooperatively for damage in the genome (10, 11). DNA-mediated CT can proceed 
over long molecular distances on a short time scale (12). Oxidative damage to DNA has been 
demonstrated with oxidants covalently tethered and spatially separated from damage sites at 
distances of > 200 Å with negligible loss in efficiency (13). Reductive CT has been shown to have 
an equally shallow distance dependence both in electrochemical studies (14) and in assemblies in 
solution (15). Previous studies establish that CT through DNA is possible in biological 
environments that include nucleosomes (16) and cell nuclei (17). DNA CT is, however, extremely 
sensitive to perturbations in the intervening base pair stack, such as DNA mismatches and lesions 
(18, 19). As an example, a single molecule of DNA covalently attached within a nanotube device 
can conduct charge perpendicular to the π-stack similarly to graphite, but the resistance increases 
300-fold with a single base mismatch (20). DNA-mediated electrochemistry has therefore been 
utilized in the development of sensors for mutational analysis (19) and protein binding (21).  
     Given that this chemistry occurs at a distance and is modulated by the structural integrity of the 
base pair stack, these reactions may be useful within the cell for long-range signaling to proteins. In 
that context, we have previously established the long-range oxidation of the DNA-bound BER 
enzymes in spectroscopic studies monitoring oxidation of the [4Fe4S] clusters by guanine radicals 
in the duplex (22). Importantly, we have also shown the injection of an electron into the base pair 
stack from the DNA-bound BER enzymes, with the electron trapped by a well-coupled modified 
base in the duplex (23). Both with respect to hole injection into the DNA-bound proteins and 
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electron injection into the DNA from the DNA-bound proteins, EndoIII and MutY behave 
equivalently, as expected given their similar DNA-bound redox potentials and structures. Here we 
now explore whether DNA-mediated CT may provide a means to facilitate the detection of damage 
in vivo.  
 
Materials and Methods All chemicals were purchased from Sigma Aldrich.  All enzymes were 
purchased from New England Biolabs unless otherwise specified.  All buffers were freshly prepared 
and filtered prior to use.  Mica surfaces were purchased from SPI supplies.  Silicon AFM probes 
were purchased from Nanoscience Instruments.  Oligonucleotides were purchased from IDT or 
synthesized on a 3400 DNA synthesizer (Applied Biosystems).  All strains used were derivatives of 
CC104 or CC102 (24) and generated as described below.  Luria-Bertani (LB) broth was used as the 
rich medium while NCE (25) medium supplemented with MgSO4 (100 µM) and glucose (11 mM) 
or lactose (6 mM) was used as the minimal medium. 
 
Genome scanning calculations The time for sliding to scan the genome is calculated from a one-
dimensional random walk (26).  The one-dimensional diffusion (sliding) constant has been 
measured (27) in vitro for the DNA repair proteins hOGG1 and Bacillus stearothermophilus MutM 
as 5x106 bp2/sec and 3.5x105 bp2/sec, respectively. Taking the more generous (faster) value for the 
diffusion constant, a genome size of 5x106 base pairs, and the MutY copy number of 30 yields a 
scanning time of 46 minutes.  Short hops have been found (26) to have an insubstantial effect on the 
total search time.  This result is consistent with the analysis of Mirny et al. (28). The tight 10-7 Kd of 
MutY for undamaged DNA 30mers corresponds to greater than 99.99% bound protein in vivo, 
inconsistent with facile three-dimensional translocation (29). 
     We can calculate the step time for three-dimensional diffusion of the reduced protein to the DNA as 
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where V is the cell volume, Cp(1-Θ) is the number of reduced repair proteins in the volume 
(Θ = fraction  oxidized), and ka is the bimolecular rate constant for protein association with the 
DNA target within the cellular volume.  The bimolecular rate constant can be determined using a 
modified Smoluchowski equation for protein collision with a rod of DNA within the cell volume, 
where the length of the rod is twice the number of bases, N, over which DNA-mediated CT can 
proceed, since reduced protein can transfer an electron from either side.  Any contact of the reduced 
protein within the DNA rod allows electron transfer to the DNA-bound oxidized protein. We 
assume that DNA is a rod over a region 2N base pairs long, but clearly the organization of the 
bacterial nucleoid is more complex (30). The Smoluchowski equation is constructed with two terms: 
one describes the ballistic 3-dimensional diffusion of the reduced protein to the DNA and the 
second (31) considers the gyrations of a rod with persistence length of 150 base pairs and the ends 
fixed as part of the chromosome. 
 
The protein diffusion constant (Dp) is determined from the Stokes-Einstein equation using the 10 cP 
viscosity of E. coli cytoplasm (32) and the measured Stokes radius of EndoIII (rp)
 (33).  DNA 
diffusion is considered to be negligible.  The persistence length of DNA (150 bp) is defined as a.  
The electrostatic (f) and orientational (κ) constants are taken as unity (34), in keeping with the high 
ionic strength in vivo environment.  The dissociation rate of the protein is not included in our model 
because charge equilibration should occur on a much faster time scale than dissociation of the 
reduced protein.  Note that the reduced protein is not allowed here to exploit facilitated search to 
colocalize with the oxidized protein.  We also make no distinction between 5ʹ′ to 3ʹ′ versus 3ʹ′ to 5ʹ′ 
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transport, although subtle differences have been observed (35).  We can calculate the overall time 
to search the genome of Z bases through the random walk of the electron as 
 
Since there is equal probability of reduced protein associating with each base in the CT-active target 
region, and N represents that maximum distance of interprotein charge transfer, the average distance 
of interprotein CT is N/2. Self-exchange decreases the average step distance by a further factor of 2. 
This represents the scanning time for a single oxidized protein. Each oxidized protein provides a 
separate nucleation site for CT scanning, but draws from the same reservoir of reduced protein to 
scan different portions of the genome, 
 
Scanning through sliding without a CT search represents a boundary condition, so that the total time 
is: 
 
where TD is the diffusion scanning time. 
 
Designing and constructing a labeled 100-mer DNA duplex with a single mismatch 
      Using the Glen Research Cy-3 phosphoramidite to label the 5ʹ′ end of a single strand, standard 
phosphoramidite chemistry was used to make the oligonucleotide, and this was then detritylated.  
The oligonucleotide was HPLC-purified on a semi-preparative C18 column after deprotection. 
      Separately, the Alexa Fluor 555 succinimidyl ester amine-reactive dye from Invitrogen 
(Molecular Probes) was used in a solution-phase coupling procedure.  Synthetic DNA was attached 
at the 3ʹ′ end to a resin and bears a free hydroxyl group at the 5ʹ′ end.  The 5ʹ′-OH was allowed to 
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react with 63 mg (389 µM) carbonyl diimidazole in 1 mL of dioxane for 50 minutes.  A 
methylene linker was attached via the addition of 45 mg (425 µM) diaminohexane in 1 mL of 
dioxane for 25 minutes (36). The amino-modified DNA was removed from the resin by treatment 
with NH4OH at 60°C for 12 hours and HPLC-purified on a semi-preparative C18 column.  The 
amino-modified DNA (427 µM) was dissolved in 0.1 M sodium tetraborate pH 8.9 buffer 
producing a final buffer concentration of 8 mM.  1 mg of the Alexa Fluor 555 dye was dissolved in 
DMSO, and the DNA solution was added in a total reaction volume of 10 µL.  This was stirred at 
37°C for 1 hour and stopped via ethanol precipitation (10% 3 M NaCl, 3x volume EtOH). The 
modified oligonucleotide was HPLC-purified on a semi-preparative C18 column. 
      For tethering, a biotin phosphoramidite was used to label the 5ʹ′ end of a single strand, and 
standard phosphoramidite synthesis was used to make an oligonucleotide.  The strand was 
subsequently HPLC-purified on a semi-preparative C18 column before and after trityl removal and 
deprotection. 
     DNA Stepwise Ligation/Purification: Two previously annealed duplexes (5 µg each) each 
containing a biotin and dye modification as described above were treated with 50 U polynucleotide 
kinase (PNK, New England Biolabs) in 10% T4 ligase buffer (New England Biolabs) in a 20 µl 
total volume and heated at 37°C for 1 hour.  10 U of T4 DNA ligase (Roche) was added to the 
reaction and this was held at 16°C for 4 hours and deactivated at 65°C for 10 minutes upon 
completion.  5 µg of a third duplex was treated with 50 U PNK in 10% ligation buffer for 1 hour at 
37°C, and this was then added to the initial reaction mixture for a total volume of 50 µL after the 
addition of 10 U T4 DNA ligase and 10% T4 DNA ligase buffer.  This was then held at 16°C for 4 
hours, ethanol precipitated, and resuspended in 100 µL 50mM NaCl/ 5 mM PBS buffer (Scheme 
2.1).  The resulting duplexes were then visualized and purified on a 12.5% native acrylamide gel. 
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Scheme 2.1. (Top) Schematic of six single oligonucleotide strands (Top to Bottom: A1, A2, B1, 
B2, M1, and M2) that are then annealed to form three duplexes (A, B, M) with 4 restriction sites 
incorporated (BamHI, HindIII, EcoRI, and SalI) that can then be ligated to form the 100mer (with 
or without the C:A mismatch) shown at the bottom. Stepwise strategy for ligation of three duplexes 
(represented in red with/without mismatch, blue, and green). (Bottom) Two duplexes, one 
containing the fluorescent label, are phosphorylated and ligated followed by deactivation and 
addition of the third (green) phosphorylated duplex.  More T4 DNA ligase is then added and the 
reaction is run for 4 hours at 16°C to form a 100mer with a site-specific mismatch. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A: 5’- GCA TCC TGT ACC GGA CTC GAC GAG GAT CCG CAT CCT GTA C-3’ 
       CGT AGG ACA TGG CCT GAG CTG CTC CTA GGC GTA GGA CAT GCG CTT A-5’ 
 
B:  5’- TCG ACG GCA TCC TGT AGG CCA GTG CAA GCT TGC A-3’ 
             3’-CGT AGG ACA TCC GGT CAC GTT CGA ACG T-5’ 
 
A: BamHI (40)mer 
B: HindIII (28)mer 
 
 
 
M: 5’-GCG AAT GCG AGT ACA GTC ATC GCG AG-3’ 
           3’-CGC TCA TGT CAA TAG CGC TCA GCT GC-5’ 
M: EcoRI  
   SalI 
 
20+12=32mer 
 
32+40+28=100mer 
 
5’-GCA TCC TGT ACC GGA CTC GAC GAG GAT CCG CAT CCT GTA CGC GAA TGC GAG TAC AGT CAT CGC GAG TCG ACG GCA TCC TGT AGG CCA GTG CAA GCT TGC A-3’ 
3’-CGT AGG ACA TGG CCT GAG CTG CTC CTA GGC GTA GGA CAT GCG CTT ACG CTC ATG TCA ATA GCG CTC AGC TGC CGT AGG ACA TCC GGT CAC GTT CGA ACG T-5’ 
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Generation of 3.8 kbp DNA strands with a C:A mismatch for AFM studies 
  Four primers were synthesized with the following sequences,  
5ʹ′-GTACAGAGTTCAGTCGGCATCCGCTTACAGACAAGC-3ʹ′ (forward),  
5ʹ′-CCGGTAACTATCGTCTTGAGTCC-3ʹ′ (reverse),  
5ʹ′-GACTGAACTCTGTACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward), and 
5ʹ′-GACTGAACTCTATACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward).  The underlined bases 
highlight the location of a 2ʹ′-O-methyl residue (37). These primers were used in separate PCR 
reactions using pUC19 as a template to generate two duplexes 1610 bp and 2157 bp (matched), 
each containing one 14 nt single-strand overhang. These PCR products were purified by ethanol 
precipitation and resuspended in 50 mM NaCl, 5 mM sodium phosphate, pH 7 buffer and 
quantitated by OD260.  Duplexes were phosphorylated using 100 U PNK in 10% T4 DNA ligase 
buffer for 1 hour at 37°C and deactivated for 10 minutes at 65°C.  Separate duplexes were annealed 
at 65°C for 8 minutes then cooled to 20°C over 2 hours to form a 3767 bp (mismatched) long 
strand. The resulting larger duplexes were ethanol precipitated and resuspended in 100 µL 50 mM 
NaCl/ 5 mM phosphate buffer.  15 U T4 DNA ligase and 10% T4 ligase buffer were added (total 
reaction volume ~ 150 µL) and incubated overnight at 16°C followed by deactivation for 10 
minutes at 65°C.  We did not bring the ligation reaction to completion, so as to obtain a mixture of 
DNA samples that were equivalent other than the presence of the mismatch at the ligation site.  The 
DNA duplexes (ligated and unligated) were then analyzed by 0.6% agarose gel electrophoresis.  
The strategy for preparation of samples is given in Scheme 2.2.   
 
AFM deposition conditions To optimize deposition, pUC19 plasmid DNA was digested by EcoRI, 
ScaI, (New England Bioloabs) and SalI (Roche) to produce 903 bp and 1750 bp fragments.  5 µL of 
a plasmid DNA (2 µg/mL)/6 mM MgCl2 solution was deposited onto a cleaved mica surface for 1 
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minute and rinsed at a 45 degree angle with 2 mL water.  This was then dried with argon.  For 
redistribution data, mica surfaces were freshly cleaved with scotch tape. EndoIII (0.4 µM) was 
added to the stock DNA solution containing 50-100 ng total DNA composed of the mixture of 
ligated 3.8 kb duplexes and the two unligated duplexes (1.6 and 2.2 kb) in 6 mM MgCl2 /Tris-
EDTA buffer. This protein-DNA solution was incubated at 4°C overnight and deposited (5 µL) on 
the mica surface for 2 minutes, rinsed with 2 mL water, and dried under argon. In order to study the 
effects of protein oxidation, protein-DNA solutions were treated with 1 or 5 mM H2O2, incubated 
for 2 minutes, and deposited onto the mica surface as described.  Two of the five wild-type EndoIII 
samples analyzed were deposited onto the mica surface in 5 ng quantities followed by immediate 
addition of 3.7 µM EndoIII (1 µL volume).  This difference in deposition conditions did not result 
in any significant differences in the trends observed.  Mutant protein (Y82A) was added to a stock 
solution of 50 ng DNA for a final protein concentration of 0.4 µM.  After incubation at 4°C 
overnight, deposition conditions were identical to that for wt EndoIII-DNA samples. For each AFM 
experiment, at least 6 images and > 200 strands were counted using several preparations of 
protein/DNA samples.  
 
AFM instrument setup Silicon AFM Probes purchased from Nanoscience Instruments 
(BudgetSensors), with a spring constant of 3 N/m and a resonance frequency of 75 kHz, were used 
in a Digital Instruments Multimode SPM. Images with scan areas of 2 x 2 µm2 or 1 x 1 µm2 were 
acquired in tapping mode, using an amplitude of 0.54-2.00 V at a scan rate of 3.05 Hz.  Scan rates 
of 3.05 Hz were used to obtain images of higher quality.  Data analysis was performed using the 
WSxM program (38).   
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Scheme 2.2. Two synthesized primers, one incorporating a 2ʹ′-O-methyl ribonucleotide (blue and 
orange, respectively), are utilized to amplify plasmid sequences via PCR.  A nucleotide is 
incorporated within the synthesized primer containing the 2ʹ′-O-methyl ribonucleotide (orange) that 
will result in a mismatched or matched final product.  As the vector is amplified, polymerase stops 
at the ribonucleotide (green), resulting in a large single-strand overhang.  Upon performing two 
separate PCR reactions with two primers each (orange and blue), the resulting duplexes with 14 bp 
single-strand overhangs can be annealed/ligated together in good yield to produce long duplexes 
with or without a mismatch. 
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Strain construction CC104 and CC102 strains were generously donated (24), as was CC104 
mutY- (CC104 muty::mini-tn 10) (39).  Nth was replaced by a chloramphenicol resistance cassette 
(cm) in CC104 and CC104 mutY- using a previously described in-frame deletion method (40).  See 
Table 2.1 for primer sequences; nth homology regions are shown in regular text and cm priming 
regions are highlighted in boldface.  CC102 strains were constructed using P1 transduction (41).  
Inactivation in all strains was verified with colony PCR. 
 
Lac+ reversion assays Strains were streaked to LB medium and incubated overnight at 37°C.  For 
nth knockouts, strains were streaked to LB+chloramphenicol (17 µg/mL), and for mutY knockouts, 
strains were streaked to LB+tetracycline (50 µg/mL).  1 mL LB cultures were started from single 
colonies and grown overnight in a shaking incubator at 37°C, 220 rpm.  20 µL of each starter 
culture was used to inoculate a 10 mL NCE+glucose culture which was then grown to a density of 
109 cells/mL at 37°C, 250 rpm.  Cell density was determined by dilution plating a 10 µL aliquot of 
the NCE+glucose culture onto NCE+glucose solid medium followed by incubation at 37°C for 36 
hours.  5 mLs of this culture was centrifuged in a clinical tabletop centrifuge at 4°C and plated on 
NCE+lactose solid medium and then incubated at 37°C for 36 hours.  Colonies arising are reported 
as lac+ revertants/mL cells plated.  In experiments incorporating plasmid vectors, CC104 and 
CC102 strains were made electrocompetent (41) and transformed via electroporation at 1.8 kV.  
Transformants were selected on LB+ampicillin (amp) (100 µg/mL) solid medium after incubation 
overnight at 37°C.  Single colonies were restreaked to LB+amp (100 µg/mL) solid media and 
incubated 12 hours at 37°C.  1 mL LB+amp (100 µg/mL) cultures were started from these colonies 
and grown overnight at 37°C, 220 rpm.  20 µL of this starter culture was used to inoculate a 10 mL 
NCE+glucose+amp (40 µg/mL) culture which was grown to a density of 109 cells/mL at 37°C, 250 
rpm.  5 mLs of this culture was plated onto NCE+lactose+amp (40 µg/mL) and incubated at 37°C 
for 36 hours.  Lac+ revertants were reported as described above. 
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Table 2.1. Primer Sequences Used for nth Inactivation, Cloning, and Mutagenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Function Primer Sequence
Wanner inactivation 
of nth
5'-gaagcagctgcagaacgtgcattgccaaacggtgaaacagggaatgtctggtgtagg
ctggagctgcttc-3'
5'-agaggataaagaaaggttatcaatggggtaatcggtgttaccccttttctcatatgaatat
cctccttag-3'
Cloning nth into
pBBR1MCS-4
5'-ggaattcgcaatggcacattgtttgac-3'
5'-aggttcctcaatggggtaatcggtgtt-3'
D138A mutant 
generation
5'-cggctggccgactattgctgtcgccacgcacattttccgcg-3' + complement
Y82A mutant 
generation
5'-ggggtgaaaacctatatcaaaactattgggcttgctaacagcaaagc-3' 
+ complement
Table S4.  Primer sequences used for nth inactivation, cloning and mutagenesis.
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Mutagenesis Nth was cloned into pBBR1MCS-4 (p) using standard techniques (42).  Primer  
sequences are given in Table 2.1; restriction sites are highlighted in boldface.  Gene incorporation 
was verified by PCR and sequencing (Laragen) using KS/SK (pBBR1MCS-4 derived vectors) or 
M13 (pNTH10 derived vectors) sequencing primers.  Mutants were generated using a QuikChange 
site-directed mutagenesis kit (Stratagene) and verified by 3 independent sequencing reactions 
(Laragen).  Primers used are shown in Table 2.1; the altered codon site is highlighted in boldface.  
 
Protein expression and purification EndoIII and Y82A EndoIII were expressed from the pNTH10 
expression vector and purified as described previously (43).  Protein concentrations were 
determined using the UV-vis absorbance of the [4Fe4S] cluster (410 nm, ε = 17,000 M-1cm-1) (9).  
 
 Glycosylase assays Oligonucleotides were synthesized containing a 5-OH-dU lesion site (purchased  
as a phosphoramidite from Glen Research), HPLC purified and verified with MALDI-TOF mass 
spectrometry.  The following sequences were used:  
5ʹ′-TGTCAATAGCAAGXGGAGAAGTCAATCGTGAGTCT-3ʹ′ + complementary strand where X 
= 5-OH-dU base-paired with G.  The strand containing the lesion was 5ʹ′-32P endlabelled as 
previously described (42) and annealed to its complement.  Reactions were run at 37°C for 15 
minutes with 10 nM DNA and 100 or 10 nM protein and quenched with 1M NaOH (44).  Samples 
were analyzed by denaturing 20% PAGE and imaged by autoradiography.  Band intensity was 
quantified using ImageQuant software. 
 
Electrochemistry at DNA-modified electrodes  DNA-modified electrodes for protein  
electrochemistry experiments were prepared as described (11) using the following sequences: thiol-
modified strand, 5ʹ′- AGTACAGTCATCGCG-3ʹ′, TA complementary strand, 5ʹ′-
  
40 
CGCGATGACTGTACT-3ʹ′, and abasic site (Ab) complementary strand, 5ʹ′-
CGCGATGACTGTXCT-3ʹ′, where X = dSpacer (Glen Research).  Surfaces were backfilled with 1 
mM mercaptohexanol for 30 minutes and rinsed at least 3 times with protein storage buffer (20 mM 
sodium phosphate, 100 mM NaCl, 0.5 mM EDTA, 20% glycerol, pH 7.5).  Protein solution was 
introduced to the electrode surface and allowed to incubate for ~ 20 minutes until signal reached full 
intensity.  Cyclic voltammetry experiments were performed on a CH Instruments 760 potentiostat 
using a 50 mV/s scan rate, Ag/AgCl reference electrode, and Pt wire auxiliary electrode in an 
electrochemical cell modified for protein experiments (11). 
 
Results and Discussion 
A CT model to detect DNA damage We have proposed that BER proteins bearing [4Fe4S] clusters 
exploit DNA-mediated CT as a fast, sensitive method to detect damage (Figure 2.1). This redox 
signaling model is initiated when one 2+ protein (donor) binds DNA (b, e), promoting electron 
transfer from the donor protein to a distal protein (acceptor) (c, f), already bound in the 3+ state. The 
newly oxidized donor protein remains DNA-bound while the reduced acceptor diffuses away (d, f). 
Integral to this model is a differential DNA affinity for the [4Fe4S]
3+ and [4Fe4S]
2+
 forms of the 
protein. We have demonstrated this differential affinity by measuring a -200 mV potential shift 
associated with DNA binding that corresponds thermodynamically to ≥1000-fold difference in DNA 
affinity between the oxidized and reduced proteins (45).  
     Importantly, the DNA-mediated CT reaction between two repair proteins can be considered a scan 
of the integrity of the intervening DNA, since DNA-mediated CT can only proceed through a well-
stacked duplex. As illustrated in Figure 2.1 (g), when the repair protein, already oxidized, is bound 
near a base lesion, DNA-mediated CT does not provide a pathway for reduction and subsequent 
protein dissociation. The protein instead remains bound to the duplex so that, on a slower time scale, 
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the protein can processively diffuse to the target site; now, however, sliding is needed only across 
a small region and the low target specificity of the protein is sufficient for recognition (3, 46, 47). 
Essentially, then, our proposal for base lesion detection utilizing DNA CT yields a redistribution of 
the BER enzymes onto local regions of the genome that contain lesions. Critical to this mechanism is 
DNA-mediated signaling among proteins bound at long range so that the proteins, despite their low 
abundance, cooperate with one another in localizing onto target sites. 
     To exploit DNA-mediated CT, some proteins must exist in the oxidized state. There are many 
oxidants in the cellular milieu, and the level of oxidative stress will govern the proportion of oxidized 
protein. Indeed, we have shown that these proteins (22) and others (48) can be oxidized by guanine 
radicals, the first genomic signal of oxidative stress (49), via DNA-mediated CT.  A basic model of 
genome scanning involving only facilitated diffusion, without CT, but where interrogation is assumed 
to be instantaneous, yields a genome scanning time of at least 46 minutes for MutY (Methods), 
wholly insufficient given the doubling time in E. coli of 20 minutes (41). This calculated scanning 
time is based upon measured values of protein diffusion constants (7), intracellular protein 
concentration (1), and genome size using a model of one-dimensional diffusion with short localized 
hops (7). Recent calculations of global searches by low copy number proteins suggest a still slower 
search time (28), and the nanomolar dissociation constant excludes three-dimensional mechanisms. 
This estimate significantly understates the problem, moreover, since the actual interrogation time is 
not instantaneous and protein traffic on the DNA necessarily interferes with sliding. 
     In our model, the DNA is essentially scanned by the electron with the repair proteins facilitating 
electron migration. Thus we calculate a genome scanning time for MutY in E. coli that is significantly 
more efficient through DNA CT. Since an injected charge equilibrates on the nanosecond timescale 
(12), and protein diffusion occurs in micro- to milliseconds (7), the rate-limiting step in this process is 
the 3D diffusion of this reduced protein within CT range of the oxidized DNA-bound protein.  
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Figure 2.1. A model for DNA-mediated CT in DNA repair. In this model, DNA repair proteins, 
containing [4Fe4S]2+ clusters, for example, EndoIII (green) and MutY (orange), bind DNA, 
activating them towards oxidation to the [4Fe4S]3+ state. The sequence of events is as follows: 
Guanine radical formation can oxidize a repair protein in a DNA-mediated reaction, stabilizing the 
oxidized protein bound to DNA (a). A second protein binds in the vicinity of the first protein (b, e). 
CT to a distally bound protein can occur through the DNA p-stack if the intervening DNA is 
undamaged (c, f). The newly reduced protein has a diminished affinity for DNA and diffuses away 
(d). If, instead, a lesion site is present between the proteins (g), the DNA-mediated CT step is 
inhibited and the oxidized protein remains bound to DNA. In this search mechanism the sum of the 
DNA-mediated electron transfer steps between proteins constitutes a full search of the genome 
yielding a redistribution of low abundance DNA repair proteins in the vicinity of lesions. 
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  Hence scanning can be modeled as a random walk of the electron (or hole) on the DNA, where 
the step time for the walk is the average time for a reduced protein to approach within 
range to carry out DNA-mediated CT to the oxidized protein. In our calculation, we conservatively 
utilize 3D diffusion of the reduced protein within the cellular volume to approach its target site on the 
DNA. We also use experimental values for protein concentrations (1), genome size, and protein 
binding affinities (2).  
     Importantly, since this model involves cooperation among the repair proteins, we can utilize the 
total concentration of these proteins within the cell, rather than copy numbers for MutY or EndoIII 
individually. Thus MutY, present in < 30 copies, benefits from 500 copies of EndoIII (1). We do, 
however, neglect contributions from any other proteins that might participate in DNA-mediated 
signaling; other DNA-bound proteins containing iron-sulfur clusters exhibit similar potentials and CT 
reactions involving these proteins too would substantially speed the search process. 
     Our model relies on the fact that DNA-mediated interprotein CT is much faster than protein 
diffusion, and that the oxidized repair proteins have higher nonspecific DNA affinity than the reduced 
proteins; both assumptions have experimental support (12, 45). As we did for facilitated diffusion, we 
assume here also that intervening DNA-binding proteins do not inhibit scanning. In fact, one 
advantage of DNA CT over other search mechanisms is that the electron travels through the DNA 
base pairs and no proteins need to be displaced (16).  
     Figure 2.2 shows how the interrogation time varies as a function of N, the maximum distance 
over which DNA-mediated CT proceeds, and ox, the percentage of proteins oxidized. Remarkably, 
permitting DNA CT over 500 bp with 10% oxidized protein yields a conservative interrogation time 
of 5 minutes, while DNA CT over only 200 bp with 20% oxidized protein yields an interrogation 
time of 8 minutes; permitting DNA CT over several hundred bp yields scan times less than a 
minute. These values are well within the 20 minute doubling time of E. coli (Figure 2.3).  
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Figure 2.2. Scanning time as a function of maximum distance of DNA-mediated interprotein CT 
(N) and the fraction of repair proteins that are in the 3+ state (% ox) using the CT scanning model. 
At 10% oxidized protein with a maximum CT distance of 500 bp, the time required to interrogate 
the genome is ~ 5 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Plot showing the contour from Figure 2.2 that corresponds to a genome scanning time 
(T) of 20 minutes, the doubling time of an E. coli cell. 
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     While we have not yet established the distance limits for DNA CT, we have demonstrated 
substantial oxidative damage in tethered DNA assemblies in vitro over 60 bp and in DNA within 
mitochondria over ~ 100 bp (13, 50). The dependence of interrogation time on the percentage of 
proteins oxidized is also noteworthy (Figure 2.2). The scanning efficiency resembles a switch that is 
turned on at low levels of oxidation, when DNA repair is needed. Activation of this switch depends 
upon the redox buffering capacity of the cell and the level of oxidative stress.  
 
An AFM assay to measure protein redistribution onto mismatched DNA While we have earlier 
carried out studies establishing hole and electron injection across the protein/DNA interface (23, 
45), our model also predicts that DNA/protein CT would promote the redistribution of repair 
proteins in the vicinity of base lesions or mismatches. We can assay for this redistribution by AFM. 
There are many challenges associated with making long strands of DNA containing a site-specific 
mismatch, and initially methods were chosen (ligation, PCR modular vectors) such that a variety of 
modifications could easily be made for further experiments.  Strategically, it is important to find a 
consistent way of forming long duplexes. The duplexes that are ligated together must also contain 
single-stranded overhangs long enough to overcome blunt end or non-specific ligation.  In 
preparation for AFM measurements, mismatched DNA has been synthesized and ligated with 
matched duplexes to yield a 100 bp helix with a C:A mismatch, which is not the primary substrate 
for MutY or EndoIII, but does significantly attenuate charge transport. The strand has been 
designed to incorporate at least four restriction sites that could later be used to introduce additional 
lesions (Scheme 2.1).  As Scheme 2.1 shows, six strands of DNA were synthesized: A1, A2, B1, 
B2, M1, and M2 that were then annealed to form a 40mer (A), 28mer (B), and a 32mer (M), where 
M contains the C:A mismatch as well as restriction sites at the overhangs which were then ligated to 
duplexes A and B.  A was constructed with a blunt end as well as a sticky end, and similarly, B was 
constructed the same way.  M incorporates two sticky ends that, upon ligation, yield an A:M:B 
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100mer duplex configuration.  Functionalizing the blunt ends of the strands with modifications 
such as biotin or dyes for use in AFM and other surface experiments. 
     Importantly, a stepwise strategy was developed to produce a higher yield of 100mer by ligating 
two of the duplexes, followed by the addition and ligation of the last one.  Scheme 2.1 shows the 
method employed to construct the 100mer and isolate it in high yield. The final duplex was 
obtained by phosphorylating two of the duplexes and ligating them under previously described 
ligation conditions.  Concurrently, the last duplex was treated with PNK and added to each of the 
reactions that had been used to assemble 60mers. Figure 2.4 shows the 100mer product, formed 
using the stepwise ligation strategy to attach one duplex containing a 5ʹ′ biotin tag, one containing a 
mismatch/match, and the other labeled with Cy-3 to be used for surface experiments. 
      AFM experiments, however, require very long strands of DNA (> 1,000 bp) to accurately 
observe protein distribution. As a control, restricted pUC19 plasmid pieces (1750 and 900 bp) were 
deposited onto a cleaved mica surface (0.01 µg) in deposition buffer and visualized on a 1 x 1µm2 
scale.  Samples were diluted to yield uniform surface coverage. In Figure 2.5, strands are 
identifiable based on length and height. Notably, though some of the longer strands are curled, most 
are linear.  Histograms for the images were made using a WSxM (38) program to quantitate the 
amount of DNA on the surface of different lengths.  900 bp strands are 300 nm long, and the 1750 
bp strands are 578 nm.  
     Following the protocol described in the methods section, a mixture of DNAs, both long (3.8 
kilobase) DNA duplexes containing a single C:A mismatch and short (2.2 and 1.6 kilobases) well-
matched duplexes of the same total sequence were prepared (37) (Figure 2.6); the longer sequence 
was obtained by ligation of the two shorter sequences. This mixture of matched and mismatched 
DNA strands was incubated with EndoIII and examined using established AFM techniques (51) 
(Figure 2.7). Only clearly identifiable long or short strands were counted.  
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Figure 2.4. 12.5% acrylamide gel run at 12W for 1.5 hours showing in Lanes 1−6: mismatched 
100mer (13 µM), matched 100mer (11 µM), three duplexes without ligase (A has biotin tag, B has 
Cy-3 tag, and M with/without mismatch), 5 µg of 10 bp marker, mismatched 60mer made from two 
duplexes, and matched 60mer made from two duplexes.  Bands with Cy-3 appear pink over UV-
light.  Cy-3 absorbs at 546 nm and emits at 563 nm.   
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Figure 2.5. 0.6% agarose gel run at 12W for 1 hour.  Lanes 1, 2: ~ 600 ng total of two duplexes 
amplified post-PCR and ligation to form matched strands ~ 3800 bp.  Lane 3: 5 µg of Marker III 
(Roche), Lanes 4, 5: ~ 600 ng total of two duplexes amplified post-PCR and ligation to form 
mismatched strands 
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Figure 2.6.  (Top left) A 2 x 2 µm2 image using tapping mode AFM on a cleaved mica surface in 
air.  DNA is a mixture of 1750 and 900 bp fragments from the restriction of pUC19 (0.01 µg) in 6 
mM MgCl2, Tris-EDTA deposition buffer. The inset shows a zoomed-in image to differentiate sizes 
of DNA. (Top right) Image of DNA at higher concentration (5 µL of a 2 µg/mL solution of DNA 
plasmid restriction pieces in 5 mM MgCl2). (Bottom) DNA (1 µg/mL) of different lengths on  ~ 3 x 
3 µm2 scale.  Large blotches (white) are salt. The average height of DNA strands is 2 nm. 
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Figure 2.7. Measurements of repair protein distributions on DNA by AFM.  A zoomed-in view 
(top) and a zoomed-out view (bottom) of representative AFM images of DNA strands incubated 
overnight with wild-type EndoIII.  A higher density of proteins is apparent on the longer DNA 
strands containing the single base C:A mismatch.   
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     Protein assignments were verified through analysis of their 4 nm heights in the images; 
without protein, features of this dimension are not observed and still larger heights indicate salt 
precipitates. Although a C:A mismatch effectively inhibits DNA CT (12), it is not a lesion that is 
preferentially bound by EndoIII; a gel shift assay on 21-mers with and without a central C:A 
mismatch shows no detectable difference in EndoIII binding.  Thus without DNA CT between 
bound EndoIII molecules, one might expect an equal density of proteins on the short and long 
strands. 
     We find that EndoIII shows a significant preference for the longer strands containing the C:A 
mismatch (Figure 2.8). Examination of the number of proteins bound to 300 long strands and 465 
short strands reveals a greater density of proteins bound to the long strand; r(long/short) is 1.6. If 
instead we examine the distribution of EndoIII on long versus short strands, where all strands are 
matched, we see a small preference for the short strands; the ratio of protein densities, r(long/short), 
is 0.9. When we calculate the strand preference based on DNA CT, this protein density ratio 
depends upon the DNA CT length and/or the length of the DNA over which protein can diffuse 
before dissociating. Using a signaling/sliding length of 90 base pairs, we calculate a protein density 
ratio of 1.6, that which we find, where half of the protein population is near the mismatch (Figure 
2.9). 
 AFM measurements as a function of oxidation of proteins bound to DNA, using H2O2 as oxidant,  
reveal an additional increase in the ratio of EndoIII bound to mismatch-containing strands (Figure 
2.10). Examination of more than 250 long C:A mismatch-containing strands and 300 shorter 
matched strands incubated with EndoIII and treated with 5 µM peroxide reveals a ratio of bound 
protein densities, r (long/short), of  2.4; when both long and short strands are matched, the ratio is 
0.83.  
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Figure. 2.8. Tapping mode AFM images of DNA and EndoIII protein on mica imaged in air. 
DNA (strands) and protein (dots) are visible on the surface. Images were acquired with a scan size 
of 3 x 3 µm2, at a rate of 3.05 Hz with a data scale of 10 nm.  (Bottom) Zoomed-in images of a 
DNA strand with a bound protein subjected to height profiling to distinguish protein.  The profile of 
the strand, to the right of the zoomed-in image, shows the height of DNA ranges from 1-2 nm, with 
a much higher (> 2 nm) protein peak. 
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Figure 2.9. Quantitation of protein density ratios. A C:A mismatch is contained on the long 
strand except for the sample indicated by matched DNA where both the long and the short strands 
are fully matched. EndoIII redistributes onto the strand with the C:A mismatch. 
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Figure 2.10. Quantitation of protein density ratios.  A C:A mismatch is contained on the long 
strand except for the sample indicated by matched DNA where both the long and the short strands 
are fully matched. EndoIII redistributes onto the strand with the C:A mismatch and that preference 
is increased with increasing concentrations of peroxide.  
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     These results are consistent with our model. DNA-mediated CT will drive the redistribution of 
repair proteins away from undamaged regions such that the proteins will cluster near damaged sites.  
As a result, we see the proteins redistribute preferentially onto the DNA strands containing the 
mismatch even though a C:A mismatch is not a substrate for EndoIII. Moreover, as predicted by the 
model, the redistribution of EndoIII is more pronounced in the presence of oxidative stress. 
 
Cooperation between EndoIII and MutY inside the cell This CT scanning model can also be tested 
in vivo by assaying for the cooperation among repair proteins facilitated by DNA-mediated 
signaling. If these proteins are able to help each other in their search for damage using DNA CT, 
knocking out the gene for EndoIII or reducing its capability to carry out CT should lead to a 
decrease in MutY activity in vivo. Assays for MutY and EndoIII activity inside E. coli cells have 
already been developed (24). The assay for “helper function” used here employs engineered 
mutations in the lacZ gene to report the frequency of a particular base pair substitution. The strain 
that serves as an assay for MutY activity, CC104, substitutes a cytosine for an adenine in the lacZ 
Glu 461 codon, which is essential for β-galactosidase activity. Since MutY prevents GC to TA 
transversions (52), reversion of this original mutation back to wild-type (wt) lacZ reflects a 
deficiency in MutY activity. Analogously, the CC102 strain (24) serves as an assay for EndoIII 
activity by monitoring GC to AT transitions (53, 54).  
     In the CC104 MutY activity reporter strain (Table 2.2), 20 ± 9 lac+ revertants are observed  
per 109 cells, while inactivation of mutY in CC104 (CC104 mutY-) causes the number of lac+ 
revertants to increase 15x (300 ± 33) as expected (24, 52). When the gene encoding EndoIII (nth) is 
inactivated in CC104 (CC104 nth-), the lac+ reversion frequency observed is 54 ± 5, more than a 
factor of two increase over CC104. Thus, loss of EndoIII does have a small but significant effect on 
MutY activity in vivo. This loss in activity is consistent with a loss in helper function by EndoIII, as 
predicted; the lower activity of MutY without EndoIII could reflect the lack of cooperative 
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searching via DNA CT. An alternative explanation, however, is that MutY and EndoIII share 
some overlapping ability to repair lesions. In this case, the lac+ reversion frequency of the CC104 
mutY-/nth- strain (270 ± 29) should be greater than that of CC104 mutY, but they are, within error, 
equivalent.  
     This in vivo relationship between EndoIII and MutY has been observed previously, although in 
different experimental contexts. Small increases in mutational frequency have been detected when 
mutY is inactivated in CC102 (24) (Table 2.3) or when nth is inactivated in CC104 (54). In the latter 
case, it was proposed that this could be due to some intrinsic ability of EndoIII to repair oxidatively 
damaged guanine residues. Reported EndoIII repair activities do not prevent GC to TA transversion 
mutations (55) and, thus, are not relevant to the CC104 assay. 
     We can furthermore test directly whether the loss of MutY activity in the CC104 assay is the 
result of overlapping glycosylase activities by determining whether the number of lac+ revertants is 
still suppressed by an EndoIII mutant that is biochemically incompetent to carry out the glycosylase 
reaction. A mutant of EndoIII (D138A) that is known to be deficient in glycosylase activity (56) 
was introduced on a plasmid into both the CC102 and CC104 strains along with appropriate vector 
controls. Because this mutant cannot perform the base excision reaction, D138A fails to reduce the 
high reversion frequency observed with CC102 nth-. However, D138A is able to complement the 
CC104 nth- strain (Table 2.4).  Thus, the glycosylase activity of EndoIII is not required for its 
helper function to aid MutY in repairing lesions inside the cell.  Nonetheless, it appears that EndoIII 
lacking D138 can bind DNA and contains an intact [4Fe4S] cluster (39).  Based upon our model, 
D138A should be competent to carry out DNA-mediated CT and thus serve as a helper to MutY, as 
we observe.  
 
A mutant defective in DNA/protein CT In our model, it is the ability to carry out DNA-mediated 
CT not the glycosylase activity of EndoIII that is critical to its helper function.  
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Table 2.2. Assay for DNA Repair in E. coli by MutY (CC104).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain     Lac+ Revertantsa,b  Increase   
     (lac+ colonies/ 109 cells) (x/CC104) 
CC104c     20 + 9      --- 
CC104 nth-     54 + 5      2.7 
CC104 mutY-              300 + 33   15 
CC104 mutY-/nth-             270 + 29   13.5    
 
a.  Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 cells 
plated on minimal lactose media. 
b.  These data represent a single set of experiments with 10 replicates per strain assayed 
concurrently.  Values reported as the mean ± s.d. 
c.  CC104 strains reflect the rate of GC to TA transversion mutations and serve as a reporter for 
MutY activity in E. coli. 
  
58 
Table 2.3.  Assay for DNA Repair in E. Coli by EndoIII (CC102) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain     Lac+ Revertantsa,b  Increase   
     (lac+ colonies/ 109 cells) (x/CC102) 
CC102c     14 + 4       --- 
CC102 nth-     34 + 8       2.4 
CC102 mutY-               27 + 9        1.9 
CC102 mutY-/nth-              48 + 16        3.4    
 
a.  Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells plated on minimal lactose media. 
b.  These data represent a single set of experiments with 10 replicates per strain assayed 
concurrently. 
c.  CC102 strains reflect the rate of GC to TA transversion mutations and serve as a 
reporter for MutY activity in E. coli. 
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Table 2.4. (Top) MutY Activity Assay (CC104) with an Enzymatic EndoIII Mutant (D138A). 
(Bottom) EndoIII Activity Assay (CC102) with an Enzymatic EndoIII Mutant (D138A) and a DNA 
CT Mutant (Y82A)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control experiments, including an empty vector p or a vector containing wt nth, pnth, are 
also show .   
 
Strain     Lac+ Revertantsa,b  Increase   
     (lac+ colonies/ 109 cells) (x/CC104/p) 
CC104/pc     33 + 2.0     --- 
CC104 nth-/p     64 + 7.4   1.9 
CC104 nth-/pnth    36 + 3.3   1.1 
CC104 nth-/D138A              32 + 3.2   1.0    
 
a.  Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells plated on minimal lactose media with ampicillin (40 µg/mL). 
b.  These data represent a single set of experiments with 10 replicates per strain assayed 
concurrently. 
c.  CC104 strains reflect the rate of GC to TA transversion mutations and serve as a 
reporter for MutY activity in E. coli. 
 
Strain     Lac+ Revertantsa,b  Increase   
     (lac+ colonies/ 109 cells) (x/CC102/p) 
CC102/pc     10 + 4.2     --- 
CC102 nth-/p     68 + 26   6.8 
CC102 nth-/pnth    18 + 5.4   1.8 
CC102 nth-/D138A              62 + 31   6.2 
CC102 nth-/Y82A    16 + 7.1   1.6 
 
a.  Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells plated on minimal lactose media with ampicillin (40 µg/mL). 
b.  These data represent a single set of experiments with 10 replicates per strain assayed 
concurrently. 
c.  CC102 strains reflect the rate of GC to AT transition mutations and serve as a reporter 
for EndoIII activity in E. coli. 
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     Thus, perturbing the path for electron transfer to the DNA would interfere with this helper 
function. Aromatic tyrosine and tryptophan residues often facilitate long-range electron transfers in 
proteins (57, 58), and EndoIII contains many of these residues. In particular, Y82 is conserved in 
most EndoIII and MutY homologs (44), and an analogous mutation (Y166S) in the human homolog 
of MutY is associated with cancer (59). In the crystal structure, Y82 is located very close to the 
DNA backbone (4). Y82A EndoIII was thus introduced on a plasmid into both reporter strains 
(CC102 and CC104) and their nth knockouts to explore whether this mutation attenuates helper 
function (Table 2.5).  Significantly, Y82A in the CC104 nth- strain shows an increase in mutation 
rate versus the CC104/Y82A and CC104/p controls (Figure 2.11). The number of lac+ revertants is 
found to increase by 53±16% when comparing CC104 nth-/ Y82A to CC104/p. When comparing 
CC104 nth-/Y82A to CC104/Y82A, the number of lac+ revertants increases by 68 ± 13%. 
Similarly, for these trials, the ratio of the number of lac+ revertants for CC104 nth-/ p versus 
CC104/p is 165 ± 13%. These results clearly indicate that Y82A does not restore helper function.  
     It is noteworthy that inclusion of Y82A EndoIII in CC102 nth- leads to a diminished mutation 
rate indicating that this mutant is competent for EndoIII activity inside the cell (Table 2.5). 
Interestingly, the observation that Y82A complements CC102 nth-, but not CC104 nth-, is 
consistent with the conclusion that the glycosylase activity of EndoIII is not a source of helper 
function. Moreover the fact that Y82A complements CC102 nth- is understandable in the context of 
our model, because of the higher copy number of EndoIII in E. coli cells than MutY. In our model, 
without oxidative stress, we would predict that DNA CT is not essential for EndoIII repair activity 
inside the cell. We would therefore anticipate that the role of EndoIII in helping MutY search for 
lesions may be more important than the ability of EndoIII to find its own lesions. This distinction 
becomes more complex when considering that other DNA-binding proteins with iron-sulfur clusters 
might also participate in the signaling process. 
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Figure 2.11. Bar graph showing lac+ revertants for CC104/p, CC104 nth-/p, CC104/Y82A and 
CC104 nth-/Y82A strains, where p denotes inclusion of an empty vector.  Lac+ revertants are 
reported as the average number lac+ colonies that arise per 109 cells plated on minimal lactose 
media containing ampicillin.  Data for the CC104 strains are shown based upon five sets of 
independent experiments, each containing 10 replicates per strain. 
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     To establish the biochemical characteristics of Y82A EndoIII, the protein was purified and its 
redox and glycosylase activities examined. Importantly, the mutant enzyme does contain the 
[4Fe4S] cluster, characterized by its distinctive absorbance spectrum (Figure 2.12). Y82A EndoIII 
also maintains glycosylase activity against a 5-OH-dU lesion in a 32P-5ʹ′-endlabelled 35-mer duplex 
(Figure 2.12); the activity of the mutant in this assay is equal to that of wild-type. Note that this 
experiment on a 35-mer duplex measures only the base excision reaction, not the search process. 
Similarly, in the E. coli EndoIII activity assay, where we expect that the search process is not rate-
limiting, Y82A EndoIII activity is comparable to that of wt EndoIII.  In contrast, D138A EndoIII, 
which instead inhibits the base excision reaction, fails to complement the nth knockout in the 
EndoIII activity reporter strain but does complement the nth knockout in the MutY activity reporter 
strain, where lesion detection is limiting.  
     To test for DNA-bound redox activity, Y82A was examined on a Au electrode modified with 
thiol-terminated DNA duplexes. Significantly, in the cyclic voltammogram, the potential for the 
DNA-bound mutant resembles that of the wild-type (11), but the signal intensity is diminished 
(Figure 2.13). The protein concentrations are determined based on the 410 nm absorbance of the 
[4Fe4S] cluster; the smaller electrochemical signal observed with Y82A does not reflect a lower 
concentration of [4Fe4S] clusters. Over several trials, Y82A EndoIII exhibits a signal that is 50 ± 
13% smaller than that for wt EndoIII (per [4Fe4S] cluster). This signal intensity provides a reliable 
measurement of reduction/oxidation of the DNA-bound protein. Since the glycosylase activity on 
the 35-mer is equal for the mutant and wild-type, this diminished signal cannot reflect diminished 
binding of the mutant to the DNA. Instead this lowered signal intensity would be expected with an 
attenuated efficiency of CT from the cluster to DNA and reflects poor electronic coupling of the 
mutant with the DNA duplex. These results therefore indicate that Y82A EndoIII is defective in 
DNA-mediated signaling.  
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Figure 2.12. Characterization of Y82A protein. (Left) The UV-visible spectrum of Y82A 
EndoIII.  A peak in the visible region is observed at 410 nm characteristic of a [4Fe4S] cluster. 
(Right) Autoradiogram after denaturing PAGE of 32P-5ʹ′-TGTCAATAGCAAGXGGAGAAGT-
CAATCGTGAGTCT-3ʹ′ + complementary strand where X = 5-OH-dU base-paired with G.  Protein 
samples (100 or 10 nM) were incubated with duplexes for 15 min at 37°C and quenched with 1 M 
NaOH. Cleavage of the 32P-labelled strand at the lesion site (X) by EndoIII results in formation of a 
14mer.  No significant difference in glycosylase activity (10% uncertainty) is observed between 
Y82A and wt EndoIII. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
200 300 400 500 600250 350 450 550
0.2
0.4
0.6
0.8
1.0
0
l (nm)
Ab
so
rb
an
ce
 (A
U)
  
64 
Figure 2.13. Cyclic voltammetry of Y82A EndoIII at a Au electrode modified with 
SH(CH2)2CONH(CH2)6NHOCO-5ʹ′-AGTACAGTCATCGCG-3ʹ′ + complementary strand showing 
the reduction and reoxidation of the DNA-bound protein. DNA-modified surfaces were prepared, 
backfilled with mercaptohexanol, and wt or Y82A EndoIII was tested.  Surfaces were then rinsed 
and the other protein analyzed on the same surface. Over several trials, the electrochemical signal 
associated with Y82A is 50 ± 13% smaller per [4Fe4S] cluster compared with wt EndoIII, reflecting 
poor electronic coupling of the mutant to the DNA-modified electrode. 
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     Significantly, and consistent with these results, examination of the distribution of Y82A on 
mismatched and matched strands by AFM shows no preference for the mismatched strand; we 
observe 0.11 proteins per kilobase long strand and 0.13 proteins per kilobase short strand (Figure 
2.14). In fact, the ratio of protein densities on mismatched versus matched strands with Y82A, 
r(long/short) is 0.9, essentially equal to that of wild-type EndoIII bound to fully matched long 
versus short strands (Figure 2.14). Since the Y82A mutant, biochemically defective only in DNA 
CT, cannot redistribute to the vicinity of the lesion, DNA CT must play a role in finding the lesion 
both in the AFM experiment and in the helper function assay. These results together demonstrate a 
distinct connection between DNA-mediated CT to the [4Fe4S] cluster, the detection of DNA 
defects, and the in vivo relationship observed between MutY and EndoIII. 
 
Discussion 
     These experiments indicate that MutY and EndoIII cooperate in their search for damage in the 
genome and redistribute in the vicinity of lesions consistent with CT scanning. This cooperation, or 
helper function, does not involve the glycosylase reaction. Based on their chromosomal 
arrangement, the expression of MutY and EndoIII, furthermore, do not appear to be linked (60). 
There is also no chemical evidence that the proteins physically bind to one another, and their low 
abundance within the cell makes random associations improbable. This cooperation thus arises from 
a distance. Importantly, what does appear to be required for helper function is an intact [4Fe4S] 
cluster as well as an electroactive protein-DNA interface. Mutation of an aromatic amino acid 
residue near the DNA binding site, Y82A, leads to a decrease in CT efficiency in vitro, the inability 
of the protein to redistribute near lesions by AFM, and diminished helper function in vivo. These 
experiments thus establish a link between DNA-mediated CT and the cooperative search for 
damage by these repair proteins both in vitro and in vivo.  
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Figure 2.14. (Top) Comparative densities for WT and Y82A EndoIII bound to matched versus 
mismatched (C:A) strands measured by AFM.  Although wt EndoIII preferentially redistributes onto the 
mismatched strand, (bottom) Y82A shows no preference.  
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      BER glycosylases are known to prevent mutations inside the cell, yet in most organisms, 
these enzymes are not required for normal growth and development (2). Recently it was discovered 
that germline mutations in human BER homologs result in genetic predisposition to cancer (59).  
Specifically, the human homolog of mutY (MUTYH) is found mutated in a subset of patients 
predisposed to colorectal cancer. Many of the cancer-associated mutations in MUTYH are missense, 
or single amino acid, mutations. Though several of the most common mutants have been 
characterized biochemically, it remains unclear exactly how these variants lead to disease. Given 
that initial detection of lesions is likely the rate-limiting step in BER (6), it is possible that that 
mutants with defects in protein-DNA CT would be associated with cancer. Indeed, many of these 
MUTYH missense mutations found in colorectal cancer patients result in loss or gain of aromatic 
residues near predicted protein-DNA interfaces (59). Significantly, MUTYH contains two adjacent 
tyrosine residues (Y165 and Y166) that closely align with Y82 in E. coli EndoIII and inherited 
mutations in these MUTYH residues (Y165C and, less commonly, Y166S) are clinically relevant in 
cancer. These results thus provide tantalizing evidence for association between defects in lesion 
detection via DNA-mediated CT by BER enzymes and human disease. 
     Iron-sulfur clusters are becoming increasingly ubiquitous to proteins that repair, replicate, and 
transcribe DNA (61, 62). Recent characterizations of archaeal DNA primase, RNA polymerase, and 
nucleotide excision repair helicase (XPD) homologs reveal an iron-sulfur cluster required for 
normal enzyme function. Though the precise role of the cluster in these proteins is unclear, the 
cysteine residues ligating the cluster are conserved in eukaryotic homologs of these proteins. In 
archaeal XPD, moreover, the iron-sulfur cluster occupies a site far from the ATP hydrolysis domain 
but implicated in DNA binding (61). It is interesting to consider whether in these proteins, as in 
BER enzymes, the iron-sulfur cluster is poised to send and receive redox signals mediated by the 
DNA helix, which may, in turn, modulate DNA binding affinity, enzyme activity, or protein 
structure. Such long-range signaling among proteins bound to DNA would make searching for 
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lesions much more efficient and may generally provide a means of genome-wide communication 
to monitor cellular stresses.  
     DNA-mediated CT serves as a fast and efficient reaction that is exquisitely sensitive to lesions in 
the base pair stack. This chemistry helps to explain how these repair glycosylases locate their 
lesions efficiently in the cell, a key function since mutations in these enzymes in humans are 
implicated in colorectal cancer (59). This mechanism furthermore provides a rationale for iron-
sulfur clusters in DNA repair proteins. More generally, these experiments illustrate the importance 
of DNA-mediated CT in long-range signaling among proteins in low abundance that are bound to 
DNA. Other roles for DNA-mediated CT in biological signaling must now be considered.  
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CHAPTER 3 
Mutants of the Base Excision Repair Glycosylase, Endonuclease III: DNA Charge 
Transport as a First Step in Lesion Detection 
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INTRODUCTION 
     With millions of DNA bases encountering more than 10,000 oxidative lesions per day (1), DNA 
repair proteins are charged with the daunting task of searching an entire genome to detect and repair 
these multiple sites of damage (2, 3). Our laboratory has proposed that DNA repair proteins search 
for DNA lesions by exploiting DNA/protein charge transport (CT). DNA CT occurs over long 
molecular distances but is remarkably sensitive to DNA lesions (4, 5, 6). Endonuclease III (EndoIII) 
and MutY are base excision repair (BER) proteins in Escherichia coli that contain [4Fe4S] clusters 
which, when bound to DNA, are activated toward one electron oxidation (7,8). EndoIII and MutY 
homologues are found in many species, ranging from bacteria to humans, and their structural 
biology and enzymatic properties have been studied in great detail by both crystallography (9-14) 
and mutagenesis-based enzymology (7, 13, 15-22). Both enzymes are present in low copy number 
in vivo (~ 30 copies per cell of MutY and ~ 500 copies per cell of EndoIII) (3), making their ability 
to find and repair DNA lesions all the more remarkable. MutY has also drawn attention from the 
biomedical community because patients with mutations in its human homologue, MUTYH, are 
predisposed towards developing colorectal cancer (23-27). 
     Despite these extensive studies, two features of the BER family of enzymes remain intriguing to 
consider. First, what is the role of the [4Fe4S] cluster? The [4Fe4S] cluster does not participate in 
base excision in either enzyme, nor is it necessary for MutY to fold properly (7), although it is 
essential for MutY to bind DNA. Secondly, how are these proteins able to scan the vast amount of 
DNA present in a cell in order to detect their substrate lesions? Although the excision step in repair 
by these BER glycosylases has been well characterized, the answer to these questions has not been 
resolved.  
     Our laboratory has proposed a model in which MutY and EndoIII cooperatively scan the genome 
for DNA lesions using their [4Fe4S] clusters to participate in DNA-mediated redox signaling (28-
31). DNA mediates CT very efficiently owing to the π-stacking of the aromatic, heterocyclic base 
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pairs within the helix (5, 32, 33). CT through proteins occurs through a variety of mechanisms 
(34-39). These CT mechanisms could permit charge to travel from the DNA into a bound protein, 
and then through the protein to a redox-active cofactor, such as a [4Fe4S] cluster. In this model, 
under oxidative stress, oxidation of some DNA-bound protein occurs by a nearby guanine radical, 
taking the [4Fe4S] cluster from the 2+ form to 3+. DNA-mediated CT to another distally DNA-
bound protein would lead to its reduction and dissociation. This CT process relies on proper π-
stacking of the bases between the donor protein and the distal acceptor protein, however (28); if the 
π-stack is perturbed by a lesion, DNA-mediated CT will not proceed. Thus this signaling serves as a 
scan for the integrity of the intervening DNA as the first step in damage detection, promoting the 
dissociation of repair proteins away from unmodified DNA and leading to their relocalization in the 
vicinity of damage (Figure 3.1).  
     One question that remains is how charge is transported from the DNA, through the protein, to the 
[4Fe4S] cluster of MutY or EndoIII. Specifically, which amino acids in these proteins facilitate CT 
between the DNA helix and the protein metal cluster? One EndoIII mutant, Y82A, has already been 
shown to be deficient in CT activity, implicating Y82 as a crucial residue in the CT pathway of 
EndoIII (28). The current study builds on this result by characterizing several novel mutants of 
EndoIII to discover other residues that mediate protein/DNA CT. Several categories of mutants 
were prepared, including five additional mutants at or near the Y82 position, to better assess the 
types of amino acid side chains that are CT proficient in EndoIII. Mutations were also made 
targeting other aromatic residues in the protein because aromatic amino acids have been shown to 
mediate CT in other systems (35-39). A third category of mutations were made near the [4Fe4S] 
cluster, assuming that amino acids close to this redox-active moiety would likely lie along the CT 
pathway. All of the mutants were characterized by cyclic voltammetry on DNA-modified 
electrodes, glycosylase assays, and some by circular dichroism (CD) spectroscopy.  
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Figure 3.1. Model for the first step in damage detection by BER proteins. Given two repair 
proteins of similar potential (red and blue), CT can proceed through well-matched unmodified DNA 
(top). Stimulated through oxidation by guanine radicals (yellow) formed under oxidative stress, 
DNA CT occurs between DNA-bound repair proteins, promoting the dissociation of reduced 
protein. DNA CT does not occur (bottom), however, in the presence of an intervening mismatch or 
lesion (red X); repair proteins are not reduced, do not dissociate, and instead remain bound in the 
vicinity of the lesion. On a slower time scale, the proteins can then processively move to the lesion 
site for repair.  This process leads to the redistribution of proteins in the vicinity of the lesion. 
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These experiments helped us identify several amino acids that facilitate CT between the DNA 
helix and the [4Fe4S] cluster.  
    Upon characterization of EndoIII mutants, we then applied them in atomic force microscopy 
(AFM) studies to examine this first step of lesion detection. AFM is a valuable technique that 
allows for visualization of single-molecule protein/DNA interactions (40-42). AFM requires very 
low concentrations of DNA and protein for measurements and relies on cationic interactions for 
DNA/surface contact rather than chemical modifications. AFM images can be used to pinpoint the 
position of proteins on DNA, and hence the statistical distribution of proteins along the strand (43, 
44). Here, then AFM may be used to test our model of protein redistribution on DNA in the vicinity 
of a lesion that interferes with CT. Indeed we find a correlation between the ability of mutants to 
carry out DNA/protein CT and their ability to relocate near a single base mismatch. 
 
Materials and Methods 
Preparation of DNA and protein samples for electrochemistry experiments Redmond Red 
(RR) is a redox active probe used to quantify the amount of DNA on the electrode surface (45). The 
sequences used for electrochemistry experiments were SH-(C6H12)-(RR)-5ʹ′-GA GAT ATA AAG 
CAC GCA-3ʹ′ and complement, and SH-(C6H12)-5ʹ′-AGT ACA GTC ATC GCG-3ʹ′ annealed to 5ʹ′-
CGC GAT GAC TGT ACT-3ʹ′-RR. Redmond Red was connected to the oligonucleotide via a 
pyrrolidinyloxy linker. RR-labeled DNA was prepared according to established methods (4). 
Briefly, all DNA sequences were prepared using standard phosphoramidite chemistry on an Applied 
Biosystems 3400 DNA synthesizer. Phosphoramidites were purchased from Glen Research. For 
thiolated strands, the 5′ end was modified with the Thiol Modifier C6 S-S phosphoramidite using 
standard protocols from Glen Research, Inc. DNA modified with RR on the 3′ terminus was 
prepared on Epoch Redmond Red CPG columns from Glen Research with ultramild 
phosphoramidites and reagents. DNA modified with Redmond Red attached to the thiol was 
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prepared with Epoch Redmond Red phosphoramidite from Glen Research with ultramild 
phosphoramidites and reagents.  
     Deprotection, purification, chemical modification of DNA, annealing, and preparation of the 
DNA-modified Au electrode were performed as described previously (6, 46-48). Au substrates were 
purchased from Agilent Technologies. Each experiment used 50 µL of 50-100 µM EndoIII in 
protein buffer (20 mM NaH2PO4 pH 7.5, 100 mM NaCl, 5% glycerol, 1 mM EDTA). The protein 
concentration was quantified using ε410= 17,000 M-1cm-1 (49). 
 
Cyclic voltammetry All cyclic voltammetry experiments were performed as described previously 
(28-30). A Au on mica (Molecular Imaging) electrode was assembled and incubated with thiol-
modified DNA duplex for 24-36 hours in the absence of Mg2+; under these conditions, the DNA is 
loosely packed on the surface and protein can diffuse through the monolayer. The electrode was 
then backfilled with 1 mM mercaptohexanol, rinsed in DNA buffer (50 mM NaCl, 5 mM NaH2PO4 
pH 7.5), and then rinsed in protein buffer before protein samples were added to the surface. The 
DNA-modified Au electrode served as the working electrode, a Pt wire served as the auxiliary 
electrode, and the reference was either a Ag/AgCl electrode modified with an agarose tip or a 66-
EE009 Ag/AgCl reference electrode (ESA Biosciences). All scans were taken at a rate of 50 mV/s 
on a CH Instruments 760 potentiostat. To begin an experiment, a protein sample was placed on an 
electrode surface and successive scans were taken every five minutes until the signal stabilized. 
Protein concentrations used were those required to saturate binding to the surface as determined by 
titration (29, 30). It should be noted that interfacial electron transfer rates redox moieties bound to 
DNA on these DNA-modified surfaces are limited by tunneling through the alkane-thiol linker 
based on measurements of peak widths as a function of scan rate (4).  
     To determine the relative CT efficiencies of EndoIII mutants, the signal intensity of the proteins 
was normalized to DNA concentration using the intensity of the RR signal and compared one to 
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another on the same surface. For each comparison, the protein samples were measured 
consecutively on the same electrode surface. Thus, to compare the CT signal strength of each 
mutant relative to wt EndoIII, the peak under the reductive and/or oxidative cyclic voltammogram 
curve (consistently for different proteins on a given surface) was measured using the linear baseline 
correction of CH Instruments’ Electrochemical Workstation software program. After each 
measurement of a protein sample, the electrode surface was rinsed, and the measurement was 
repeated for the RR signal. The intensity measured for each mutant was divided by that of the RR 
signal measured on the rinsed electrode immediately following the mutant scan. This ratio was also 
tabulated for wild-type EndoIII on each electrode. The final ratios reported are those of the RR 
corrected mutant value divided by the RR corrected wild-type value. This procedure provides a 
correction for the variability in surface coverage associated with individual DNA-modified surfaces. 
Surface coverages were typically 5 pmole/Å2 but variations of ~ 50% were apparent for different 
electrodes on different days. 
 
Preparation of EndoIII overexpression construct The nth gene that encodes EndoIII was 
cloned using the Failsafe System with Buffer G (Epicentre Biotechnologies) and plasmid 
pBBR1MCS-4 (50), which contains the nth gene as a template. (This construct was originally 
prepared by cloning the nth gene from Escherichia coli chromosomal DNA). Primers used were 5ʹ′- 
CGC CCGCG GTGGT ATG AAT AAA GCA AAA GCG CTG– 3ʹ′ and 5ʹ′- CGC GGATCC TCA 
GAT GTC AAC TTT CTC TTT- 3ʹ′. PCR products were purified on a 1% agarose gel and then 
excised using the QIAquick gel extraction kit (Qiagen). These fragments were ligated into the 
BamHI and SacII sites of the pET11-ubiquitin-His vector, which expresses hexahistidine and 
ubiquitin tags at the N-terminus of the insertion site. This vector was derived from the pET11 vector 
(Novagen), but the ubiquitin gene and hexahistidine tag were engineered into the vector by the 
  
80 
laboratory of S. Mayo, from whom this vector was a kind donation. The ligation reaction was 
used to transform both DH5α E. coli (Invitrogen) for sub-cloning, and BL21star(DE3)pLysS E. coli 
(Invitrogen) for overexpression. Transformants resistant to ampicillin and chloramphenicol were 
selected and the plasmids were isolated using the QIAPrep MiniPrep kit (Qiagen). After the size of 
the insert was verified by restriction digestion, plasmids from positive transformants were submitted 
for sequencing (Laragen). Freezer stocks of transformants containing the correct EndoIII sequence 
were prepared and stored at -80 °C. 
 
Purification of EndoIII and mutants WT EndoIII and Y82A samples used for AFM experiments 
were prepared as described previously (28). Protein samples for other experiments and all other 
mutants were prepared as described here. Freezer stocks of BL21star(DE3)pLysS containing 
pET11-ubiquitin-His with the nth gene were used to inoculate 10 mL of LB media containing 100 
µg/mL ampicillin and 30 µg/mL chloramphenicol. Each 10 mL culture was incubated at 37°C 
overnight and then used to inoculate 1 L of LB/ampicillin/chloramphenicol. Each 1 L flask was 
grown to OD600 = 0.6 at 37°C and then isopropyl β-D-1-thiogalactopyranoside was added to a total 
concentration of 0.3 mM. Cells were incubated at 30°C for 3.5 hours and harvested by 
centrifugation (5000 rpm, 10 minutes). Pellets were stored at -80 °C. For lysis, pellets were 
dissolved in 25 mL lysis buffer (50 mM Tris-HCl, pH 8, 5% glycerol, 250 mM NaCl, 5 mM DTT, 1 
mM phenylmethylsulfonyl fluoride) and lysed by sonication. Cell lysate was fractionated by 
centrifugation (7000 rpm, 10 minutes). The supernatant was filtered, and then loaded onto a 5 mL 
HisTrap HP column (GE Healthcare) pre-equilibrated with binding buffer (20 mM sodium 
phosphate, 0.5 M NaCl, 20 mM imidazole, 1 mM DTT, pH 7.4) at a flow rate of ~ 1 mL/min The 
column was washed with binding buffer until the UV baseline was stable. The fusion protein was 
eluted using a gradient of 0−100% elution buffer (20 mM sodium phosphate, 0.5 M NaCl, 500 mM 
imidazole, 1 mM DTT, pH 7.4) over 10−20 column volumes on an AKTA FPLC (GE Healthcare). 
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Fractions containing protein (determined by their yellow color) were pooled and loaded onto a 
Superose 12 column (GE Healthcare) that had been pre-equilibrated with Superose 12 Buffer (50 
mM NaH2PO4, 0.15 M NaCl, pH 7.0). The tagged EndoIII, His6-ubiquitin- EndoIII, eluted after ~ 
12 mL. Fractions containing EndoIII were pooled and dialyzed overnight into protein storage buffer 
(20 mM sodium phosphate pH 7.5, 0.5 mM EDTA, 100 mM NaCl, 20% glycerol). Aliquots of 50-
70 µL EndoIII were prepared, frozen in dry ice, and stored at -80 °C. Protein purity was assessed by 
SDS-PAGE, and concentration was measured using ε410= 17,000 M-1cm-1 (49). 
 
Site-directed mutagenesis Mutations were encoded on the pET-11 based EndoIII overexpression 
plasmid using the Quikchange Site-Directed Mutagenesis Kit (Stratagene). Primers used are listed 
in Table 3.1, where bold letters indicate the encoded mutation. DNA primers were purchased from 
Integrated DNA Technologies. All mutagenized plasmids were sequenced (Laragen) to verify 
accurate mutagenesis before being used for protein overexpression. 
 
Instrumentation All protein samples were examined using a Beckman DU 7400 
spectrophotometer. Protein concentration was measured using ε410 = 17,000 M-1cm-1 (49). 
 
Circular dichroism Samples were measured at a concentration of ~ 5 µM at ambient temperature 
on a Model 62A DS Circular Dichroism Spectrometer (AVIV, Lakewood, NJ). For thermal 
denaturation experiments, the temperature was varied from 20°C to 60°C. Each trace shown is the 
average of at least three independent experiments. 
 
DNA glycosylase assay This protocol was adapted from methods described previously (15). DNA 
strands synthesized were 5ʹ′- TGT CAA TAG CAA GXG GAG AAG TCA ATC GTG AGT CT-3ʹ′ 
where X = 5-hydroxyuracil, and the complement with G opposite X.  
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Table 3.1. Primer Sequences Used for EndoIII Mutagenesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutant          Primer Sequence 
H140A 5’- ccgactattgctgtcgacacggccattttccgcgtttgtaatcg-3’  
5’- cgattacaaacgcggaaaatggccgtgtcgacagcaatagtcgg-3’  
L81C 5’- gggtgaaaacctatatcaaaacgattgggtgttataacagcaaagc-3’  
5’- gctttgctgttataacacccaatcgttttgatataggttttcaccc- 3’  
Y82S 5’- ggggtgaaaacctatatcaaaacgattgggctttctaacagcaaagc -3’  
5’- gctttgctgttagaaagcccaatcgttttgatataggttttcacccc-3’  
Y82W 5’ - ggggtgaaaacctatatcaaaacgattgggctttggaacagcaaagc-3’  
5’-gctttgctgttccaaagcccaatcgttttgatataggttttcacccc-3’  
W178A 5’-gtcgactgccaccatgcgttgatcctgcacgggcg-3’  
5’- cgcccgtgcaggatcaacgcatggtggcagtcgac-3’  
Y82F 5’-ggtgaaaacctatatcaaaacgattgggctttttaacagcaaagc-3’  
5’-gctttgctgttaaaaagcccaatcgttttgatataggttttcacc-3’  
Y82C 5’-ggtgaaaacctatatcaaaacgattgggctttgtaacagcaaagc-3’  
5’-gctttgctgttacaaagcccaatcgttttgatataggttttcacc-3’  
Y185A 5’-cctgcacgggcgtgctacctgcattgcccgcaagccccgc-3’  
5’-gcggggcttgcgggcaatgcaggtagcacgcccgtgcagg-3’  
F30A 5’- ccgagcttaatttcagttcgcctgctgaattgctgattgccgtactgc-3’  
5’- gcagtacggcaatcagcaattcagcaggcgaactgaaattaagctcgg-3’  
Y55A 5’- gcgacggcgaaactcgccccggtggcgaatacgcctgcagc-3’ 
5’- gctgcaggcgtattcgccaccggccggagtttcgccgtcgc-3’ 
Y75A 5’-gaaggggtgaaaaccgctatcaaaacgattgggctttataacagc-3’  
5’-gctgttataaagcccaatcgttttgatagcggttttcaccccttc-3’  
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DNA was prepared using standard phosphoramidite chemistry with reagents purchased from 
Glen Research. Prior to annealing, single-strand DNA was purified using reversed-phased HPLC 
and the substrate-containing strand was 5ʹ′- radiolabeled using 32P-ATP (51) with polynucleotide 
kinase (Roche). 
     Glycosylase activity was determined by monitoring nick formation in the hydroxyuracil-
containing duplex using denaturing gel electrophoresis (16). For this assay, 100 nM radiolabeled 
duplex was incubated with EndoIII or a variant at a range of concentrations (10 nM, 100 nM or 1 
µM) in reaction buffer (10 mM Tris pH = 7.6, 1 mM EDTA, 50 mM NaCl) for 15 minutes at 37°C. 
The reactions were quenched upon addition of NaOH to a final concentration of 100 nM. Samples 
were dried, counted by scintillation, and diluted with loading buffer (80% formamide, 10 mM 
NaOH, 0.025% xylene cyanol, 0.025% bromophenol blue in Tris-Borate-EDTA buffer) to 
normalize the radioactivity. Samples were then heated at 90 °C for five minutes prior to loading and 
then separated by denaturing PAGE. Glycosylase activity was determined by quantifying the 
amount of 14-mer product visualized in the gel relative to the total amount of DNA present. 
 
Lac+ reversion assays This protocol was adapted from methods described previously (28). Strains 
were streaked to LB medium and incubated overnight at 37°C.  For nth knockouts, strains were 
streaked to LB+chloramphenicol (17 µg/mL). 1 mL LB cultures were started from single colonies 
and grown overnight in a shaking incubator at 37°C, 220 rpm.  20 µL of each starter culture was 
used to inoculate a 10 mL NCE+glucose culture which was then grown to a density of 109 cells/mL 
at 37°C, 250 rpm. 5 mLs of this culture was centrifuged in a clinical tabletop centrifuge at 4°C and 
plated on NCE+lactose solid medium and then incubated at 37°C for 36 hours.  Colonies arising are 
reported as lac+ revertants/mL cells plated.  In experiments incorporating plasmid vectors, CC104 
were made electrocompetent and transformed via electroporation at 1.8 kV.  Transformants were 
selected on LB+ampicillin (amp) (100 µg/mL) solid medium after incubation overnight at 37°C.  
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Single colonies were restreaked to LB+amp (100 µg/mL) solid media and incubated 12 hours at 
37°C.  1 mL LB+amp (100 µg/mL) cultures were started from these colonies and grown overnight 
at 37°C, 220 rpm.  20 µL of this starter culture was used to inoculate a 10 mL NCE+glucose+amp 
(40 µg/mL) culture which was grown to a density of 109 cells/mL at 37°C, 250 rpm.  5 mLs of this 
culture was plated onto NCE+lactose+amp (40 µg/mL) and incubated at 37°C for 36 hours. 
 
Mismatched (C:A) strand synthesis Four primers with the following sequences were 
synthesized using standard phosphoramidite chemistry: 
5ʹ′-GTACAGAGTTCAGTCGGCATCCGCTTACAGACAAGC-3ʹ′ (forward), 
5ʹ′-CCGGTAACTATCGTCTTGAGTCC-3ʹ′ (reverse), 
5ʹ′-GACTGAACTCTGTACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward), 
5ʹ′-GACTGAACTCTATACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward) 
The underlined bases highlight the location of a 2ʹ′-O-methyl residue (Glen Research). Primers were 
phosphorylated using 5 U PNK, 10% PNK buffer, 0.5 mM ATP for 5 hrs at 37 °C. Primers were 
purified using phenol-chloroform extraction followed by ethanol precipitation (52). After being 
dried in vacuo, primers were redissolved in 20 µL water and used in separate PCR reactions (53) 
using pUC19 as a template to generate three duplexes 1610 bp, 2157 bp (matched), or 3767 bp 
(mismatched) long and each containing one 14-nucleotide single-strand overhang. Each 100 µL 
PCR reaction contained 50 pmol of each of two primers, 1X Taq buffer (100 mM Tris-HCl, 15 mM 
MgCl2, 500 mM KCl, pH 8.3, 0.2 mM each dNTP, 1 ng plasmid template pUC19 and 3 U Taq 
polymerase (Roche). A typical step program for PCR was as follows: After incubation at 94°C for 
10 minutes, 34 cycles were performed as follows: 94°C for 1 minute, (52°C for primers 1+2, 54°C 
for primers 2+3 or 2+4), for 1 min, and 72°C for 3 minutes. The PCR product was then suspended 
in 50 mM NaCl/ 5 mM phosphate buffer and quantitated. Separate duplexes were annealed at 65 °C 
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for 8 min in 10 mM Tris buffer, then cooled to 20 °C during 2 h. A total of 15 units of T4 DNA 
ligase (New England Biolabs) and 10% T4 ligase buffer were added (total reaction volume ~ 20 µL) 
and incubated overnight at 16 °C, followed by deactivation for 10 min at 65 °C. We did not bring 
the ligation reaction to completion, so as to obtain a mixture of DNA samples that were equivalent 
other than the presence of the mismatch at the ligation site (Figure 3.2). The DNA duplexes (ligated 
and unligated) were then analyzed by 0.6% agarose gel electrophoresis. 
 
AFM experiments The protocol used was similar to that reported previously (28). Briefly, mica 
surfaces were freshly cleaved with tape. EndoIII (0.4 µM) (28), stored in 20 mM phosphate, 20 mM 
NaCl, 20% glycerol, 1 mM EDTA was added to the stock DNA solution containing 50–100 ng of 
total DNA composed of the mixture of ligated 3.8 kbp duplexes and the two unligated duplexes (1.6 
and 2.2 kb) in 6 mM MgCl2/Tris-EDTA buffer. This protein/DNA solution was incubated at 4 °C 
overnight and deposited (5–10 µL) on the mica surface for 1–2 min, rinsed with 2 mL of water, and 
dried under argon. Two of the five wt EndoIII samples analyzed were deposited onto the mica 
surface in 5 ng quantities, followed by immediate addition of 3.7 µM EndoIII (1 µL volume). This 
difference in deposition conditions did not result in any significant differences in the trends 
observed. Mutant protein (Y82A) was added to a stock solution of 50 ng DNA for a final protein 
concentration of 0.4 µM. After incubation at 4 °C overnight, deposition conditions were identical to 
that for wt EndoIII-DNA samples.  
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Figure 3.2. Synthesis of DNA with site-specific C:A mismatch. Two synthesized phosphorylated 
primers, one incorporating a 2ʹ′-O-methyl ribonucleotide (black and gray, respectively), are utilized 
to amplify plasmid sequences via PCR. A nucleotide is incorporated within the synthesized primer 
containing the 2ʹ′-O-methyl ribonucleotide (green) that will result in a mismatched or matched final 
product. As the vector is amplified, polymerase stops at the ribonucleotide, resulting in a large 
single-strand overhang. Upon performing two separate PCR reactions (red and blue) with two 
primers each, the resulting duplexes (2.2 or 1.6 kbp) with 14 base single-strand overhangs can be 
annealed/ligated together in good yield to produce long duplexes with or without a mismatch. 
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For Y82F EndoIII, W178A EndoIII, or Y75A EndoIII mutants (0.6 µM), stored in 20 mM 
sodium phosphate, pH 7.5, 100 mM NaCl, 20% glycerol, and 0.5 mM EDTA, protein/DNA 
complexes were formed with DNA solution containing ~ 200 ng of the mixture of ligated PCR 
product as well as the two non-ligated duplexes with overhangs (~ 6 µM DNA) in 6 mM 
MgCl2/Tris-EDTA buffer at 4°C overnight. The reaction mixture was then deposited (5–10 µL) on 
the mica surface for 1–2 minutes, rinsed with 2 mL water and dried under argon. 
 
AFM instrumentation Silicon AFM Probes purchased from Nanoscience Instruments 
(BudgetSensors), with a spring constant of 3 N/m and a resonance frequency of 75 kHz, were used 
in a Digital Instruments Multimode SPM. Images were captured in air with scan areas of 2 x 2 µm2 
or 3 x 3 µm2 in tapping mode, at an amplitude of 0.54-2.00 V, and at a scan rate of 3.05 Hz. Scan 
rates of 3.05 Hz were used in order to obtain images of higher quality. 
 
Binding density ratio calculations WSxM software was used to measure general DNA 
contour lengths and height profiles of the proteins as described previously (28, 54). For each data 
set, images from at least three independent samples were analyzed, compared, and pooled (> 200 
long or short strands). Distinguishable strands and proteins were counted by hand. The binding 
density ratio, r, is defined as the ratio of the proteins bound on long strands divided by proteins 
bound on short strands. The ratio is normalized for length by dividing by 1.9 kbp, which is the 
average length of the short strands. The uncertainty was determined through the total number of 
proteins observed. 
 
Gel shift assays of EndoIII and C:A DNA strands In order to examine whether EndoIII 
preferentially binds to duplex DNA containing a C:A mismatch, strands of DNA were synthesized 
to anneal forming matched and mismatched duplexes.  The sequences were chosen to examine 
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nonspecific binding of Endo to shorter duplexes (21 mer) (Figure 3.3). Strands were ordered 
from IDT and purified via HPLC DMT off methods.  Maldi-TOF was performed and strands 
yielded the correct masses within 9 mass units. Upon quantitating strands with UV-Vis. 400 pmol 
of strands were 5ʹ′ labeled with 32P according to standard labeling procedures, and excess ATP was 
removed (51).  Titration was used to quantitate the amount of labeled hot strand by titrating cold 
strand (0–128 nM) to constant (100 nM) hot strand.  Samples were annealed in NaCl/PBS buffer for 
1 hour using a standard program on the thermocycler.  Scintillation counting was performed to 
ensure an equal amount of radioactivity was used for each sample. Cold and hot strands were 
annealed on the thermocycler to yield 40 nM stock duplexes.  116 µM wt EndoIII  stock was placed 
on ice and diluted.  Sample volumes were 20 µL in protein storage buffer with 3 nM duplex.  
EndoIII concentration ranged from 0 nM-1 µM with 3 nM matched or mismatched duplexes. Upon 
addition of protein to the DNA samples for 25 minutes, scintillation counting was performed. 
Mismatched samples were loaded into the gel 5 minutes prior to matched samples  (10% TBE), run 
for 1.5 hours at 50 V, blotted one hour, and exposed overnight. Utilizing ImageQuant, where: 
DNA=1, Protein binding area=2, Total lane area=3, ratios 1/3 and 2/3 were used to determine 
percentage of protein bound.  2/3 divided by 2/3+1/3 where 2/3 has been corrected for 0 binding x 
100 yields percent bound.  Kd values were determined using Origin nonlinear curve fit, 
pharmacology function, one site bind basic fit for 10 iterations where y=Bx/k+x where k=Kd 
(Figure 3.3).   
 
Results  
Electrochemistry on DNA-modified electrodes The CT capabilities of several mutants of EndoIII 
were investigated on DNA-modified electrode surfaces passivated with mercaptohexanol (Figure 3.4). 
This strategy has been used previously to measure the DNA-bound electrochemical properties of 
proteins containing [4Fe4S] clusters (28, 30).  
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Figure 3.3. Gel shift assay of EndoIII with 3 nM matched (left) and C:A mismatched (right) 
DNA duplex.  EndoIII is added to the DNA and incubated for 25 minutes.  10% TBE gel run 2 
hours at 50 V.  EndoIII concentration is increasing from 0–100 nM.  Nonspecific binding occurs 
around 100 nM for both. EndoIII/matched Kd: 105 nM and EndoIII/mismatched Kd: 183 nM 
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In this study, the thiolated DNA duplex was also modified with Redmond Red, a redox probe 
whose signal intensity can be used to measure the amount of DNA on a given electrode surface (45). 
The Redmond Red was positioned so that it could contact the Au surface and be directly reduced 
without requiring DNA-mediated reaction.  
     For each EndoIII sample, the electrochemical signal grew in over 30-45 minutes. Scan rate 
dependence measurements on the protein signal showed a linear relationship between the peak current 
and the square root of scan rate, indicative of a diffusion-limited process (55). These same 
experiments showed a linear relationship between the peak current of Redmond Red and scan rate, 
indicative of a surface-bound species. Thus, while the modified DNA is surface bound, the protein 
freely diffuses to the DNA. Figures 3.4B and 3.4C show typical cyclic voltammograms of two 
separate surfaces, with two peaks evident, one from the [4Fe4S] cluster of the DNA-bound protein 
and one from the Redmond Red probe. When compared on these surfaces, all mutants exhibited 
midpoint potentials of 80 (±30) mV vs. NHE, and all were within error of that of WT (Table 3.2). 
While the DNA-bound potential for these mutants was seen to be invariant, significant variations in 
redox signal intensity were observed (Table 3.2 and Figure 3.4D). The signal strength of each mutant 
was quantified and normalized to the amount of DNA covalently bound on the electrode. To compare 
the signal strength of each mutant relative to that of WT, these signals were then normalized to the 
Redmond Red-corrected signal strength of wt EndoIII measured on the same surface. This 
normalization accounts for the variability in surface coverage associated with different electrodes. 
     Among the first samples to be examined were mutants relevant to colorectal cancer research, 
those at positions L81 and Y82. Y82F and Y82W exhibit signal strengths within error of that of WT, 
suggesting that other aromatic residues at position 82 confer CT capabilities equivalent to those of the 
native tyrosine. By contrast, Y82S exhibits a very weak electrochemical signal relative to WT (Figure 
3.4B, 3.4D).  
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Figure 3.4. Quantitative cyclic voltammetry of EndoIII variants on DNA-modified electrodes.  
(A) Schematic of DNA-modified electrochemistry.  A Au surface is treated with thiol-modified 
DNA and then backfilled with mercaptohexanol.  The covalent Redmond Red redox probe, (red 
oval), is used to quantify the amount of DNA on the surface.  Each protein mutant was allowed to 
bind DNA on such a surface, and the [4Fe4S] cluster was measured by cyclic voltammetry.  The 
protein was then rinsed from surface and WT was measured on the same surface.  (B) 
Representative cyclic voltammogram of Y82S (brown) compared to wt EndoIII (blue).  Y82S 
exhibits a weaker electrochemical signal.  For reference, a scan taken in the absence of protein 
(buffer only) is also shown (gray).  (C) Representative cyclic voltammogram of W178A (orange) 
compared to wt EndoIII (blue) and a buffer-only scan (gray).  (D) The CT capability of each mutant 
was quantified based on the area under its redox peak.  Each mutant’s signal intensity was 
normalized to the intensity of the signal for WT measured on the same surface.  
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Table 3.2. DNA Electrochemistry of EndoIII Mutants. a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Experimental conditions are described in materials and methods.  Each experiment used 50 µL of 
50-100 µM EndoIII in protein buffer (20 mM NaH2PO4 pH 7.5, 100 mM NaCl, 5% glycerol, 1 mM 
EDTA). 
 
b) Measurements have an uncertainty of ± 30 mV. 
 
c) This sample was not measured using Redmond Red-modified DNA, although extra trials were 
performed to verify the midpoint potential and signal strength ratio that are shown. 
 
 
 
 
 
 
 
 
 
 
 
Table 1: DNA Electrochemistry of EndoIII Mutants a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Experimental conditions are described in materials and methods.  Each experiment used 50 µL of 50-
100 µM EndoIII in protein buffer (20 mM NaH2PO4 pH 7.5, 100 mM NaCl, 5% glycerol, 1 mM EDTA). 
b Measurements have an uncertainty of ± 30 mV 
c This sampl  was not measured using Redmond Red-modified DNA, although extra trials were 
performed to verify the midpoint potential and signal strength ratio that are shown. 
EndoIII 
 
Midpoint potential 
(mV vs. NHE)b 
Mutant / WT Ratio 
(RR corrected) 
WT 78  
F30A 97 0.88 ± 0.03 
Y55A 97 0.7 ± 0.1 
Y75A 88 0.6 ± 0.2 
L81C 84 1.1 ± 0.2 
Y82C 92 0.8 ± 0.6 
Y82F 91 1.2 ± 0.4 
Y82S 91 0.4 ± 0.2 
Y82W 92 1.4 ± 0.4 
H140Ac 71 1.0 ± 0.2 
W178A 83 3.5 ± 2.3 
Y185A 85 2.2 ± 1.2 
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The signal intensity from Y82C is on average the same as that of WT, although highly variable, 
possibly due to the ability of cysteine to facilitate electron transfer in certain contexts (34, 56, 57), 
albeit through the formation of an unstable radical. 
     After the experiments with Y82 mutants established the importance of aromatic residues for 
DNA/protein CT, other aromatic amino acids in EndoIII were targeted for mutagenesis studies. F30A, 
Y55A, Y75A, and H140A were examined. The first three of these mutants all displayed a CT 
deficiency relative to wt EndoIII (Figure 3.4D).  In the protein structure, Y75, Y55, and F30 are 
relatively close to Y82, and form a line along one side of the protein (10, 12, 14). These residues may 
comprise a pathway of aromatic amino acids through which electrons can travel efficiently. Such 
aromatic “π-ways” have been found in other peptides (38, 39). The H140A mutant, by contrast, 
proved CT-proficient in the experiments performed here so no conclusions can be made about its 
electrochemical properties. However, this residue was found to be enzymatically important (Table 
3.3). 
     The final category of EndoIII mutants examined were W178A and Y185A, substitutions involving 
aromatic residues close to the [4Fe4S] cluster. These mutants were expected to produce weak 
electrochemical signals because of their proximity to the metallocluster, but they instead produced 
signals that were large and highly variable relative to WT (Figure 3.4C, 3.4D). One explanation for 
this phenomenon is protein aggregation, as denatured samples can produce large and erratic signals on 
DNA-modified electrodes (data not shown). However, because the midpoint potentials of these 
mutants are within error of those produced by other EndoIII samples, it is unlikely that the [4Fe4S] 
cluster degraded in W178A and Y185A, given that [3Fe4S] clusters have different potentials (58-60) 
than the [4Fe4S] cluster. These results with W178A and Y185A prompted further experiments, 
described below, that suggest these residues may help protect the [4Fe4S] cluster from exposure to 
solvent. 
 
  
94 
Table 3.3. Summary of Glycosylase Assay Results with EndoIII Mutants.a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Experimental conditions are described in materials and methods.  Experiments were conducted 
using 1 µM protein and 100 nM annealed duplex in reaction buffer (10 mM Tris pH = 7.6, 1 mM 
EDTA, 50 mM NaCl) for 15 minutes at 37°C.  The reactions were quenched upon addition of 
NaOH to a final concentration of 100 nM.  Samples were dried, counted by scintillation, and diluted 
with loading buffer (80% formamide, 10 mM NaOH, 0.025% xylene cyanol, 0.025% bromophenol 
blue in Tris-Borate-EDTA buffer) to normalize the radioactivity.  Samples were then heated at 90°C 
for five minutes prior to loading and then separated by denaturing PAGE Glycosylase activity was 
determined by comparing the amount of 14-mer produced to the total amount of DNA.  The 
glycosylase activity of each mutant as a percentage of WT is shown.  Most mutants have activity 
within error of that of WT. 
 
 
 
 
 
 
 
 
Glycosylase Assay Results with EndoIII Mut ntsa 
 
 
 
 
 
 
 
 
 
 
 
 
 
EndoIII % Activity relative to WT at 1 µM concentration 
F30A 93.7 ± 2.6 
Y55A 96.7 ± 1.0 
Y75A 99.8 ± 4.0 
L81C 99.2 ± 0.6 
Y82C 99.2 ± 0.5 
Y82F 99.4 ± 1.1 
Y82S 99.4 ± 1.6 
Y82W 98.1 ± 3.6 
H140A 39.1 ± 6.8 
W178A 98.2 ± 1.7 
Y185A 97.3 ± 0.6 
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Enzymatic assays of mutant glycosylase activity The glycosylase activity of each mutant was 
measured according to established methods (15, 28). Briefly, 35-mer strands of DNA were 
synthesized with 5-hydroxyuracil (5-OH-dU), an EndoIII substrate analogue, incorporated into the 
sequence. The sequence was 5ʹ′-radiolabeled with 32P-ATP and annealed to its complement. 
Solutions of 100 nM DNA were incubated with 1 µM enzyme. Active enzymes will remove 5-OH-
dU from the DNA backbone, leaving an abasic site whose phosphodiester bonds are cleaved with 1 
M NaOH.  This cleavage produces a 14-mer strand, which can be visualized by denaturing PAGE 
and autoradiography (Figure 3.5). The amount of 14-mer relative to the total quantity of DNA was 
used to assess enzymatic activity. Mutants that are glycolytically active bind DNA comparably to 
WT, while mutants that bind DNA poorly show diminished glycolytic activity (15-17). 
Consequently, this experiment is an important complement to the electrochemical studies, as it 
verifies that any weak cyclic voltammetry signals produced by mutants stem from a CT deficiency 
and not an inability to bind DNA.  
     Of the eleven mutants examined, most were found to exhibit glycosylase activity within error of 
that of wt EndoIII (Table 3.3). The exceptions were F30A and H140A. F30A was slightly impaired 
in its glycolytic activity, possibly because F30 is located near the substrate binding pocket of 
EndoIII (10, 12, 14), so mutations at this position may impede DNA binding. H140A is deficient in 
glycosylase activity relative to WT. In earlier crystallographic studies, the H140 residue was 
identified as possibly increasing DNA binding by providing a positively charged histidine (12). The 
enzymatic activity results presented here are consistent with that hypothesis. 
 
Circular dichroism to examine the structural stability of EndoIII mutants While most of the 
mutants examined gave electrochemical signals with intensities weaker than or within error of those 
of wt EndoIII, the mutants W178A and Y185A were exceptions to this trend.  
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Figure 3.5. Glycosylase assay results of EndoIII variants.  For this assay, 1 µM, 100 nM, or 10 
nM protein sample was incubated with 100 nM of 5ʹ′-radiolabeled 35-mer duplex DNA containing 
5-hydroxy-uracil.  Reactions were incubated for 15 minutes at 37°C and quenched with 1 M NaOH.  
Reactions were then examined by denaturing gel electrophoresis.  Cleavage of the DNA results in a 
14-mer.  The representative gel below shows the results of wt EndoIII (blue) compared to Y75A 
(purple) and Y185A (black).  Enzyme-free control reactions were loaded into the final two lanes.  
The reactions with 1 µM protein were used to compare the glycosylase activities of EndoIII variants 
(Table 3.3). 
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Consequently, CD experiments were performed to examine the secondary structure of W178A 
and Y185A. The CD spectra of wt EndoIII and several mutants were examined for both fully folded 
and thermally denatured protein (Figure 3.6). All folded samples exhibited similar spectral shapes.  
     In order to examine the stability of W178A and Y185A relative to wt EndoIII, thermal 
denaturation experiments were performed. In these experiments, the protein sample was heated 
gradually and its ellipticity was measured as a function of temperature. The ellipticity of all variants 
measured decreased with increasing temperature, but W178A and Y185A denatured at a lower 
temperature than wt EndoIII and a CT proficient mutant, Y82F (Figure 3.6). These data indicate 
that W178A and Y185A are less stable than wt EndoIII. 
 
Cooperation between MutY and EndoIII Variants inside the cell  This CT scanning model can 
also be tested in vivo by assaying for the cooperation among repair proteins facilitated by DNA-
mediated signaling. If these proteins are able to help each other in their search for damage using 
DNA CT, variants of EndoIII with decreased or increased capability to carry out CT will alter 
MutY activity in vivo. Assays for MutY (CC104) and EndoIII activity inside E. coli cells have 
already been developed (28). The assay for “helper function” used is described in reference 28.  
     EndoIII variants W178A, Y82F, and Y82S EndoIII were introduced into the reporter strain 
CC104 nth via independent plasmids to explore whether these mutations attenuate or enhance 
helper function (Table 3.4).  Significantly, W178A, a CT-proficient mutant, in the CC104 nth- 
strain shows a decrease in mutation rate versus the CC104 nth-/p controls (Figure 3.7). The number 
of lac+ revertants with W178A decreases to a count within error of CC104 nth-/pnth 
measurements, indicating that W178A is able to help MutY repair damage in the assay.  
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Figure 3.6. Circular dichroism of EndoIII.  (A) Comparison of fully folded and denatured spectra 
of EndoIII.  Samples were measured at room temperature at a concentration of ~ 5 µM.  WT spectra 
are shown, although all mutants displayed a similar trend with denatured samples (gray) 
consistently displaying less ellipticity than fully folded samples (blue).  The spectra shown are the 
average of three trials.  (B) Circular dichroism thermal denaturation of select EndoIII variants.  
Samples were measured at concentrations of ~ 5 µM.  Each trace shown is the average of at least 
three independent experiments.  The graphs show the fractional change in ellipticity for each variant 
measured, where the fully folded protein was given a value of 0 and the denatured form was given a 
value of 1, consistent with previous secondary structure studies (7). The variants WT (dark blue) 
and Y82F (pale blue) display more structural stability than W178A (orange) and Y185A (black).   
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Alternatively, when comparing CC104 nth-/p to CC104 nth-/Y82F and CC104 nth-/Y82S, the 
number of lac+ revertants increases by a ratio of 1.5 for both mutants. These results clearly indicate 
that Y82F and Y82S are unable to restore helper function.  It is noteworthy that inclusion of Y82F 
and Y82S EndoIII in CC104 nth- strains may not couple to the DNA as well as other mutants, 
including Y82W, which will be examined in this assay in future studies. 
 
Experimental strategy using AFM to probe protein redistribution We tested our model for protein 
redistribution stimulated by DNA CT by preparing DNA strands containing a single base mismatch, 
a modification that inhibits CT, and DNA strands containing no mismatches. Our model would 
predict the redistribution of proteins onto the mismatched strands. To distinguish the strands by 
AFM, we made mismatched strands > 1000 base pairs longer than the matched strands. We 
employed AFM to obtain a snapshot of repair proteins bound to DNA as they search for damage 
(Figure 3.8). 
     Long (3.8 kilobase) DNA duplexes containing a site-specific C:A mismatch and short (2.2 and 
1.6 kilobases) well-matched duplexes of the same total sequence were therefore constructed. To 
prepare these DNA samples, pUC19 plasmid was amplified with primers incorporating a 2ʹ′-O-
methyl residue to yield two short duplexes containing 14-nucleotide single-strand overhangs. Upon 
ligation of these two duplexes, 3.8 kbp strands contain only one C:A mismatch in the middle of the 
strand (Figure 3.2). The ligation reaction was not taken to completion so as to have a mixture of 
well-matched short and mismatched long strands for protein distribution studies. 
     Although a C:A mismatch effectively inhibits DNA CT (61), it is not a lesion that is 
preferentially bound by EndoIII. Gel shift assays on 21-mers with and without a central C:A 
mismatch show no detectable differences in EndoIII binding (Figure 3.3). Therefore, any 
differences in protein distribution can be attributed to nonspecific association. 
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Table 3.4. MutY Activity Assay (CC104) with EndoIII Mutants W178A, Y82F, and Y82S. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 cells plated 
on minimal lactose media. 
 
b) These data represent a triplicate set of experiments (p, pnth, Y82F), a duplicate set (W178A), and 
a single set of experiments (Y82S) with 10–12 replicates per strain assayed concurrently. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Lac+ Revertantsa,b Increase
CC104 nth-/p 4 ± 0.4
CC104 nth-/pnth 2.9 ± 0.2 0.7
CC104 nth-/W178A 3.4 ± 0.6 0.9
CC104 nth-/Y82F 5.9 ± 0.7 1.5
CC104 nth-/Y82S 6.2 ± 2.1 1.5
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Figure 3.7. Bar graph showing lac+ revertants for CC104 nth-/p, CC104 nth-/pnth, CC104 nth-
/W178A, CC104 nth-/Y82F, and CC104 nth-/Y82S strains, where p denotes inclusion of an empty 
vector.  Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 cells 
plated on minimal lactose media containing ampicillin.  Data for the CC104 strains are shown based 
upon three sets (p, pnth, Y82F), two sets (W178A), and one set (Y82S) of independent experiments, 
each containing 10–12 replicates per strain. 
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     We determined the proper biochemical conditions for protein/DNA deposition by varying 
the volume of reaction mixture deposited onto the mica surface (5–10 µL) and the concentration of 
Mg2+ cation in the adsorption buffer (5–10 mM MgCl2). To insure that proteins were not attracted to 
the mica surface, DNA/protein complexes were formed in solution one day prior to deposition. 
Some unbound proteins were observed on the mica surface although the concentration of DNA (6 
µM bp) was much higher than that of the protein (0.4–0.6 µM) so as to reach binding saturation. 
Protein assignments were verified through analysis of their 3–5 nm heights in the images. In 
samples prepared without protein, features of this dimension were not observed, although some 
larger heights (> 7 nm) were noted and attributed to salt precipitates. Only clearly identifiable long 
or short strands and bound proteins were counted.  
 
 
Atomic force microscopy of EndoIII mutants AFM images of DNA-bound protein complexes 
are represented in Figure 3.8. As observed, protein bound to DNA (Figure 3.8A/B) can be easily 
distinguished based on strand height profiles of tapping mode images (Figure 3.8C). Images of 
DNA with/without (Figure 3.8D) protein were acquired with a scan size of 2 x 2 µm2 or 3 x 3 µm2 
at a scan rate of 3.05 Hz. Since biomolecule surface density varied between samples, > 200 long 
and short strands were counted in at least three independent trials. Error was calculated based on the 
total number of proteins counted. Previously, we found that wt EndoIII showed a significant 
preference for the longer strands containing a C:A mismatch (28). The ratio of protein binding 
densities, r, for (long/short) was 1.6 with 5.6% error (total proteins counted=318). If instead we 
examined the distribution of EndoIII on long versus short strands, where all strands were matched, 
we saw a small preference for the short strands; with r (long/short)=0.9. Based on the DNA CT 
length and/or the length of the DNA over which proteins can diffuse, we would expect a ratio of 1 if 
there were an equal distribution of proteins on matched and mismatched strands.  
 
  
103 
Figure 3.8. Atomic force microscopy to visualize protein. Tapping mode AFM images of DNA 
and EndoIII protein on mica imaged in air. The mixture of mismatched and matched strands (A) or 
fully matched long and short strands (B) and protein (dots) are visible on the surface. Images were 
acquired with a scan size of 2 x 2 µm2 or 3 x 3 µm2, at a rate of 3.05 Hz with a data scale of 10 nm/ 
0.5 V. In C is shown a zoomed-in image of a DNA strand with a bound protein subjected to height 
profiling to distinguish protein; the profile of the strand, to the right of the zoomed-in image, shows 
the height of DNA ranges from 1–2 nm, with a much higher protein peak. In D is an AFM image 
taken of the DNA in the absence of protein. 
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     Note that these micrographs also provide a measure of relative binding affinity of the 
mutants for DNA. All mutants examined in these trials showed similar total amounts of proteins 
bound per base pair, although variations were found in relative distributions on the long and short 
strands. 
     In order to probe the CT role of aromatic residues at the 82 position, Y82F (0.6 µM) and DNA 
complexes were examined with AFM. Y82F EndoIII, a mutant with CT activity comparable to that 
of WT (Table 3.2), shows a redistribution onto long mismatched strands with a binding density 
ratio, r (long/short) of 1.4 ± 0.09 (total proteins counted=212), similar to that of wt protein. We 
observed 0.15 proteins per kilobase of long strand and 0.10 proteins per kilobase of short strand 
upon counting 260 long mismatched strands and 346 shorter matched strands. Matched controls 
were found from counting 250 long matched strands and 313 shorter matched strands. We had 
earlier tested Y82A, which shows diminished CT efficiency (50% ± 13%) relative to wt EndoIII 
(28). For Y82A, r (long/short) is 0.9 ± 0.1, within error of wild-type EndoIII bound to fully matched 
long versus short strands. These results led us to mutate other aromatic residues potentially involved 
in the DNA-protein CT pathway. 
     Y75A EndoIII mutant exhibits a signal that is 58 ± 20% smaller than that of wt EndoIII (Table 
3.2). Significantly, similar to Y82A, examination of the distribution of Y75A on mismatched and 
matched strands by AFM shows no preference for the mismatched strand. Upon counting 303 long 
strands and 497 short strands with 5% error, there is no preference for the mismatched strands; 
Y75A exhibits a protein binding density ratio, r (long/short) of 1.1 ± 0.05 (total proteins 
counted=495) in mismatched samples, which is within error of fully matched (221 long strands and 
296 short strands) density ratio r (long/short) of 0.94 ± 0.06 for protein binding for fully matched 
strands (221 long strands and 296 short strands). Thus this mutant that is also deficient in DNA CT 
also does not redistribute in our AFM assay. Though the [4Fe4S] cluster is intact and the protein 
maintains glycolytic activity, it cannot search for damage efficiently. 
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     In order to probe residues near the [4Fe4S] cluster, residues W178 and Y185 were mutated 
to alanines. Both mutants displayed DNA-bound electrochemical signals significantly greater 
than that of wt EndoIII (Table 3.2). When W178A/DNA complexes were studied by AFM, 
interestingly, they exhibit a very high protein binding density ratio r (long/short) of 1.9 ± 0.09 
(total proteins counted=393). More strands were counted in W178A samples than with other 
proteins: 303 long mismatched strands and 395 short matched strands. 499 long matched strands 
and 505 short matched strands were counted for controls with < 5% error. We observed 0.25 
proteins per kilobase long strand and 0.14 proteins per kilobase short strand in mismatched 
samples. There are ~ twofold more proteins bound to the longer strands containing one single 
base mismatch in 3.8kb compared to the well-matched strands. Upon performing comparisons for 
the three individual samples from both long matched and long mismatched strand images, all 
measurements are within error of one another. W178A redistributes to an even greater extent than 
wt EndoIII. This redistribution clearly cannot be explained by binding specificity of EndoIII for 
the mismatch. Note that all mutant/DNA complexes display heights and strand lengths within 
error of wt EndoIII/DNA complexes (Figure 3.9A). Figure 3.9B shows binding density ratio 
comparisons for wt EndoIII and mutants: Y82A, Y75A, Y82F, and W178A. These data indicate a 
strong correlation between the ability of EndoIII to carry out DNA CT and its localization in the 
vicinity of mismatches in AFM studies. 
 
Discussion 
Biochemical characterization of EndoIII mutants Eleven mutants of EndoIII were prepared and 
characterized biochemically in order to identify residues important for protein/DNA CT. They 
were selected based on several criteria including sequence conservation, aromatic character, and 
possible association with cancer. Additionally, mutations were made in several different regions 
of the protein to ascertain CT characteristics of different domains (Figure 3.10). When assayed by 
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cyclic voltammetry on DNA-modified electrodes, all of the mutants display midpoint 
potentials within error of that of wt EndoIII, indicating an intact [4Fe4S] cluster, irrespective of 
the mutation. Thus our focus shifted to monitoring changes in signal intensity as a function of 
mutation, reflecting differences in coupling along the path for DNA/protein CT. The 
electrochemical studies coupled with AFM experiments provide a measure of CT function: the 
ability to redistribute repair proteins in the vicinity of a base lesion.  
     It is therefore remarkable to see the clear correlation between electrochemical signal and the 
ability of the repair proteins to redistribute in the vicinity of lesions (Figure 3.11). First this 
correlation provides some confidence that electrochemical signal strength on the DNA-modified 
electrodes is a useful measure of protein/DNA coupling. But more importantly, this correlation 
provides a direct link between DNA CT activity and lesion detection, between protein/DNA 
coupling and function. We can therefore consider various mutants we have prepared in the 
context of protein/DNA CT (Table 3.5). 
 
Variations at the protein-DNA interface L81 and Y82 are both residues whose MUTYH 
equivalents exhibit mutations in cancer patients (25), and Y82 is well conserved. Additionally, 
L81 and Y82 are extremely close to the DNA interface in bound EndoIII. This proximity is 
important when the CT properties of DNA are considered. DNA is able to mediate CT by means 
of π-stacking, or the overlap of aromatic nucleotides whose many π-bonds provide an efficient 
conduit for electron flow (5, 31, 32, 62-66). L81 and Y82 may be able to intercalate into the DNA 
helix (9). L81 and Y82 would thus join the network of π-bonds in DNA that facilitate electron 
flow. Consequently, L81 and Y82 were seen as potentially important residues for mediating CT. 
Earlier research from our laboratory confirmed this hypothesis by establishing that Y82A is CT 
deficient relative to wt EndoIII (28).  
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Figure 3.9. EndoIII mutant binding density ratio comparisons. (A) Representative AFM 
images of DNA strands incubated overnight with Y82F EndoIII. (B) Quantitation of protein 
density ratios (< 10% uncertainty) where C:A indicates a mismatch is contained in long strands. 
The unmarked bars show the control measurements of for fully matched long and short strands. 
Y82A and Y75A, both CT deficient, do not show a redistribution onto the mismatched strand. 
Y82F and W178A, both CT proficient, redistribute similarly to WT. 
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Figure 3.10. Crystal structure of DNA-bound Endonuclease III. The structure shown was 
adapted from references (10, 14) and formatted using PyMol (75). Residues targeted for 
mutagenesis studies are emphasized in color. 
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Figure 3.11. Plot of protein binding density ratio versus electrochemical signal. EndoIII 
mutants (Y82A (green), Y75A (purple), WT (red), Y82F (blue), W178A (orange)) binding density 
ratios obtained for the mixture of mismatched and matched strands are plotted against 
electrochemical signals. Mutants that are CT-deficient show low binding density ratios and do not 
redistribute onto the mismatched strand, while those with particularly high coupling to the DNA 
electrochemically (albeit with a high uncertainty in the measurement) show high binding density 
ratios. 
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Table 3.5. EndoIII Variant Characterization Comparisons. BDR=Binding density ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EndoIII Variant 4Fe4S Cluster? Glycolytic Activity? Electrochem. Signal vs. WT C:A BDR Total Proteins/bp
WT + Yes 1.6 ± 0.09 1.6 x 10-4
Y82A + Yes 0.5 ± 0.07 0.9 ± 0.1 1.2 x 10-4
Y75A + Yes 0.6 ± 0.2 1.1 ± 0.05 2.2 x 10-4
Y82F + Yes 1.2 ± 0.4 1.4 ± 0.09 1.3 x 10-4
W178A + Yes 3.5 ± 2.3 1.9 ± 0.09 2.1 x 10-4
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To follow up on these experiments, additional mutants were made at L81 and Y82 to assess, 
in more detail, the characteristics of CT-proficient amino acids in EndoIII. L81C is CT-proficient, 
so no definite conclusions can be made about the electrochemical properties of L81. The mutant 
Y82S is electrochemically deficient relative to wt EndoIII, whereas Y82F and Y82W are CT 
proficient, indicating that aromatic amino acids are important mediators of CT at the Y82 
position. This CT proficiency with an aromatic residue at position 82 is reinforced by our AFM 
study where Y82F shows an ability to relocalize onto the mismatched strand that is comparable to 
WT. 
     It is interesting to consider mutations at these positions in the context of colorectal cancer and 
DNA repair. EndoIII bears structural similarity MUTYH.  When MUTYH acquires certain 
mutations, it is no longer able to repair damage in the adenomatous polyposis coli (APC) gene, 
which regulates the proliferation of colonic cells (25, 67). APC is thought to be particularly 
susceptible to MUTYH activity because it contains 216 “GAA” codons in which a G:C à T:A 
transversion would result in a stop codon. Genes associated with other cancers do not contain as 
many such sites (25). Several MUTYH mutations have been detected in colorectal cancer 
patients, including those at positions Y114 and Y166 (25). These residues align with F30 and 
Y82 in EndoIII, respectively. Since certain mutations at Y82 are deficient in CT activity but not 
enzymatic activity, perhaps the MUTYH mutants are similarly deficient in CT. According to our 
BER search model, these mutants would be less effective at detecting DNA damage, allowing 
mutations to accumulate in the APC gene that could lead to colorectal cancer. 
 
Consideration of pathways for DNA-mediated CT Crystal structures of DNA-bound EndoIII 
place the [4Fe4S] cluster and DNA roughly 14 Å apart at their closest (10, 12, 14). At this 
distance, CT could proceed by either a single-step tunneling process or a multi-step tunneling 
process, also called hopping, in which amino acids act as “stepping stones” for the electron as it 
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travels through the protein (35, 36, 68-70). In hopping systems, many of the amino acids 
through which electrons hop are aromatic residues (36, 68). With this information in mind, 
additional mutations were made at aromatic residues closer to the interior of EndoIII to find 
residues that could be part of a CT pathway. Emphasis was placed on aromatic residues near Y82, 
as this tyrosine has already been established as CT-active. F30, Y55, and Y75 all display weaker 
electrochemical signals than wt EndoIII, suggesting they participate in a CT pathway. The 
distances covered are 9 Å from Y82 to Y75, 8 Å from Y75 to Y55, and 6 Å from Y55 to F30, 
which are reasonable distances to consider in the context of hopping (35). It is interesting to see 
the effects of mutations at Y75 both electrochemically and by AFM. Y75 is clearly biochemically 
active as a glycosylase. However, functionally, both in carrying out DNA/protein CT and in 
redistributing in the vicinity of a mismatch, Y75 is defective. These results support the idea that 
Y75 is part of a hopping pathway from the cluster to DNA interface. Time-resolved spectroscopy 
will be necessary to distinguish these pathways. Tunneling efficiency is exponential with distance 
(69), so even a slight reduction in tunneling distance can increase CT rates significantly. 
     Beyond F30, the remainder of the CT pathway was not probed for several reasons. First, many 
residues in the region between F30 and the [4Fe4S] cluster are part of the helix-hairpin-helix 
motif of EndoIII, a well conserved motif in DNA-binding proteins (14, 71) that helps these 
proteins interact with their substrates. Mutations in this region could render the protein unstable 
and/or unable to bind DNA. Second, mutations in this region of the protein may not exhibit a 
detectable CT deficiency even if the targeted residues are able to facilitate CT, because multiple 
CT pathways could be present, as is often the case in redox-active proteins (70). In ribonucleotide 
reductase, for example, electrons are known to find alternative pathways between two redox 
centers if a primary pathway is impeded by mutagenesis or incorporation of a non-natural amino 
acid (36, 37). Similar phenomena could occur in EndoIII, especially given that all of the mutants 
examined display at least a partial signal, and that the degree of attenuation lessens as the 
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mutations are made further from the DNA. The signal from Y82A is 50 % ± 13 % that of WT 
(28), whereas the signal from F30A is 88 % ± 3 % that of WT. These values suggest that 
protein/DNA CT may involve Y82, but that it could circumvent F30. Third, mutations very close 
to the [4Fe4S] cluster could compromise the stability of this cluster, as may have been the case 
with the mutants W178A and Y185A. 
 
Characterization of EndoIII mutants with large electrochemical signals After establishing that 
mutations in aromatic residues are more likely to impede CT in EndoIII, the mutants W178A and 
Y185A were expected to produce weak cyclic voltammetry signals. However, their CT activity is 
unexpectedly high, larger even than that of wt EndoIII. It is more remarkable still that AFM 
results support this higher coupling of the protein with DNA for CT. This increase in 
protein/DNA coupling may be attributed to structural changes near the [4Fe4S] cluster of the 
protein. The loss of the bulky, aromatic residues could increase the conformational flexibility of 
EndoIII, allowing water molecules to access the protein and accelerate CT to the [4Fe4S] cluster 
(72, 73). 
          One question that could be raised by this result is why alanine is not present at positions 
178 and 185 in the native protein since it permits more efficient CT than tryptophan and tyrosine 
at these positions. A possible answer to this question is presented by the circular dichroism data. 
W178A and Y185A are found to be less stable structurally than WT, and the resulting instability 
or flexibility could affect the nearby [4Fe4S] cluster. Aromatic residues could play a protective 
role as well. Given the proximity of W178 and Y185 to the [4Fe4S] cluster of EndoIII, it is also 
possible that these aromatic residues shield the cluster from solvent exposure under physiological 
conditions. However, these mutants still exhibit WT level enzymatic activity, indicating that the 
structural perturbations are probably localized. 
 
  
114 
DNA-mediated search for damage within the genome DNA CT provides a solution to the 
problem of how these BER proteins can effectively scan the E. coli genome despite the low copy 
number and poor specificity of the repair proteins. In fact, CT through DNA with transfer over only 
a few hundred base pairs is sufficient to decrease the genome scanning time significantly (28). Here, 
AFM is utilized to probe this model of genome scanning by following the redistribution of proteins 
near lesions. It is interesting to note that in our AFM experiments only 1–4 proteins are bound to the 
long (3.8 kbp) strands, suggesting that DNA CT is occurring over distances much greater (> 500 
bp) than those we have measured electrochemically (4). 
     Moreover, here, using mutagenesis, electrochemistry and AFM, we have probed possible 
electronic pathways between DNA and the [4Fe4S] cluster of the repair protein. Significantly, Y82 
has already been established as a cancer-relevant aromatic residue located at the protein/DNA 
binding surface (28). Is Y82 the moiety that captures electrons from the DNA: the protein’s “toe in 
the water?” Mutation of W178, interestingly, results in both an increase in DNA CT and efficient 
redistribution in AFM assays. Likely here, as in other proteins, W178 serves to shield the EndoIII 
[4Fe4S] cluster, protecting the cluster from solvent and reaction with water and oxygen (74). These 
results certainly support the idea that mutations in repair proteins that alter DNA CT influence the 
search for damage. 
     Importantly, the requirement for a rapid, comprehensive search for damage is not a process 
limited to BER glycosylases. DNA-binding proteins that contain [4Fe4S] clusters with no obvious 
functional role have been increasingly ubiquitous (31). The results presented here elucidate a 
possible pathway through which charge can travel between the DNA and the iron sulfur cluster of 
EndoIII. Moreover these results demonstrate that the ability of the protein to perform DNA CT 
directly correlates with its function as a first step in damage detection. Consequently, these results 
add further support to the possibility that DNA-bound proteins communicate in vivo by means of 
DNA-mediated long-range signaling. 
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CHAPTER 4 
Monitoring MutY Activity: Interactions Among Base Excision Repair Proteins In 
Vivo in the Presence of Oxidative Stress 
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Introduction 
 
     Given that CT chemistry can occur over long molecular distances and is sensitive to intervening 
mismatches and lesions that perturb the base pair stack, we have begun to explore how DNA CT 
might be exploited within the cell (1-12). Specifically, we have examined proteins from the base 
excision repair (BER) pathway, the major network cells use to find and repair oxidative damage in 
the genome (12). Significantly, the BER enzymes contain a [4Fe4S] cluster that is not required for 
protein structure or folding (13, 14). We have established that these proteins exhibit DNA-bound 
redox potentials of ~ 100 mV vs. NHE, which is biologically relevant (10-12). Additionally, as 
BER proteins bind to DNA, the [4Fe4S] cluster is activated toward oxidation, and, necessarily, the 
protein has a > 1000-fold higher affinity for the duplex (12). On the basis of electrochemical, EPR, 
transient absorption, and genome scanning calculations, we have developed a model that describes 
how these proteins may cooperate to recognize lesions in an efficient manner (12). According to the 
model we have proposed, charge migrates between two redox-active proteins bound to DNA, thus 
any proteins with similar redox potentials could participate in the search for damage.  We have used 
genetic techniques to assay for cooperation among repair proteins from E. coli, Endonuclease III 
and MutY, in vivo (Figure 4.1) (12).  This assay for “helper function” employs a strain, CC104, 
which contains a single cytosine to adenine substitution in the lacZ Glu 461 codon (lac-) (15-18).  E. 
coli strains expressing this mutant form of β-galactosidase cannot use lactose for energy, and 
therefore cannot grow on lactose media (15-18).  Since MutY can prevent GC to TA transversions 
by excising adenine mispaired with 8-oxo-G (Figure 4.2), reversion of the CC104 strain from lac- to 
lac+ is indicative of a decrease in the ability of MutY to find and repair its substrate (15-18).  When 
EndoIII is knocked out of the CC104 strain (nth-) or a mutant of EndoIII (Y82A) that cannot 
perform DNA CT is introduced on a plasmid, MutY activity decreases (12).  If, instead, a mutant of 
EndoIII (D138A) that is glycolytically inactive yet exhibits a redox potential ~ 100 mV vs. NHE is 
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added, MutY activity is restored (12).  Results from the assay for helper function indicate that 
EndoIII and MutY help one another in the search for damage using DNA-mediated CT.  We are 
currently extending this method to evaluate the abilities of other EndoIII mutants to cooperate with 
MutY in vivo.  We have used a variety of oxidizing agents (e.g., methyl viologen, Rh(phi)2bpy3+) 
and anaerobic methods to generate additional lesions that must be repaired by MutY to enhance the 
overall signal in the assay. Importantly, this assay allows us to evaluate whether specific proteins, 
that we identify individually, cooperate with MutY in vivo. 
     Further, we have begun developing a high-throughput screen to identify proteins, like EndoIII, 
may exploit DNA-mediated CT to help MutY scan the genome to find sites of damage.  The 
methodology for this screen is inspired by the helper function assay.  We have designed and 
evaluated a 96-well microtiter plate-based screen to examine single-gene knockout strains from the 
KEIO knockout collection (19). Since β-galactosidase is not endogenously expressed in these 
strains, each strain is transformed with a reporter plasmid that contains lacZ from the CC104 strain. 
Then, after a period of growth, the cells are lysed and assayed with a fluorescent substrate to 
detect total β-galactosidase activity. Differences in cell growth between samples are taken into 
account by assaying for total cellular protein.  Strains with high β-galactosidase activity are 
associated with high transversion rates, which indicates one of two possibilities: i) that the specific 
protein that was knocked helps MutY locate its target lesion via DNA-mediated CT signaling or ii) 
it interferes with expression of MutY or affects the repair of 8-oxo-guanine. Our method to 
identify the former case requires restoring the activity of MutY in these strains using a plasmid 
containing EndoIII D138A. If MutY activity is restored, this suggests DNA CT signaling rather 
than some other metabolic change being responsible for the increase in revertants. Guided by these 
principles, we have performed controls and initial studies to examine the feasibility of the high-
throughput screen. 
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Figure 4.1 A schematic illustrating the helper function assay (in vivo), which is used to monitor 
MutY activity. MutY contains a [4Fe4S] cluster (green cube) and repairs A:8-oxo-G lesions. MutY 
is able to perform DNA CT to/from other proteins that have similar DNA-bound redox potentials, 
and could cooperate to search for lesions (1). When one of the helper proteins (i.e., EndoIII) is 
knocked out, MutY cannot find lesions as efficiently, and an increase in unrepaired lesions (red) is 
observed in the assay (2). 
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Figure 4.2. Reversion from the CC104 strain to wild-type depends on formation of an oxidized 
guanine product (8-oxo-G, red), misincorporation of an adenine opposite this lesion (blue), and a 
second round of replication to revert the point mutation.  MutM excises 8-oxo-G from DNA, and 
MutY excises adenine mispaired to the 8-oxo-G lesion. 
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Materials and Methods In the experiments conducted, all strains were first streaked to 
selective media.  Independent colonies of each strain were grown to a density of 109 cells/mL in 
minimal media (NCE) supplemented with glucose.  These cells were then plated on NCE media 
supplemented with lactose and incubated for 36 hours at 37°C.  The resulting lac+ revertants are 
reported as the average ± the standard error per 109 cells/mL plated (if 7 or more replicates were 
tested, the two highest and lowest values are removed).  In experiments where plasmids were 
utilized all media was supplemented with ampicillin (40 µg/mL in NCE, 100 µg/mL in LB). 
Luria-Bertani (LB) broth was used as the rich medium while NCE (20) medium supplemented 
with MgSO4 (100 µM) and glucose (11 mM) or lactose (6 mM) was used as the minimal medium. 
Minimal Media A (MMA) (21) was supplemented with 46 mM K2HPO4, 33 mM KH2PO4, 7.5 
mM (NH4)2SO4, 1.7 mM sodium citrate • 2 H2O, 5 mL 20% glucose, 800 µM MgSO4, and 0.5 
mL 1% B1 (thiamine hydrochloride). L-rhamnose (Fluka) was prepared such that the final 
concentration is 1 mM (0.5 mL of a sterile 20 mM stock). 
Lac+ reversion assays The protocol was adapted from methods described previously (12). Strains 
were streaked to LB medium and incubated overnight at 37°C.  For nth knockouts, strains were 
streaked to LB+chloramphenicol (17 µg/mL). 1 mL LB cultures were started from single colonies 
and grown overnight in a shaking incubator at 37°C, 220 rpm.  20 µL of each starter culture was 
used to inoculate a 10 mL NCE+glucose culture which was then grown to a density of 109 cells/mL 
at 37°C, 250 rpm. 5 mLs of this culture was centrifuged in a clinical tabletop centrifuge at 4°C and 
plated on NCE+lactose solid medium and then incubated at 37°C for 36 hours.  Colonies arising are 
reported as lac+ revertants/mL cells plated.  In experiments incorporating plasmid vectors, CC104 
were made electrocompetent and transformed via electroporation at 1.8 kV.  Transformants were 
selected on LB+ampicillin (amp) (100 µg/mL) solid medium after incubation overnight at 37°C.  
Single colonies were restreaked to LB+amp (100 µg/mL) solid media and incubated 12 hours at 
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37°C.  1 mL LB+amp (100 µg/mL) cultures were started from these colonies and grown 
overnight at 37°C, 220 rpm.  20 µL of each starter culture was used to inoculate a 10 mL 
NCE+glucose+amp (40 µg/mL) culture which was grown to a density of 109 cells/mL at 37°C, 250 
rpm.  5 mLs of this culture was plated onto NCE+lactose+amp (40 µg/mL) and incubated at 37°C 
for 36 hours. 
 
Lac+ reversion assays with Oxidative Stress: Rh(phi)2bpy3+ Cell strains were streaked onto LB 
solid medium and incubated overnight at 37°C.  For nth knockouts, strains were streaked to 
LB+chloramphenicol (17 µg/mL). For treated samples, 50 µM Rh(phi)2bpy3+ complex was added to 
LB, and 1 mL cultures were started from single colonies. Cultures were grown overnight in a 
shaking incubator at 37°C. Cultures were spun down and resuspended in 2 mL NCE+glucose 
minimal media in a 24-well plate.  Cells were irradiated at 365 nm using a solar simulator (340 nm 
internal filter) for 1 hour. Cells were grown to an OD at 600 nm of 0.6–0.7 (with Rh) or 2 (controls 
without Rh). 500 µL of the solution was spun down and plated on NCE+lactose solid medium.  No 
cells grew on NCE+glucose solid medium. Upon irradiation, the temperature of the samples did not 
get above 26° C.  
 
Lac+ reversion assays with Oxidative Stress: Methyl viologen Cell strains were streaked onto LB 
medium and incubated overnight at 37°C.  For nth knockouts, strains were streaked to 
LB+chloramphenicol (17 µg/mL). 1 mL LB cultures were started from single colonies and grown 
overnight in a shaking incubator at 37°C. 20 µL of each starter culture was used to inoculate a 10 
mL NCE+glucose culture. After two hours, cultures were treated with methyl viologen (Sigma) (50 
or 100 µM sterile-filtered in water) and grown to for 6 hours at 250 rpm. Cells grown in the 
presence of methyl viologen did not grow to the same OD (600 nm) as the control strains (0.1 and 
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0.6, respectively).  5 mLs of these cultures were plated onto NCE+lactose solid medium and 
incubated at 37°C for 40 hours.   
 
Growth Curves of strains under oxidative stress (CC104, CC104 + Rh(phi)2bpy3+, and CC104 + 
methyl viologen) CC104 strain was streaked onto LB medium and incubated overnight at 37°C. 
Single colonies were used to start 1 mL LB cultures. A 1:100 inoculation was performed into LB 
and with (50 µM Rh(phi)2bpy3+ oxidant or 50 µM methyl viologen ) to track growth. Cells were 
grown in a shaking incubator at 220 rpm and OD measurements (600 nm) were made every 30 
minutes. Samples that had been treated with methyl viologen grow at the same rate as untreated 
cells over ~ 6 hours. 
 
Lac+ reversion assays (CGSC CC104, CC104 nth- strains) Cell strains were streaked onto LB 
medium and incubated overnight at 37°C.  For nth knockouts, strains were streaked to 
LB+chloramphenicol (17 µg/mL). A colony was then chosen for a 1 mL LB starter culture (grown 
for 12 hours in a shaking incubator). 20 µL of the starter culture was used to inoculate 10 mL 
NCE+glucose culture which was grown for 8 hours. OD measurements at 600 nm were recorded. 5 
mL of these cultures was plated onto NCE+lactose solid medium and incubated at 37°C for 36 
hours.  The experiment was repeated using anhydrous MgSO4; however for all of the experiments 
that follow, heptahydrate MgSO4 was used as the standard reagent.  
 
 Lac+ reversion assays under anaerobic conditions (argon) Cell strains were streaked onto LB 
medium and incubated overnight at 37°C.  For nth knockouts, strains were streaked to 
LB+chloramphenicol (17 µg/mL). 1 mL LB cultures were started from single colonies, purged for 
one minute with argon gas, capped, and grown overnight in a shaking incubator at 37°C (Figure 
4.3). 20 µL of each starter culture was used to inoculate a 10 mL NCE+glucose culture which was 
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grown to a density of 109 cells/mL at 37°C, 250 rpm.  5 mL of this culture was plated onto 
NCE+lactose and incubated at 37°C for 36 hours.  
 
Lac+ reversion assays under anaerobic conditions (glovebox + methyl viologen) Similar to the 
protocol described above, cell strains were streaked onto LB medium and incubated overnight at 
37°C.  For nth knockouts, strains were streaked to LB+chloramphenicol (17 µg/mL). 1 mL LB 
cultures were started from single colonies, and these cultures were grown for 36 hours in an 
anaerobic incubator glovebox (10% CO2, 10% H2, and 80% N2) located in the Mazmanian lab at the 
California Institute of Technology (Figure 4.3). 20 µL of each starter culture was used to inoculate a 
10 mL NCE+glucose culture which took much longer to grow to a density of 109 cells/mL. Half of 
the NCE+glucose cultures were treated with 50 µM methyl viologen (Sigma) that was sterilized 
prior to use.  The cells treated with methyl viologen reached an OD at 600 nm of only 0.4, even 
after 23 hours, but they did not grow in the assay. 
 
Lac+ reversion assays with methyl viologen (pelleting method in NCE or MMA) Strains were 
streaked to LB medium and incubated overnight at 37°C.  For nth knockouts, strains were streaked 
to LB+chloramphenicol (17 µg/mL). 1 mL LB cultures were started from single colonies and grown 
overnight in a shaking incubator at 37°C, 220 rpm.  20 µL of each starter culture was used to 
inoculate a 10 mL LB culture with/without the addition of methyl viologen (sterile).  Cells were 
placed back in the shaking incubator for 1–1.5 hours.  Samples were then centrifuged and 
resuspended in 10 mL NCE+glucose culture which was then grown to a density of 109 cells/mL at 
37°C (~ 5 hours), 250 rpm (22).  Cell density was determined by dilution plating a 10 mL aliquot of 
the NCE+glucose culture onto NCE+glucose solid medium followed by incubation at 37°C for 24 
hours.   
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Figure 4.3. Schematic illustrating anaerobic methods employed to increase oxidative stress. 
(Top) Cells are bubbled with argon and capped prior to inoculating minimal media with starter 
culture, spinning down, and plating onto minimal media/lactose plates. (Bottom) The cells are 
cultured inside a glovebag with a 10% H2, 10% CO2, and 80% N2 atmosphere and transferred to 
minimal media. Prior to spinning the cells down and plating them on minimal media, some cultures 
are treated with methyl viologen to induce additional stress. 
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Figure 4.4. Schematic of helper function assay method with plasmid transformation. Strains are 
streaked onto media (Day 1). Colonies are incubated in LB for 12 hours to generate a starter culture. 
Following this, 10 mL LB is inoculated with the starter culture (Day 2) and set to shake for 2–3 
hours. Cells are pelleted and prepared for plasmid transformation (glycerol). Upon electroporation, 
cells are recovered in LB for 2 hours and plated onto LB/amp. Once the cells are restreaked (Day 
3), they are grown to isolate the colonies that have successfully been transformed with plasmids. 
Colonies are chosen and cultured in LB/amp for 18 hours. 10 mL LB/amp to which methyl 
viologen has been added is inoculated with the starter culture (Day 4) and shaken for 1 hour. Cells 
are spun down and resuspended in minimal media. 5 mL of the culture is spun down and plated 
onto minimal media plates for revertant counts (Day 5). 
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5 mL of this culture was centrifuged in a clinical tabletop centrifuge at 4°C and plated on 
NCE+lactose solid medium and then incubated at 37°C for 36 hours. Methyl viologen was prepared 
by dissolving 30 mg of the compound in 600 µL (50 µM) water and sterile-filtered into a sterile 
eppendorf prior to use. 
      In experiments incorporating plasmid vectors, CC104 strains were made electrocompetent and 
transformed via electroporation at 1.8 kV.  Transformants were selected on LB+ampicillin (amp) 
(100 µg/mL) solid medium after incubation overnight at 37°C.  Single colonies were restreaked to 
LB+amp (100 µg/mL) solid media and incubated 12 hours at 37°C.  1 mL LB+amp (100 µg/mL) 
cultures were started from these colonies and grown 18 hours at 37°C, 220 rpm.  20 µL of this 
starter culture was used to inoculate a 10 mL LB+ amp (100 µg/mL) culture with/without the 
addition of methyl viologen (sterile). Cells were placed back in the shaking incubator for 1–1.5 
hours.  Samples were then centrifuged and resuspended in 10 mL NCE or MMA+glucose+amp (40 
µg/mL) culture which was then grown to a density of 109 cells/mL at 37°C (~ 3 hours), 250 rpm.  
Cell density was determined by dilution plating a 10 mL aliquot of the NCE or 
MMA+glucose+amp culture onto NCE or MMA+glucose+amp solid medium followed by 
incubation at 37°C for 24 hours. 5 mLs of this culture was plated onto NCE or MMA+lactose+amp 
(40 µg/mL) and incubated at 37°C for 36 hours.  Lac+ revertants were reported as described above. 
 
Growth Curves (wild-type CC104, CC104 nth-, and CC104 Δnth) A new EndoIII knockout strain, 
CC104 Δnth was prepared by Christine Romano (23). CC104, CC104 Δnth strains were streaked 
onto LB plates and CC104 nth- to LB+chloramphenicol (17 µg/mL). 1 colony was chosen for a 1 
mL starter culture in LB (3 replicates). A 1:100 inoculation was performed into LB to track growth. 
Cultures were grown in a shaking incubator at 37 °C, 220 rpm, and the OD at 600 nm was 
measured every 30 minutes. Strains, including the EndoIII reinsertion CC104 Δnth WTnth that 
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Christine prepared, were also examined in the presence of inducer, rhamnose, and oxidative 
stress. Cells were streaked onto LB plates and incubated for 12 hours.  Starter cultures of 1 mL LB 
were made and grown overnight at 37°C, 220 rpm.  19 mL LB (with 1 mM rhamnose, 50 µM 
methyl viologen) was inoculated with 200 µL starter culture.  OD measurements were taken every 
30 minutes over ~ 800 minutes. The strains grew at identical rates. 
 
Lac+ reversion assays (CC104, CC104 Δnth, CC104 ΔnthWTnth, CC104 ΔnthY82A) +/- methyl 
viologen, +/- 1 mM rhamnose  Strains were streaked to LB medium and incubated overnight at 
37°C.  For nth knockouts, strains were streaked to LB+chloramphenicol (17 µg/mL). 1 mL LB 
cultures were started from single colonies and grown overnight in a shaking incubator at 37°C, 220 
rpm.  20 µL of each starter culture was used to inoculate a 10 mL LB culture with/without the 
addition of methyl viologen (sterile) or 1 mM rhamnose.  Cells were placed back in the shaking 
incubator for 1–1.5 hours.  Samples were then centrifuged and resuspended in 10 mL NCE+glucose 
culture which was then grown to a density of 109 cells/mL at 37°C (~ 5 hours), 250 rpm.  Cell 
density was determined by serial dilution plating a 10 µL aliquot of the NCE+glucose culture onto 
NCE+glucose solid medium followed by incubation at 37°C for 24 hours.  5 mL of this culture was 
centrifuged in a clinical tabletop centrifuge at 4°C and plated on NCE+lactose solid medium and 
then incubated at 37°C for 36 hours. 
 
Materials for the microtiter screen Strains were purchased from the KEIO knockout collection 
from CGSC Coli Center at Yale (19). ∆soxR; ∆uvrA; ∆mutM; ∆mutY; ∆iscU; ∆nth-; 
∆dinG=kanamycin resistant and ∆lacz WT: BW25113 ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, 
rph-1, ∆(rhaD-rhaB)568, hsdR514. Strain stocks were prepared from the glycerol filter disk by 
placing the disk on LB solid medium, adding ~ 100–200 µL LB media, and streaking the cells. A 
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single colony was added to 1 mL LB with 1 µL kan (34 µg /mL) and cultured in a shaking 
incubator overnight at 37 °C. The culture was combined with 500 µL 50% glycerol stock solution 
and stored at -80 °C. The MutM- strain was generously donated by Professor Sheila David at UC 
Davis. Reporter and control plasmids used in the assay were prepared by Helen Segal from 
pBBR1MCS (gentamicin/tetracycline resistant) or pUC19 (ampicillin resistant). The CPRG kit is 
purchased from Gelatins. CPRG=chlorophenol red β-galactopyranoside which cleaves β-
galactosidase to galactose and chlorophenol red. BCA total protein assay is performed at 
concurrently with β-galactosidase standard curves, following the protocols in the thermo scientific. 
Standards are made with 2000-0 µg/mL BSA to generate curves. Only a small volume of cell lysate 
(6 µL) is used in the experiment as lysis buffer is not compatible with the BCA assay. 
 
Helper screen for Lac+ reversion (no plasmids; 96-well plastic plate) Cells were streaked onto 
LB/antibiotic plates and incubated at 37 °C 12 hours. Each colony was added to 200 µL LB in a 96-
well microtiter plate and grown in a shaking incubator at 500 rpm at 37 °C ~ 3 hours. The OD of 
each well was measured at 600 nm using a microtiter plate reader. 1 µL starter culture was used to 
inoculate 200 µL fresh LB. The plate was left to shake for 1 hour and centrifuged for 5 minutes at 
250 g. Supernatant was extracted, and the pellet was resuspended in 1x lysis buffer (50 µL). Cell 
lysate was incubated 10–15 minutes at room temperature and gently swirled. Standard dilution 
buffer (50 µL) was added to new wells. A blank sample contained 50 µL lysis buffer to which 50 
µL dilution buffer was added. 50 µL of each sample was then added to wells that had been filled 
with standard dilution buffer. 100 µL of 1xCPRG substrate solution was added to each well and 
incubated at room temp. Absorbance at 570-595 nm was measured using the plate reader.  
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Helper screen for Lac+ reversion (polypropylene plate: 96-well) The edges of 2.2 mL deep 
well polypropylene plates were filled with 1 mL LB. Each colony from streaked plates, described 
above, was added to 1 mL LB and grown for 12 hours shaking at 500 rpm. The plate was placed on 
ice. 1 mL LB was inoculated with 5 µL starter culture and allowed to shake 6.5 hours.  50 µL of 
each sample was transferred to a fresh microtiter plate and centrifuged for 5 min at 250 g. The 
protocol then continued as described above. 
 
Helper screen for Lac+ reversion (polypropylene plates 96-well plate no plasmids/restreak strains) 
Strains were streaked on LB/antibiotic plates and incubated at 37 °C 12 hours. Strains were then 
restreaked onto LB/antibiotic plates for normalization and incubated at 37 °C 12 hours. Starter 
cultures were made by selecting individual colonies from the restreaked plate and placing them in 1 
mL LB. Cultures were grown overnight (12 hours) at 500 rpm. 1 mL LB was then inoculated with 5 
µL starter culture and grown for 7 hours in a shaking incubator. 50 µL-200 µL was then transferred 
to a new 96-well microtiter plate and spun down 12 min at 1390 rpm. The plate was flipped to 
gently remove supernatant. The protocol returns to the original description above. 
 
Helper screen for Lac+ reversion (transformation with plasmids) Cells were streaked onto 
LB/antibiotic plates and incubated 37 °C 12 hours. 1 mL LB starter cultures (1 colony each) were 
grown overnight at 500 rpm. 1 mL LB was inoculated with 10 µL starter culture and grown to an 
OD at 600 nm of 0.3–0.4 (approx. 2–3 hours at 500 rpm). The plate was placed on ice for 30 min. 
Cells were centrifuged at 2500 rpm for 10 min. Supernatant is decanted by flipping the plate.  Cells 
were resuspended in 1 mL ice cold CaCl2 solution and centrifuged 5 min at 2863 rpm (60 mM 
CaCl2, 15% glycerol, 10 mM PIPES (pH 7): PIPES was first dissolved in water, the pH was 
adjusted, and the CaCl2 was added). Supernatant was decanted, 1 mL CaCl2 solution was added, 
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and the cells were placed on ice for 30 min. Cells were  then centrifuged 5 min at 2750 rpm. 
Pellets were resuspended in 300 µL CaCl2 and aliquoted into 75 µL fractions for transformation in a 
pre-chilled microtiter plate. The plate was frozen with liquid nitrogen and thawed on ice. 0.5 µL-1 
µL plasmid was added to cells and swirled.  This was left on ice for 10 min. The plate was held in a 
42 °C hot water bath for 2 min and put on ice for 2 min.  
     Cells that had been transformed with plasmid were recovered in 1 mL LB in a deep well 
polypropylene plate (incubate 1 hour 37 °C) followed by plating or culture with the appropriate 
antibiotic. Another method was performed as follows: 200 µL LB was added to the microtiter plate 
containing the cells and incubated 1 hour at 37 °C. After this, 200 µL was plated onto LB/antibiotic 
plate and incubated at 37 °C 12 hours to observe colony growth. A colony from the plate could then 
be added to 1 mL LB with the appropriate antibiotic and allowed to shake at 37 °C for 12 hours at 
500 rpm. 1 mL LB with the appropriate antibiotic was then inoculated with 10 µL of the overnight 
culture. The cells were then grown to an OD at 600 nm of 0.3–0.4. The protocol then returned to the 
original CPRG assay described above. Alternatively, rather than growing colonies on plates, the 200 
µL of recovered transformed cells could be transferred to a polypropylene plate with 800 µL LB 
with antibiotic. As an example, if the plasmid is resistant to gentamicin, 0.4 µL of 50 µg/mL 
gent.=20 µg/mL total concentration would be added. Cultures were grown at 37 °C for 12 hours at 
500 rpm. 1 mL LB with the appropriate antibiotic was then inoculated with 10 µL of the overnight 
culture. The cells were then grown to an OD at 600 nm of 0.3-0.4/~ 1 hour.  50 µL of the culture 
was extracted, pelleted down, and resuspend. The protocol then returned to the original CPRG assay 
described above. 
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Results and Discussion 
Cooperation Between MutY and EndoIII Inside the Cell We have used genetic methods to test the 
CT scanning model in vivo. We can assay for the cooperation among repair proteins facilitated by 
DNA-mediated signaling. If these proteins are able to help each other in their search for damage 
using DNA CT, variants of EndoIII with decreased or increased capability to carry out CT will alter 
MutY activity in vivo. Assays for MutY (CC104) and EndoIII activity inside E. coli cells have 
already been developed (12). Prior to adding oxidative stress to the experiments, we first wanted to 
reproduce previous results (12). Utilizing the CC104 MutY activity reporter strain (Figure 4.5), 3.8 
± 0.5 lac+ revertants are observed per 109 cells. When the gene encoding EndoIII (nth) is 
inactivated in CC104 (CC104 nth-), the lac+ reversion frequency observed is 4.8 ± 0.3, more a 
factor of ~ 1.3-fold over CC104. Thus, loss of EndoIII does have a small but significant effect on 
MutY activity in vivo. This loss in activity is consistent with a loss in helper function by EndoIII, as 
predicted; the lower activity of MutY without EndoIII could reflect the lack of cooperative 
searching via DNA CT. Significantly, when a plasmid encoding EndoIII (pnth) is transformed back 
into the cells, full MutY activity is restored, and the revertant count decreases to 2.8 ± 0.1. These 
findings are consistent with values that have been reported previously by our lab; however, the 
number of revertants counted in the experiment is low (<5 colonies). We aimed to increase the 
overall revertant count and, subsequently, decrease the error in these measurements. To generate 
more lesions for MutY repair (A:8-oxo-G), oxidative stress was introduced into the assay.  
     When the complex is irradiated with 365 nm light, Rh(phi)2(bpy)3+ is an effective photooxidant 
and consequently, promotes guanine oxidation primarily at the 5ʹ′-G of 5ʹ′-GG-3ʹ′ doublets found in 
the DNA sequence (24-26).  Thus, we have employed this complex to generate base mutations, 
such as 8-oxo-guanine, identical to naturally occurring lesions in the cell that MutY is responsible 
for repairing.  
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Figure 4.5. Bar graph showing lac+ revertants for CC104/p, CC104 nth-/p, and CC104 nth-
/pnth where p denotes inclusion of an empty vector.  Lac+ revertants are reported as the average 
number lac+ colonies that arise per 109 cells plated on minimal lactose media containing ampicillin.  
Data for the CC104 strains are shown based an independent experiment, containing 10 replicates 
per strain. 
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Rh(phi) 2(bpy)3+ is added to cells while they are growing LB. The cells are then irradiated for 1 
hour while they are in minimal media, spun down, and plated onto NCE+lactose to observe 
revertants. Irradiating the cells in the presence of Rh(phi)2(bpy)3+ increases the overall number of 
revertants in the assay (9.3 ± 1.8 lac+ revertants are observed per 109 cells); however, when the 
gene encoding EndoIII (nth) is inactivated in CC104 (CC104 nth-), the lac+ reversion frequency 
remains a factor of 2–3-fold over CC104 (17 ± 2.4 lac+ revertants) (Figure 4.6).  
     We then considered whether a redox-cycling agent, methyl viologen, that generates global 
oxidative stress, might further enhance the number of lesions, thereby increasing the workload for 
MutY. In this case, when EndoIII is knocked out of CC104 strains we would expect a large 
decrease in MutY activity. Methyl viologen (50 µM or 100 µM) is introduced into the minimal 
media during the last step of the assay. Notably, the cells treated with methyl viologen do not grow 
as well as the control samples. The ODs of the cells at 600 nm prior to plating are 0.6 (-methyl 
viologen) and 0.1 (+methyl viologen).  Figure 4.7 shows that revertant counts of the cells treated 
with methyl viologen are much lower than those of wild-type samples. Further, growth curves 
(Figure 4.8) reveal that in LB, the cells treated with methyl viologen grow at similar rates as wild-
type strains, but Rh(phi)2bpy3+ significantly slows the growth rate. From this, we have learned that 
rather than adding methyl viologen to cells in minimal media, when they are already starved for 
nutrients, we should introduce the oxidative stress while the cells are growing in LB. 
 
Methods to Increase Lac+ Revertants in the Helper Function Assay Additionally, we have 
purchased a new CC104 strain from the CGSC Yale facility as a comparison for the CC104 strain 
we have been using for the in vivo assays. We explore whether we can increase the lac+ revertant 
counts simply by employing a fresh bacterial strain.  
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Figure 4.6. Bar graph showing lac+ revertants for CC104 and CC104 nth- where Rh indicates 
that the samples were treated with 50 µM Rh(phi)2bpy3+ and irradiated in minimal media for 1 hour 
with a solar simulator (340 nm internal cutoff). There is a threefold difference from CC104 to 
CC104 nth- and a twofold difference from CC104+Rh to CC104 nth-+Rh.  There is about a two- to 
threefold increase from –Rh to +Rh overall. 
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Figure 4.7. Bar graph showing lac+ revertants for CC104 and CC104 nth- where MV indicates 
that the cells, in minimal media, were treated with 100 µM or 50 µM methyl viologen (MV) to 
induce oxidative stress. Lac+ revertants are reported as the average number lac+ colonies that arise 
per 109 cells plated on minimal lactose media.   
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Figure 4.8. Growth curves comparing the OD at 600 nm of untreated CC104 strain cells in LB 
(red), + 50 µM Rh(phi)2bpy3+ (blue), and + 50 µM methyl viologen (green).  Cells treated with 
Rh(phi)2bpy3+  grow at half the rate of the other strains. 
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Here, the CGSC CC104 MutY activity reporter strain yields only 0.7 ± 0.2 lac+ revertants per 
109 cells. Yet, surprisingly, the original CC104 nth- strain produces a lac+ reversion frequency of 5 
± 0.6, more than a factor of > 6 over CC104 (Table 4.1). When the experiment is repeated in a 
separate trial, the number of lac+ revertants in CC104 nth- strain is twofold more than that of 
CC104, consistent with the previous results. Regardless of the OD of the cells at 600 nm prior to 
plating on NCE+lactose solid media, we consistently observe a twofold increase in revertants from 
wild-type to the EndoIII knockout strain (Table 4.1). However, the new strain does not improve the 
lac+ revertant count or the standard error in the assay.  
     In an effort to increase the number of lesions in the cells, we have designed and employed three 
strategies: i) purge cultures with argon while they are growing, and once they are starving in 
minimal media, expose them to oxygen (Figure 4.2) ii) grow the LB cultures in an anaerobic 
chamber (10% H2, 10% CO2, and 80% N2 atmosphere), expose the cells to oxygen while they are in 
minimal media (and add the redox-cycling agent, methyl viologen) (Figure 4.2), and iii) grow the 
LB cultures over time in the presence of methyl viologen at concentrations of 50-500 µM, pellet the 
cells, and resuspend them in minimal media (Figure 4.3) (22).  The first two methods do not 
increase total lac+ revertants (Table 4.2); however, the third method produces counts slightly higher 
than those we have observed in prior experiments (Table 4.2). When the cells are transformed with 
plasmids and treated with methyl viologen, the revertant counts are higher than those reported 
earlier. Adding methyl viologen to the LB cultures has generated more oxidative stress in the cells. 
At high concentrations of methyl viologen (100 µM) CC104 nth-/p lac+ revertants decrease from 
5.7 ± 0.4 to 5.1 ± 0.5. This trend is consistent in samples treated with 500 µM methyl viologen: 
CC014/p reversion frequency is 3.2 ± 0.4, CC104 nth-/p increases to 16 ± 4, CC104 nth-/pnth 
decreases to 13 ± 2, and CC104 nth-/Y82W decreases further to 11 ± 1.9 (Figure 4.9).  
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Table 4.1. Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells plated on minimal lactose media. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) These data represent a single set of experiments with 5 replicates at each OD measurement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OD @ 600 nm CC104 CC104 nth- Increase
 0.5-0.6 0.73 ± 0.2 5  ± 0.6 6.8
 0.5-0.6 0.96  ± 0.2 1.8  ± 0.2 1.9
0.5a 1.0  ±  0.2 1.9  ±  0.1 2
0.7a 1.9  ±  0.2 3.2  ± 0.3 1.7
0.5-0.7a 1.4  ± 0.2 2.4  ± 0.2 1.7
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Table 4.2. Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells from CC104 and CC104 nth- strains plated on minimal lactose media as a function of 
oxidative stress. These data represent at least five replicates in each trial with high and low values 
removed. Error reported is standard error based on the number of replicates reported.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Lac+ Revertants Increase
CC104 0.9 ± 0.1
CC104 nth- 1.4 ± 0.1 1.5
CC104 1.7 ± 0.3
CC104 nth- 2.5 ± 0.6 1.5
CC104 1.3 ± 0.2
CC104 nth- 1.4 ± 1.0 (2.1 ± 1.3) 1 (1.6)
CC104 1.2 ± 0.2
CC104 nth- 1.7 ± 0.3 1.4
CC104 1.6  ± 0.1
CC104 nth- 2.3  ± 0.3 (3.2  ± 0.2) 1.4 (2)
CC104 1.5  ± 0.1
CC104 nth- 2.7  ± 0.4 (3.7 ± 0.3) 1.8 (2.5)
Trial 2: Resuspend Pellet (50 µM MV)
No Oxidative Stress
Argon Bubbled
Argon + (100 µM MV)
Anaerobic Chamber
Trial 1: Resuspend Pellet (50 µM MV)
  
144 
Figure 4.9. Bar graph showing lac+ revertants for CC104/p, CC104 nth-/p, and CC104 nth-
/pnth where p denotes inclusion of an empty vector.  Lac+ revertants are reported as the average 
number lac+ colonies that arise per 109 cells plated on minimal lactose media containing ampicillin.  
Methyl viologen (MV) is added at the concentrations indicated below (50, 100, and 500 µM). In the 
presence of 500 µM, there is an increase in the overall number of revertants. 
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Y82W is an EndoIII mutant that is able to perform DNA CT, and this data supports that the 
mutant can cooperate with MutY to help it repair damage (27).  
     Concurrently, we have examined a CC104 strain that, rather than incorporating an antibiotic 
cassette in place of EndoIII, (nth-), it lacks the gene entirely (Δnth). In parallel, we have compared 
CC104 Δnth strains that either wild-type EndoIII reinserted (WTnth) or that have Y82A mutant 
EndoIII (Y82A). Although the growth rates of CC104, CC104 nth-, and CC104 Δnth, and CC104 
ΔnthWTnth (not shown) are identical (Figure 4.10), the CC104 Δnth strain behaves differently in 
the lac+ reversion assay. With methyl viologen (50 µM), CC104 yields 2.9 ± 0.2 revertants, and 
CC104 Δnth increases slightly less than twofold to 4.9 ± 1. Upon the addition of 1 mM rhamnose, 
to induce the expression of WTnth and Y82A in the bacterial cultures, the trend is absent (Table 
4.3).  When we compare CC104, CC104 Δnth, and CC104 nth- in the assay (using 50 µM methyl 
viologen), CC104 nth- consistently shows an increase in revertant counts, but the CC104 Δnth strain 
does not. 
 
High-Throughput (96-Well-Plate) Screen Following the protocols described in the materials and 
methods section, we have begun developing a high-throughput screen (Figure 4.11) to identify 
proteins that may cooperate with MutY in a DNA-mediated manner to find lesions in the genome. 
Each strain is transfected with a plasmid containing lacZ. Mutant lacZ  has been PCR-amplified 
from the CC104 strain alongside a positive control, wild-type lacZ, from the wild-type MG1655 
strain. These genes have been inserted into both pBBR1MCS and pUC19 plasmids (28), which 
contain tetracycline, gentamicin, or ampicillin resistance cassettes. The antibiotic resistance ensures 
that the strains contain the reporter plasmid after transfection.  
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Figure 4.10. Growth curves comparing the OD at 600 nm of untreated CC104 strain cells in LB 
(blue), CC104 Δnth (red), and CC104 nth- (green). All of the strains show identical growth curves. 
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Table 4.3. Lac+ revertants are reported as the average number of lac+ colonies that arise per 109 
cells from CC104, CC104 Δnth-, and CC104 nth- strains plated on minimal lactose media as a 
function of oxidative stress and rhamnose induction. Error reported is standard error based on the 
number of replicates reported.  There is no increase in revertant counts from wild-type CC104 to 
CC104 Δnth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Lac+ Revertants
CC104 (+ 50 μM MV) 1.3 ± 0.2 (2.9 ± 0.2)
CC104 Δnth (+ 50 μM MV) 2.2 ± 0.4 (4.9 ± 0.9)
1 mM Rhamnose, 50 μM MV
CC104 1.8 ± 0.2
CC104  Δnth 1.8 ± 0.2
CC104 Δnth/nth reinserted 3.2 ± 1
CC104 Δnth/Y82A 1.5 ± 0.3
50 μM MV (+ 1 mM Rhamnose)
CC104 1.7 ± 0.3 (1.36 ± 0.2)
CC104  Δnth 1.3 ± 0.2 (1.52 ± 0.2)
No MV (+ 1 mM Rhamnose)
CC104 1.7 ± 0.2 (1.9 ± 0.3)
CC104  Δnth 1.6 ± 0.2 (1.7 ± 0.4)
50 μM MV
CC104 1.6 ± 0.1
CC104  Δnth 1.3 ± 0.1
50 μM MV
CC104 1.3 ± 0.1
CC104  Δnth 1.4 ± 0.3
CC104 nth- 4.9 ± 1.4
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Figure 4.11. A flowchart of the helper screen is shown.  Single-gene knockout cells are 
transformed with plasmids that report on MutY activity. Yellow circles indicate the lack of β-
galactosidase activity, and red circles represent β-galactosidase production. If the knocked out 
enzyme helps MutY detect sites of DNA damage, there will be an increase in the number of 
revertants, and thus an increase in β-galactosidase activity. An increase in in β-galactosidase activity 
will be visualized as an increase in absorbance at 572 nm. If the protein that has been knocked out 
helps MutY in a DNA-mediated process, transforming the cells with D138A, a mutant that is CT-
proficient but glycolytically inactive, will restore MutY activity reverting the well to a yellow color. 
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     Prior to utilizing the vectors, we ran a variety of controls to reduce the technical error in the 
microtiter-based assay. Control strains, TB1 and MG1655, were chosen as TB1 ΔlacZ strain and 
MG1655 is wild-type-these were streaked onto LB plates. First, TB1, a control strain that does not 
produce β-galactosidase, and MG1655 are streaked onto LB solid media and incubated overnight at 
37 °C. Starter cultures are grown for 4 hours in a shaking incubator at 500 rpm.  The OD 
measurements at 600 nm for the strains were: TB1: 2.0 and MG1655: 2.0.  1 µL of the starter 
culture is used to inoculate 200 µL LB, incubated, and grown for 3 hours at 500 rpm.  The ODs of 
the cells are TB: 0.5 and MG1655: 0.8. Upon the addition of CPRG substrate, the wells containing 
MG1655 bacterial strains turn red, as expected, and the wells with TB1 remain yellow. 
     Plastic microtiter plates accommodate only very small volumes (< 500 µL) and are susceptible to 
contamination, thus we have switched to using deep well (2.2 mL) polypropylene plates. In each 
experiment, the edges of the plate are filled with 1 mL LB. We have examined the controls for TB1, 
CC104, CGSC CC104, CC104 Y-, and MG1655 strains.  OD values, just before the assay, are: 
TB1: 0.03, CC104 (WT Amie): 0.36, Blank: 0, CC104 (CGSC): 0.3, MG1655: 0.5 and CC104Y-: 
0.4. 50 µL is removed from these samples and transferred to a fresh plastic 96 well microtiter plate. 
The protocol then continues as described above. Figure 4.12 reveals that half of the MutY- cultures 
turn red before WT (Amie); however, WT (CGSC) turns red at the same time as MutY-. One row 
(colony) follows the trend that we expect: the wild-type CC104 strain stays yellow longer than 
MutY-.  In this assay, just as in the lac+ reversion assay of individual strains, when MutY is 
knocked out of cells, lesions persist. 
     The experiment has been repeated, and the cells grow faster: OD measurements of TB1: 0.9, 
CC104 (WT Amie): 0.3, CC104 (CGSC): 0.2, MG1655: 0.6 and CC104Y-: 0.6.  Colonies are 
diluted to observe whether the concentration of cells affects our ability to observe β-galactosidase 
production (Figure 4.12).  
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Figure 4.12. Microtiter 96-well plates with TB1, wild-type CC104, ∆mutY, and MG1655 
strains. Red wells indicate β-galactosidase activity. TB1 does not produce β-galactosidase and 
remains yellow throughout the assay. Rows with black boxes yielded absorbance patterns that 
would be expected for each strain. (Right) Dilutions of cell lysates do not alter the results. 
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CPRG is added in opposite directions to each row to ensure uniformity and reduce technical 
error. Here, we confirm that the protocol we have used for lysis/dilution yields reproducible results 
(Figure 4.12). 
 
Transfecting Cells with Plasmid (96-Well Plate) In order to develop the screen, it is necessary to 
transform the cells with plasmids that report on MutY activity. To this end, we have investigated 
whether we can reproducibly transfect cells in a 96-well microtiter plate. Thus far, using heat-shock 
methods, we have successfully transfected WT, Nth-, and MutM- strains with reporter and control 
plasmids (29). OD values for the strains post-transformation are 0.2-0.3, within error of each other. 
We have expanded our studies to strains purchased from the KEIO knockout collection: ∆soxR; 
∆uvrA; ∆mutM; ∆mutY; ∆iscU; ∆nth-; ∆dinG. Since all of the strains are kanamycin resistant, we 
examine whether it is required for cellular growth. We find that all of the strains, with the exception 
of ∆iscU, grow at similar rates (Table 4.4). It is not surprising that the ∆iscU strain does not reach 
the same OD as the other strains as iscU is a scaffolding enzyme that is required to build iron-sulfur 
clusters and deliver them to a variety of other proteins (30, 31). When this gene is absent, proteins 
that require metal cofactors may not fold or function properly. Absorption measurements at 570 nm 
are recorded over time using a microtiter plate and normalized to control wells (Figure 4.13). 
MG1655 (wild-type) turns red after a short time; whereas, all strains from the knockout collection, 
which are ΔlacZ, remain yellow. 
     Using reporter plasmids that are resistant to tetracycline/gentamicin, the assay has been repeated 
with WT, Nth-, MutY-, and MutM- strains. Results are reported as Miller Units versus time, where 
Miller Units=Absorbance 570 nm/Absorbance 630 nm (time)(volume)*1000 (32-33).  MutM- 
produces more β-galactosidase than other strains. Curiously, MutY- remains yellow (Figure 4.14). 
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Table 4.4. OD values (at 600 nm) of strains from the KEIO knockout collection. ∆iscu does not 
grow in the microtiter plates as well as the other strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MG nth mutY mutM uvR iscu dinG soxR TB1 Kan?
0.5 0.54 0.5 0.5 0.45 0.2 0.58 0.47 0.4 No
0.56 0.5 0.5 0.6 0.5 0.26 0.68 0.47 0.43 No
0.53 0.46 0.43 0.48 0.5 0.3 0.55 0.42 - Yes
0.56 0.55 0.57 0.56 0.48 0.34 0.61 0.44 0.49 Yes
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Figure 4.13. Absorbance at 570 nm vs. time (minutes) after the addition CPRG substrate. 
MG1655 produces β-galactosidase and turns red over time. 
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Figure 4.14. Miller Units vs. time (post the addition of CPRG substrate). ∆mutM, ∆mutY, ∆nth, 
and WT (BW25113) strains have been transformed with reporter plasmids. ∆mutM produces more 
β-galactosidase than the other knockout strains. 
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Just as we enhanced lac+ revertants in the helper function, we introduced methyl viologen in 
the screen to increase the number of lesions that MutY must repair. After the cells are grown to an 
OD at 600 nm of 0.4-0.6, 50 µM methyl viologen is added to the culture.  
     For each trial, standards are made using 100-0.39 milliunits of β-galactosidase. In addition, a 
BCA protein assay is performed with 200-0 µg/mL BSA standards to normalize for the total protein 
concentration in the cell lysate (Figure 4.15). In the presence of methyl viologen, WT, MutM-, 
MutY-, and Nth- strains that have been transfected with reporter plasmids produce more β-
galactosidase than those with control vectors, which is significant. On the other hand, the difference 
between WT and MutY- is not large enough to identify proteins that affect MutY activity (Figure 
4.16). The WT strain (with reporter plasmids) turns red quickly, which convolutes comparisons 
between the strains. Starving the cells in minimal media (NCE) does not enhance our ability to 
differentiate WT and MutY- strains, which are the two controls for the experiment (Figure 4.17). 
     Lastly, we have randomized the position of strains within the microtiter plate to reduce 
experimental error. When we examine WT and MutY- strains that have been transfected plasmids, 
we observe an increase in absorption at 570 nm over 7 hours only in the samples that carry reporter 
vectors (Figure 4.18). Once again, however, the difference between WT and MutY- strains is very 
small (0.4 vs. 1), which provides a challenge in further developing this screen.  
 
Summary 
     The helper function assay is a valuable tool we can utilize to investigate metalloproteins that may 
cooperate in a DNA-mediated search process, thus we have employed multiple strategies to both 
enhance the signal and reduce the error of our measurements. The results described here support the 
model that EndoIII helps MutY search DNA for damage, yet there are still ways in which the assay 
may be improved.  
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Figure 4.15. (Top) Representative β-galactosidase standard curve (Bottom) BCA standard 
curve to normalize for total protein concentration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
157 
Figure 4.16. Miller Units over time (minutes) for ∆mutY, ∆nth, ∆mutM, and WT (BW25113) 
strains transformed with reporter plasmid and treated with 50 µM methyl viologen. Wild-type 
strains have also been transformed with control plasmids and remain yellow over time. 
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Figure 4.17. Miller Units over time (minutes) for ∆mutY, ∆nth, ∆mutM, and ∆iscu, and WT 
(BW25113) strains transformed with reporter plasmid and incubated in minimal media (NCE). 
Wild-type strains have also been transformed with control plasmids and remain yellow over time. 
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Figure 4.18.  Absorbance at 570 nm vs. time (minutes). ∆mutY and WT (BW25113) strands 
have been transformed with reporter plasmid (purple and red, respectively) or control plasmid 
(green and blue). When ∆mutY is transformed with reporter plasmid, the cells produce more β-
galactosidase. The controls remain yellow over time, as MutY is active and no β-galactosidase is 
generated.  
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     Although our initial attempts to increase reversion events using the oxidants: Rh(phi)2bpy3+ 
and methyl viologen enhance the overall signal, they significantly inhibit cellular growth. Then, 
rather than using chemical reagents, we exposed the cells to environments that were free of oxygen. 
After the cells were grown under these conditions, they were shocked with air or methyl viologen to 
generate oxidative lesions. This technique was not successful, but it did inspire the development of 
a new method: treatment of LB cultures with methyl viologen. One of the main reasons that the 
initial studies with methyl viologen were futile was that the cells died during the experiment. Thus, 
instead of subjecting cells to the reagent while they are in minimal media, we have incorporated a 
modified step in the procedure. The cells are first treated with methyl viologen while they are 
growing in LB media. Following this step, the cultures are spun down, resuspended in minimal 
media, and grown according to the original protocol. From these studies, we find that 50 µM methyl 
viologen increases the number of lac+ revertants. Concurrently, a new EndoIII strain (CC104 Δnth) 
has been compared to the original EndoIII knockout strain (CC104 nth-). Since EndoIII is 
completely deleted from the Δnth strain, we expected a large decrease in MutY activity; however, 
we do not observe this trend in the assay. 
     Proteins from a variety of repair pathways and organisms that contain a redox-active [4Fe4S] 
cluster are being discovered. We would like to expedite the hunt for these specialized 
metalloproteins so that we can characterize them and determine whether they are able to participate 
in a DNA-mediated search within the cell. To this end, we are working toward the development of a 
high-throughput screen to find genes that alter MutY activity. Though we have methodically 
improved the microtiter-based technique, performed 96-well plasmid transformations, and 
successfully constructed the independent components, the sensitivity of the assay is not optimal. 
Applying the protocols that we have used to improve the helper function assay, methyl viologen and 
minimal media have been incorporated in the screen to enhance the signal, but there is no 
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differential between control strains. These studies have established that generating and 
quantitating oxidative damage are key requirements to assay for MutY activity. Only when we can 
do this, will we be able to utilize the screen to identify other proteins containing a redox-active 
[4Fe4S] cluster that might signal MutY in the search for damage.  
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CHAPTER 5 
DNA Charge Transport as a First Step in Coordinating the Detection of Lesions by 
Repair Proteins 
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INTRODUCTION 
 
     Proteins in cellular repair pathways are charged with finding and correcting genomic lesions 
arising from a variety of sources including oxidative stress, UV radiation, and environmental 
mutagens (1). Specific repair proteins are allocated to target different types of DNA damage for a 
concerted attack. For example, the nucleotide excision repair (NER) pathway involves proteins that 
repair lesions that largely distort the helical structure of DNA in a variety of ways; dipyrimidine 
adducts and cis-platin cross-links are two structurally distinct examples. In contrast, different base 
excision repair (BER) glycosylases remove specific base lesions; in Escherichia coli, for example, 
Endonuclease III (EndoIII) targets oxidized pyrimidines while MutY repairs oxo-guanine-adenine 
mismatches (1-4).  
     Given that DNA facilitates charge transport (CT) over long molecular distances (5, 6) and this 
charge transport chemistry is sensitive to the wide variety of lesions that perturb DNA base stacking 
(7, 8), our laboratory has proposed that repair proteins exploit this unique property of DNA to 
search for damage (9-11). Several DNA repair proteins contain redox-active [4Fe4S] clusters that 
are not required for folding (12, 13). Examples of these proteins from the BER pathway, EndoIII 
and MutY, are activated toward oxidation as they bind DNA (14-16). While EndoIII effectively 
removes oxidized pyrimidines, the repair protein is found in very low copy number in E. coli (~ 500 
copies per cell) (17, 18).  Surprisingly, MutY, which removes adenine from 8-oxo-G:A mismatches, 
is found in even lower copy number with only ~ 30 copies per cell (19). These low copy numbers, 
along with the low selectivity of these proteins for their substrates relative to unmodified DNA, 
begs the question of how they can so effectively find and repair their target lesions in the genome. 
Importantly, mutations in the human MutY homolog (MUTYH) directly correlate to the 
development of colorectal cancer (20, 21).  
     We have recently examined whether DNA CT may play some role in how these BER proteins 
find their site (22, 23). Using DNA electrochemistry and AFM experiments, we found that the 
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ability of EndoIII mutants to localize in the vicinity of a base mismatch correlates with their 
ability to carry out DNA CT. Moreover, using a genetics assay, we found that EndoIII cooperates 
with MutY in vivo in finding MutY lesions, but that a CT-deficient mutant of EndoIII cannot 
similarly aid MutY (22). Interestingly, more proteins involved in genome maintenance that contain 
[4Fe4S] clusters are emerging, many with no clear structural or enzymatic role for their clusters. 
One such protein is XPD, which is part of the transcription factor IIH (TFIIH) machinery and is 
involved in nucleotide excision repair (NER) (24, 25). Here we consider if XPD, which is not 
involved in BER, similarly utilizes DNA CT to relocalize in the vicinity of lesions, and whether 
signaling between different DNA-binding proteins can occur so as to coordinate the search for 
damage (26, 27).  
     XPD, an ATP-dependent 5ʹ′-3ʹ′ helicase from the NER pathway, is a major component of TFIIH, 
the transcriptional and repair machinery that unwinds damaged DNA for lesion repair in NER (28, 
29). Mutations in the human XPD helicase gene (ERCC2) lead to the genetic disorders 
trichothiodystrophy (TTD), Cockayne syndrome (CS), and xeroderma pigmentosum (XP) (28-31). 
There is now evidence that mutations specifically in the iron-sulfur cluster domain of XPD result in 
TFIIH instability, thus leading to TTD (28, 30). Similarly, mutations in the analogous region on the 
related FancJ gene (which also encodes a helicase with an iron-sulfur cluster) causes predisposition 
to early-onset breast cancer (25, 32, 33). We have demonstrated that the [4Fe4S] cluster in 
Sulfolobus acidocaldarius (Sa)XPD is redox-active, with a redox potential equivalent to that of 
BER proteins EndoIII and MutY (~ 100 mV vs. NHE) (34).  
     Here we explore, using AFM, whether XPD can participate in DNA-mediated signaling to 
localize in the vicinity of a DNA mismatch.  Similar to base lesions, a single base mismatch inhibits 
DNA CT but importantly, the base mismatch is not a substrate for repair by XPD (35).  In our 
model for facilitated search by DNA CT (Figure 5.1), the search for DNA damage is initiated, under 
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oxidative stress, by the one-electron oxidation of a DNA-bound protein by a nearby guanine 
radical; the oxidation takes the cluster from a 2+ oxidation state to a 3+ oxidation state. But it is 
DNA CT between two repair proteins that leads to the redistribution in the vicinity of a lesion.  
With a DNA-bound potential shifted negative versus free protein (14), the proteins are expected to 
have a lower affinity for DNA in their reduced form. Thus, in the model, DNA-mediated reduction 
of one protein by the other leads to the dissociation of the reduced protein from DNA, effectively 
giving overall dissociation of repair proteins away from a region of the genome without lesions. Our 
model relies on the sensitivity of CT to proper π-stacking of the bases between the donor protein 
and the distant acceptor protein (22, 23); if instead there is an intervening lesion, DNA-mediated CT 
does not occur, and the repair protein remains bound and can processively move to the lesion and 
carry out enzymatic repair.  In this process, the repair proteins eventually relocalize in the vicinity 
of lesions or any modification that inhibits DNA CT. As a result the overall search regime for the 
repair proteins is made smaller than the full genome: they preferentially localize where needed for 
repair. 
     Despite various studies of EndoIII and MutY independently, it still remains to be established 
whether these proteins from different repair pathways (NER and BER) cooperate with one another 
in a coordinated search. Since a C:A mismatch, for example, does not distort the DNA helix, it 
would be expected to evade the biological NER pathway. Alternatively, if enzymes rely on 
DNA/protein CT as a first step in finding damage, then any protein that can carry out DNA CT can 
participate in the search, integrating repair pathways that were previously thought to be separate. To 
examine this coordinated search, AFM is used to visualize mixtures containing two types of 
proteins: i) those that are able to carry out DNA CT and ii) those that are defective at DNA CT. 
AFM, a technique that allows for visualization of single-molecule protein/DNA interactions, can be 
used to observe proteins bound to long strands (3.8 kbp) of DNA containing a site-specific 
mismatch (C:A) (23, 36-39).   
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Figure 5.1. Model for damage detection and redistribution by repair proteins. (Top) Given two 
repair proteins, containing [4Fe4S] clusters, that are able to carry out DNA CT, such as XPD or 
EndoIII (blue), CT can proceed through well-matched unmodified DNA. Driven by protein 
oxidation by guanine radicals (yellow) formed under oxidative stress, DNA CT occurs between the 
DNA-bound proteins, promoting the dissociation of reduced protein (light blue). DNA CT does not 
occur, however, in the presence of an intervening mismatch or lesion (red X); with the intervening 
mismatch or lesion, repair proteins are not reduced from a distance, and therefore do not dissociate 
but instead remain bound in the vicinity of the lesion. (Bottom) If repair proteins are mutants such 
as XPD L325V or EndoIII Y82A (red) and are unable to perform DNA CT (dashed line), they 
cannot send or receive signals to locate damage. In the presence of a lesion, these proteins then do 
not preferentially redistribute in the vicinity of the mismatch.  
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Binding density ratios calculated from counting strands and proteins in AFM images can then 
give us clues to the first step in lesion detection. Here, not only do we examine whether proteins 
from the NER pathway redistribute in the vicinity of lesions as a function of their ability to perform 
DNA CT but also whether they can cooperate with other repair proteins in the DNA-mediated 
search for damage.  
 
Materials and Methods All chemicals were purchased from Sigma Aldrich.  All enzymes were 
purchased from New England Biolabs unless otherwise specified. Mica surfaces were purchased 
from SPI supplies.  Silicon AFM probes were purchased from Budget Sensors. Oligonucleotides 
were purchased from IDT or synthesized on a 3400 DNA synthesizer (Applied Biosystems). 
 
Mismatched (C:A) strand synthesis Four primers with the following sequences were synthesized 
using standard phosphoramidite chemistry:  
1) 5ʹ′-GTACAGAGTTCAGTCGGCATCCGCTTACAGACAAGC-3ʹ′ (forward),  
2) 5ʹ′-CCGGTAACTATCGTCTTGAGTCC-3ʹ′ (reverse),  
3) 5ʹ′-GACTGAACTCTGTACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward),  
4) 5ʹ′-GACTGAACTCTATACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward) 
The underlined bases highlight the location of a 2ʹ′-O-methyl residue (Glen Research). Primers 
were phosphorylated using 5 U PNK, 10% PNK buffer, 0.5 mM ATP for 5 hrs at 37 °C.  Primers 
were purified using phenol-chloroform extraction followed by ethanol precipitation (40). After 
being dried in vacuo, primers were redissolved in 20 µL water and used in separate PCR reactions 
(41) using pUC19 as a template to generate two duplexes 1610 bp and 2157 bp (matched), each 
containing one 14-nucleotide single-strand overhang. Each 100 µL PCR reaction contained 50 
pmol of each of two primers, 1X Taq buffer (100 mM Tris-HCl, 15 mM MgCl2, 500 mM KCl, 
pH 8.3), 0.2 mM each dNTP, 1 ng plasmid template pUC19 and 3 U Taq polymerase (Roche).  A 
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typical step program for PCR was as follows: After incubation at 94°C for 10 minutes, 34 
cycles were performed as follows: 94°C for 1 minute, (52°C for primers 1+2, 54°C for primers 
2+3 or 2+4), for 1 min, and 72°C for 3 minutes. The PCR product was then suspended in 50 mM 
NaCl/ 5 mM phosphate buffer and quantitated. Separate duplexes were annealed at 65 °C for 8 
min in 10 mM Tris buffer, then cooled to 20 °C during 2 h. A total of 15 units of T4 DNA ligase 
and 10% T4 ligase buffer were added (total reaction volume ~ 20 µL) and incubated overnight at 
16 °C, followed by deactivation for 10 min at 65 °C to yield the 3767 bp (mismatched) long 
strand. We did not bring the ligation reaction to completion, so as to obtain a mixture of DNA 
samples that were equivalent other than the presence of the mismatch at the ligation site. The 
DNA duplexes (ligated and unligated) were then analyzed by 0.6% agarose gel electrophoresis. 
Single DNA strands complementary to short duplex overhangs were ordered from IDT:  
5ʹ′-GACTGAACTCTGTAC-3ʹ′ Tm=41.6 ° C (1.6 kbp duplex overhang),  
5ʹ′-GTACAGAGTTCAGTC-3ʹ′ Tm=41.6 ° C (2.2 kbp matched duplex overhang), and  
5ʹ′-GTATAGAGTTCAGTC-3ʹ′ Tm=37.5 ° C (2.2 kbp mismatched duplex overhang).  
Single-strand DNA was purified using reversed-phased HPLC and verified with MALDI-TOF 
mass spectrometry.   
 
Protein purification and expression EndoIII and Y82A EndoIII were expressed from the 
pNTH10 expression vector and purified as described previously (22).  EndoIII and Y82A were 
stored in 20 mM sodium phosphate pH 7.5, 100 mM NaCl, 20% glycerol, and 0.5 mM EDTA 
buffer. Protein concentrations were determined using the UV-visible absorbance of the [4Fe4S] 
cluster (410 nm, ε = 17,000 M-1cm-1) (42).  XPD was purified as previously described (34). 
 
AFM experiments AFM experiments were performed using the protocol similar to that reported 
previously (23). Stock DNA solution contained 50–200 ng of total DNA (~ 6 µM) composed of 
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the mixture of ligated 3.8 kbp duplexes and the two unligated duplexes (1.6 and 2.2 kb) in 6 
mM MgCl2/Tris-EDTA buffer. The 1.6 kb overhang complement (60 µM) was added to the DNA 
solution to block the 14 bp single-strand overhangs generated by PCR. This sample was then 
incubated overnight at 4 °C. XPD protein was dialyzed against the protein buffer (20 mM 
phosphate, 100 mM NaCl, 1 mM EDTA, 5% glycerol, pH 7.5 and filtered prior to use) to remove 
residual DTT.  The concentration of individual proteins were determined by UV/visible 
spectrophotometry (Beckman DU 7400) using ε=17,000 M-1cm-1 at 410 nM for the [4Fe4S] 
cluster.  After addition of excess 2.2 kb duplex complement (60 µM), XPD (0.6 µM) was added 
to the stock DNA solution to block single strand overhangs. This protein/DNA solution was 
incubated at 4 °C overnight. Sample was then deposited (5–10 µL) onto a freshly cleaved mica 
surface for 1–2 min, rinsed with 2 mL of water, and dried under argon. Mutant XPD protein 
(L325V) was added to a stock solution of 50 ng DNA for a final protein concentration of 0.6 µM. 
Deposition conditions were identical to that for WT XPD- DNA samples after incubation at 4 °C 
overnight.  
     For mixed protein experiments (WTXPD/WTEndoIII, WTXPD/Y82AEndoIII, WTEndoIII/L325VXPD, and 
WTXPD/L325VXPD), XPD, EndoIII, L325V, or Y82A were added to the prepared DNA solution 
described previously at equimolar (1:1) concentrations (0.3 µM each) prior to incubation at 4 °C 
overnight. WTXPD/Y82AEndoIII (3:1) mixtures were prepared by adding 0.45 µM WT XPD and 
0.15 µM Y82A to the DNA solutions.  Protein/DNA complexes were formed with DNA solution 
containing ~ 200 ng of the mixture of PCR products and overhang complements (~ 6 µM DNA) 
in 6 mM MgCl2 /Tris-EDTA buffer at 4°C overnight. The reaction mixture was then deposited 
(5–10 µL) on the mica surface for 1–2 minutes, rinsed with 2 mL water and dried under argon.  
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AFM instrumentation Silicon AFM Probes purchased from Budget Sensors, with a spring 
constant of 3 N/m and a resonance frequency of 75 kHz, were used in a Digital Instruments 
Multimode SPM. Images were captured in air with scan areas of 2 x 2 µm2 or 3 x 3 µm2 in 
tapping mode, at an amplitude of 0.54–2.00 V and at a scan rate of 3.05 Hz.  Scan rates of 3.05 
Hz were used in order to obtain images of higher quality.  
 
Binding density ratio calculations WSxM software was used to measure general DNA contour 
lengths and height profiles of the proteins as described previously (23, 43). For each data set, 
images from at least three independent samples were analyzed, compared, and pooled (>200 long 
or short strands). Distinguishable strands and protein positions were counted by hand. The 
binding density ratio, r, is defined as the ratio of the proteins bound on long strands divided by 
proteins bound on short strands. The ratio is normalized for length by dividing by 1.9 kbp, which 
is the average length of the short strands. Binding affinities were found by determining the 
number of proteins bound per kilobasepair strand. The uncertainty was determined through the 
total number of proteins observed. 
 
Protein electrochemistry Protein electrochemistry was performed as previously described (34).  
Briefly, individual proteins samples were dialyzed to remove residual DTT and quantified based on 
410 nm absorbance.  Protein was then added to a DNA modified electrode containing a 9 nucleotide 
5ʹ′ single-strand overhang.  Cyclic voltammograms were then obtained using Ag/AgCl reference 
electrodes, Pt auxiliary electrode at 50 mV/s scan rate on a CH Instruments 620C electrochemical 
analyzer.   
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RESULTS 
Experimental strategy using AFM to probe protein distribution We have previously demonstrated 
with BER proteins that the ability of a protein to perform DNA CT directly correlates to its 
redistribution in the vicinity of base lesions or mismatches that inhibit CT (23). We tested XPD 
redistribution promoted through DNA CT by preparing DNA strands containing a single C:A 
mismatch, a modification that we know to inhibit CT (44), alongside DNA strands containing no 
mismatches. To distinguish the strands in microscopy experiments, we made mismatched strands > 
1200 base pairs longer than the matched strands. AFM was utilized to gather images of DNA and 
bound protein that could be further analyzed to examine the propensity of XPD to redistribute. ATP 
was not incorporated in AFM experiments, as XPD helicase activity should not be required for a 
DNA-mediated redistribution.  
     Long (3.8 kilobase) DNA duplexes containing a site-specific C:A mismatch and short (2.2 and 
1.6 kilobases) well-matched duplexes of the same total sequence were constructed. To prepare these 
DNA samples, pUC19 plasmid was amplified with primers incorporating a 2ʹ′-O-methyl residue to 
yield two short duplexes containing 14-nucleotide single-strand overhangs (23, 41). Upon ligation 
of these two duplexes, 3.8 kbp strands were formed that contained only one C:A mismatch in the 
middle of the strand. The ligation reaction was not taken to completion so as to have a mixture of 
well-matched short and mismatched long strands for protein distribution studies. Although a C:A 
mismatch effectively inhibits DNA CT (44), it is not a lesion that is preferentially bound by XPD. 
However, the 14-nucleotide overhangs generated with PCR are specific substrates for XPD helicase 
(Kd~1 µM) (25, 45). We directly observed this preference in initial AFM experiments.  Protein 
assignments were verified through analysis of their 3–4 nm heights in the images; without protein, 
features of this dimension were not observed and larger heights (> 7 nm) indicated salt precipitates 
or protein aggregation. Only clearly identifiable long or short strands and bound proteins were 
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counted. XPD protein position was determined based on the distance of the protein from the end 
of the strand.  
     We examined distribution with and without blocking the ends of short strands, given that XPD 
has some preferential binding affinity for single-strand overhangs. Comparing raw protein position 
(middle versus ends) on long and short strands, XPD exhibited a large preference for the ends (~ 
300 bp range) of short duplexes containing overhangs (> 50% of bound proteins) (Figure 5.2). To 
block XPD from binding to the 14 bp segment, overhang complements were added to DNA/protein 
solutions in excess. We found, when we blocked the overhangs, no preferential binding to the short 
strands was observed (vide infra). 
 
Detection of XPD Complexes AFM images of DNA-bound protein complexes are represented in 
Figure 5.3. XPD protein bound to matched DNA (Figure 5.3 top) can be easily distinguished based 
on strand height profile of tapping mode images. Zoomed-in images display clearly identifiable 
long and short strands with protein bound (Figure 5.3 bottom). Images of DNA and protein 
complexes were acquired with a scan size of 2 x 2 µm2 or 3 x 3 µm2 at a scan rate of 3.05 Hz. Since 
AFM images vary with surface cleavage, sample wetness, deposition time and volume, > 200 long 
or short strands were counted for at least three independent samples. The uncertainty was based on 
the total number of proteins counted.  Importantly, we measured the relative binding affinity of 
mutants and WT proteins, and in all of the samples described, the number of proteins bound per 
base pair remained constant. Thus, any changes we see in distribution are not due to differences in 
binding affinities of proteins. 
     In order to probe the DNA CT properties of a redox-active DNA helicase, XPD and DNA 
complexes were examined with AFM. XPD shows redistribution onto long mismatched strands 
with a ratio of protein binding densities, r (long/short) of 1.54 ± 0.08. We observed 0.23 proteins 
per kilobase of long strand and 0.15 proteins per kilobase of short strand.  
  
175 
Figure 5.2. Distribution of XPD on DNA containing short strands with overhangs. Protein 
position (middle versus ends) on long and short strands is shown in blue and red respectively. The 
middle region of the short strands is ~ 1300 bp. The middle of the long strands is ~ 3200 bp.  Ends 
of the strands are ~ 300 bp. 
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Figure 5.3. Atomic force microscopy to visualize DNA-bound proteins. Tapping mode AFM 
images of DNA and XPD protein on mica imaged in air. The matched strands and protein (dots) are 
visible on the surface (top). Since the single-strand overhangs on the short duplexes have been 
blocked by annealing short oligomers, XPD is bound in random positions on the DNA.  Zoomed-in 
images of long (3.8 kbp) and short (1.6 and 2.2 kbp) DNA strands with bound proteins (black 
arrows) are shown below. Images were acquired with a scan size of 2 x 2 µm2 or 3 x 3 µm2, at a rate 
of 3.05 Hz with a data scale of 10 nm/ 0.5 V.  
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If, instead, we examine XPD distribution when long and short strands are fully matched, we 
see a binding density ratio of 0.94 ± 0.05. Previously, for EndoIII we found r, for (long/short) was 
1.6 ± 0.09 (22). We expect a ratio of 1 if there were an equal distribution of proteins on matched 
and mismatched strands (22). Thus, similar to EndoIII distribution, XPD, an NER protein with 
DNA-bound redox-activity, redistributes to localize in the vicinity of a C:A mismatch.   
     We also tested the possible redistribution of a CT-deficient mutant of SaXPD,   (L461 in 
human XPD). L325V, aligns with mutated residues in human XPD and Schizosaccharomyces 
pombe Rad 15 that are associated with TTD, XP, and XP/CS (25, 31, 33). It should be noted, 
however, that the structural scaffold required to form the TFIIH machinery is not disrupted in the 
L325V mutant. As evident in Figure 5.4, the L325V XPD mutant exhibits an electrochemical 
signal that is less than half that of WT XPD, indicating it is deficient at performing DNA CT. 
Interestingly, L325V is 30 Å away from the [4Fe4S] cluster (Figure 5.5), yet affects protein/DNA 
CT.  Significantly, when we examine whether this electrochemically deficient mutant 
redistributes onto the mismatched strand in our AFM assay, we find that there is no preference for 
the mismatched strands; L325V exhibits a protein binding density ratio, r (long/short) of 1.14 ± 
0.06 in mismatched samples, which is within error of the fully matched binding density ratio r 
(long/short) of 1.05 ± 0.07 (Figure 5.6). Thus, as with the CT-deficient EndoIII mutant Y82A 
(22), we find a correlation between the inability of L325V to perform CT and its lack of 
redistribution onto mismatched strands. Even though the [4Fe4S] cluster is intact, this mutant 
protein cannot cooperate with other proteins using DNA CT.  
 
Atomic force microscopy of protein mixtures We have established that DNA-mediated CT occurs 
on a much faster time scale than protein diffusion (46, 47), and we have characterized several 
mutants of EndoIII, from the BER repair pathway that exhibit similar midpoint potentials of ~ 80 
(±30) mV vs. NHE yet differ in their ability to carry out DNA CT (14, 23, 26).  
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Figure 5.4.  DNA CT with the L325V mutant. Cyclic voltammogram (CV) of WT SaXPD (8 
µM) (green) and L325V SaXPD (8 µM) (red) on DNA modified electrodes after 90 minutes 
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Figure 5.5. Crystal structure of SaXPD (pdb ID: 3crv). The structure shown was adapted from 
reference (25). L325 is highlighted in red, and aromatic residues are shown in orange. 
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Figure 5.6. (Left) Representative AFM image of L325V XPD bound to mismatched DNA 
strands (red circle). The image was acquired at a rate of 3.05 Hz with a data scale of 10 nm. (Right) 
Quantitation of XPD and mutant L325V protein density ratios (< 10% uncertainty) where C:A 
indicates a mismatch is contained in long strands. The unmarked bars show the control 
measurements for fully matched long and short strands.  XPD redistributes onto mismatched 
strands. L325V, CT-deficient, does not show redistribution. 
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We have not, however, yet provided evidence that different proteins can signal one another through 
DNA-mediated CT.  AFM provides an opportunity to examine this issue by assaying protein 
mixtures.   
    To test this, WT XPD and EndoIII, both proficient at DNA CT, were mixed in a 1:1 equimolar 
ratio with DNA. Short duplex overhangs were blocked with excess complementary single strand. 
Figure 5.7 shows representative images of fully matched DNA strands or mismatched DNA strands 
incubated overnight with XPD/EndoIII 1:1 protein (WTXPD/WTEndoIII). XPD is twice as large as 
EndoIII (65 and 32 kDa, respectively) (pdb IDs: 3crv, 1p59). The average height of the protein in 
AFM studies can be estimated using the equation: R=0.717(M)1/3 where R is the radius of the 
protein globule in Å and M is the mass of the protein in Da (48). Thus, XPD is expected to have a 
height of 5.6 nm, which is within error of EndoIII (4.6 nm).  While in general we cannot distinguish 
them, select images (Figure 5.7 inset) are suggestive of both EndoIII and XPD binding. XPD (0.3 
µM)/EndoIII (0.3 µM) 1:1 protein mixture shows that XPD and EndoIII redistribute onto long 
mismatched strands, with a binding density ratio r (long/short) of 1.75 ± 0.13. Fully matched 
controls yield a binding ratio r (long/short) of 1.02 ± 0.07. Importantly, controls were also 
performed with only XPD (0.3 µM) under the same conditions as mixed protein experiments. 
Consistent with XPD at a higher concentration (0.6 µM), XPD at half the concentration (0.3 µM) 
redistributes onto long mismatched strands (r = 1.38 ± 0.07) with no redistribution in fully matched 
samples (r = 1.08 ± 0.07) (Figure 5.8).  Significantly, mixing XPD and EndoIII protein results in a 
binding density ratio of 1.75, which is higher than that of each protein separately (Figure 5.9). This 
suggests that these two proteins signal one another to localize in the vicinity of the lesion. 
     In order to explore cooperativity between XPD and EndoIII, we then replaced WT EndoIII with 
mutant Y82A EndoIII, a protein that binds to DNA but cannot perform DNA-mediated CT 
efficiently (22).  
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Figure 5.7. Representative tapping mode AFM images. Fully matched long and short DNA 
strands (left) or mismatched long DNA and matched short DNA strands (right) are incubated 
overnight with XPD/EndoIII 1:1 protein mixture. Inset shows zoomed-in view of a long DNA 
strand with both large (~ 6 nm) and small (~ 3.5 nm) proteins bound.  
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Figure 5.8. Quantitation of XPD (0.6 µM) and XPD (0.3 µM) protein density ratios (< 10% 
uncertainty) where C:A indicates a mismatch is contained in long strands. XPD redistributes at both 
concentrations. 
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In previous studies, Y82A did not redistribute in mismatched samples (r = 0.9 ± 0.1) (22). When 
XPD is mixed with Y82A 1:1 (WTXPD/Y82AEndoIII), there is no redistribution onto mismatched 
strands (r = 0.98 ± 0.05). WTXPD/Y82AEndoIII matched controls are within error of mismatched 
results with a binding density ratio of 1.11 ± 0.07 (Figure 5.9). The number of proteins bound per 
kilobasepair remains the same between WTXPD/Y82AEndoIII and WTXPD/WTEndoIII mixtures (0.13 
proteins/kbp) (Table 5.1). When WTXPD is titrated into Y82AEndoIII  at a ratio of 3:1, increasing the 
probability that two proteins bound on the same strand are both electrochemically active, the 
proteins once again redistribute onto mismatched strands (Figure 5.10). 
     Complementing WTXPD/WTEndoIII and WTXPD/Y82A EndoIII mixture studies, we also investigated 
signaling between EndoIII and XPD mutant L325V. Similar to EndoIII Y82A, XPD L325V cannot 
redistribute onto mismatched strands. WTXPD/L325VXPD 1:1 mixtures were examined initially to 
determine whether L325V, deficient in DNA CT, could signal XPD. WTXPD/L325VXPD mixtures 
showed no redistribution (r = 0.88 ± 0.04). This result was within error of matched controls, with a 
binding density ratio revealing even a slight preference for short strands (r = 0.90 ± 0.05). L325V 
inhibits XPD from relocalizing in the vicinity of lesions, but does L325V have any influence on the 
search for damage by EndoIII BER protein? WTEndoIII/L325VXPD mixtures were examined and 
exhibited no difference in mismatched versus matched samples, where r = 1.02 ± 0.05 and 0.94 ± 
0.04, respectively. As with the WTXPD/Y82AEndoIII mixture, here we see that L325V binding alters 
EndoIII redistribution. Figure 5.9 shows binding density ratio comparisons for WTXPD/WTEndoIII, 
WTXPD/Y82AEndoIII, WTEndoIII/L325VXPD, and WTXPD/L325VXPD  1:1 protein mixtures.  
     In the case of the mixtures of active proteins and CT-deficient mutants, we might have expected 
binding density ratios to be equal to that of pure samples of active repair protein.  However, we are 
testing these redistributions at protein loadings on the DNA strands of ~ 2 per strand.  Thus if one of 
the proteins is CT-defective, there is no protein to which the CT-proficient protein may signal.  
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Figure 5.9. Summary of binding density ratios for XPD (red text)/EndoIII (blue text) and 
mutant mixtures. Quantitation of protein density ratios (< 10% uncertainty) where C:A indicates a 
mismatch is contained in long strands. WTXPD/WTEndoIII mixtures 1:1 (purple), both proteins CT 
proficient, redistribute onto mismatched strands. WTXPD/Y82AEndoIII  and WTEndoIII/L325VXPD  1:1 
mixtures (green and orange, respectively), Y82A and L325V both mutants deficient in CT, do not 
show redistribution. WTXPD/L325VXPD 1:1 mixtures (blue) do not show redistribution, as XPD 
cannot perform DNA-mediated signaling if the L325V mutant is present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
186 
Figure 5.10. Titration with WT XPD. Quantitation of protein density ratios (< 10% uncertainty) 
where C:A indicates a mismatch is contained in long strands. WTXPD/Y82AEndoIII mixtures 1:1 
(purple), both proteins CT proficient, redistribute onto mismatched strands. WTXPD/Y82AEndoIII 1:1 
mixtures (green), Y82A mutant deficient in CT, do not show redistribution. WTXPD/ Y82AEndoIII 3:1 
mixtures (teal) show that redistribution redistribution is restored, as WT XPD is present at higher 
concentrations. 
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Table 5.1. Binding Density Ratios for Atomic Force Microscopy Samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Binding Density Ratio (BDR) is reported as (number of proteins bound on long strands (3.6 
kbp)) /number of long strands) divided by the (number of proteins on short strands (1.9 
kbp))/number of short strands) normalized for length. (CA) represents samples with long 
mismatched strands. 
 
b) These data represent three individual samples with 10–20 images per sample. L325V is a mutant 
of wild-type XPD, and Y82A is a mutant of wild-type EndoIII. 
 
c) Error is reported as the (total number of proteins divided by the square root of the total number of 
proteins counted) times 100 for each type of sample. 
 
 
 
 
 
 
 
 
 
Sample BDRa,b Long Strands Proteins Short Strands Proteins Error (%)c Prot./Kbp
0.6 uM XPD 0.94 307 216 360 142 5.3 0.19
0.6 uM XPD (CA) 1.54 354 304 323 95 5 0.20
0.3 uM XPD 1.08 304 123 502 99 6.7 0.11
0.3 uM XPD (CA) 1.38 376 271 354 97 5.2 0.18
L325V 0.6 uM 1.05 221 149 251 85 6.5 0.18
L325V 0.6 uM (CA) 1.14 311 236 415 145 5 0.19
XPD/EndoIII 1:1 1.02 221 127 257 76 7 0.15
XPD/EndoIII 1:1 (CA) 1.75 253 150 370 66 7.6 0.13
XPD/Y82A 1:1 1.11 468 183 665 123 6 0.10
XPD/Y82A 1:1 (CA) 0.98 496 258 538 150 5 0.14
EndoIII/L325V 1:1 0.94 327 263 412 186 4.7 0.22
EndoIII/L325V 1:1 (CA) 1.02 361 217 553 171 5.1 0.16
XPD/L325V 1:1 0.90 309 174 408 134 5.7 0.16
XPD/L325V 1:1 (CA) 0.88 564 329 653 227 4.2 0.16
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Certainly the striking differences seen between CT-active protein mixtures and those containing 
CT-deficient mutants support the idea that the proteins can carry out DNA CT to one another.  
Having established that this ability to redistribute in the vicinity of mismatches depends on the 
ability of the protein to carry out DNA CT (23), these results thus provide evidence for DNA CT as 
a means of inter-protein signaling. 
 
Discussion 
     The data presented here indicate that XPD, an archaeal protein from the NER pathway, may 
cooperate with other proteins that are proficient at DNA CT to localize in the vicinity of damage. 
XPD, a superfamily 2 DNA helicase with 5ʹ′-3ʹ′ polarity, is a component of TFIIH that is essential 
for repair of bulky lesions generated by exogenous sources such as UV light and chemical 
carcinogens (28, 49, 50). XPD contains a conserved [4Fe4S] cluster suggested to be 
conformationally controlled by ATP binding and hydrolysis (25). Mutations in the iron-sulfur 
domain of XPD can lead to diseases including TTD and XP, yet the function of the [4Fe4S] cluster 
appears to be unknown (23, 28, 29). Electrochemical studies have shown that when BER proteins 
MutY and EndoIII bind to DNA, their [4Fe4S] clusters are activated toward one electron oxidation 
(14, 26). XPD exhibits a DNA-bound midpoint potential similar to that of EndoIII and MutY when 
bound to DNA (~ 100 mV vs. NHE), indicative of a possible role for the [4Fe4S] cluster in DNA-
mediated CT (34). For EndoIII we have also already determined a direct correlation between the 
ability of proteins to redistribute in the vicinity of mismatches as measured by AFM, and the CT 
proficiency of the proteins measured electrochemically (23). Thus, we may utilize single-molecule 
AFM as a tool to probe the redistribution of proteins in the vicinity of base lesions (Figure 5.11) and 
in so doing, the proficiency of the protein to carry out DNA CT.  
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Figure 5.11. Representative tapping mode AFM images of XPD. (Left) Zoomed-in view of a 
DNA strand with XPD protein bound with height scale shown in color (yellow is ~ 4–6 nm). 
(Right) AFM to visualize multiple XPD proteins bound to a single matched strand of DNA. 
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Here we show that, like the BER protein EndoIII, XPD, involved both in transcription and 
NER, redistributes in the vicinity of a lesion.  Importantly, this ability to relocalize is associated 
with the ability of XPD to carry out DNA CT. The mutant L325V is defective in its ability to carry 
out DNA CT and this XPD mutant also does not redistribute effectively onto the mismatched 
strand. 
     Moreover, these data provide evidence that two different repair proteins, each containing a 
[4Fe4S] cluster at similar DNA-bound potential, can communicate with one another through DNA-
mediated CT. This result becomes more interesting still given that in the experiments conducted 
here, the proteins are from completely different organisms.  Nonetheless, what is critical is that the 
protein clusters have similar DNA-bound potentials, facilitate many electron exchanges, and have 
the ability to carry out DNA-mediated CT.  Furthermore, no signaling to effect the redistribution in 
the vicinity of lesions occurs when one partner is CT-deficient. 
     Lesion detection by repair proteins, based on our model, depends on the maximum distance over 
which DNA-mediated CT can occur and the percentage of proteins oxidized (6, 22, 51). While we 
have documented that DNA CT occurs over at least 100 bp, we do not yet know the maximum 
distance for this process (5, 52). If CT could proceed only over short distances (<500 bp), more than 
6 proteins would be required for signaling across strands. Instead, only 1–3 proteins are bound to 
the long matched or mismatched strands in AFM experiments, suggesting that DNA CT is 
occurring over distances much greater than those we have measured electrochemically. 
     How might this signaling be utilized inside the cell? Surely, this ability to redistribute in the 
vicinity of lesions reduces the search process required to find lesions across the genome. The higher 
the concentration of total proteins involved in signaling that are at similar potentials, the more 
efficient the search process becomes (22). Indeed, XPD may utilize DNA-mediated CT to signal its 
presence and perhaps to “call off” other proteins from other repair pathways.  Various DNA-
binding proteins, such as those involved in repair and other DNA transactions, have been found to 
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contain iron-sulfur domains and other redox cofactors (53-56). DNA-mediated signaling among 
DNA-binding proteins that are involved in maintaining the integrity of the genome allows a 
coordination of repair, transcription and replication processes. 
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CHAPTER 6 
Visualizing XPD Helicase Activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P.A.S. designed and performed the AFM experiments with summer undergraduate student, Alison 
Parisian. J.O.F and J.A.T. provided XPD. 
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INTRODUCTION 
     In the cell, DNA is under incessant attack from sources including reactive oxygen species, 
UV-light, and metabolic byproducts (1). Subsequently, lesions that arise threaten the integrity of 
the genome. Cells, however, possess a variety of repair pathways to efficiently detect and fix sites 
of damage.  One of these, nucleotide excision repair (NER), is thought to be the most versatile of 
these pathways (2). Specifically, NER repairs lesions that largely distort the helical structure of 
DNA; guanine-cisplatin adducts and benzo[a]pyrene-guanine adducts are distinct examples and 
notably, in humans, NER machinery is the only defense against photoproducts (2). In particular, 
XPD and XPB, 5ʹ′-3ʹ′ and 3ʹ′-5ʹ′ helicases, respectively, are components of the ten-subunit 
transcription factor (TFIIH) responsible for binding near the damaged site and unwinding the 
DNA that surrounds the lesion, thereby exposing it for repair (2). Mutations in XPD and XPB 
have been associated with severe diseases such as xeroderma pigmenostum, Cockayne syndrome, 
and trichothiodystrophy (2-4). The catalytic core of XPD is comprised of four domains: helicase 
domain 1 (HD1), helicase domain 2 (HD2), Arch domain, and of interest to us, a [4Fe4S] domain 
(Figure 6.1) (3, 4). Over 50% of the known point mutations that are associated with diseases are 
found in these regions (3). Additionally, XPD contains a loop motif in the [4Fe4S] cluster domain 
similar to the FeS cluster loop motif (FCL) found in MutY, a BER protein from E. coli that 
exhibits a DNA-bound redox potential of ~ 100 mV vs. NHE (2, 5, 6). Two arginines, R88 in 
XPD and R153 in MutY, are conserved, similarly oriented, and shield the [4Fe4S] cluster (2). We 
then ask whether the resemblance between MutY and XPD extends beyond the presence of an 
[4Fe4S] cluster to a relationship, mediated by DNA charge transport (CT), between proteins to 
cooperate in the search for damage within the genome. 
     Helicase activity of XPD is required for repair but not for transcription (3). Because of its 
proximity to the ATP-binding site (HD1/HD2 interface), the [4Fe4S] cluster may be coupled to  
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Figure 6.1. SaXPD crystal structure with domains HD1 (yellow) and HD2 (green) forming 
the ATP-binding interface (red). The [4Fe4S] domain holds the cluster (blue: residues 81–149), 
and the Arch domain is in purple.  Structure constructed based on reference (3) using pdb ID: 
3crv. 
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ATP binding and hydrolysis (3). Wild-type XPD has an ATP-hydrolysis rate of 0.55 mol 
ATP/mol/s and a rate of unwinding ssDNA containing a 5ʹ′ overhang of 2.22 bp/min (human 
XPD: Kd=46 nM) (3). Loss of the [4Fe4S] cluster abolishes the helicase activity, however, this is 
not necessarily coupled to the ability of the protein to bind DNA nor to its structure and folding 
properties (3). For example, a conserved mutation found in disease phenotypes, G34R lacks 
ATPase activity and helicase activity yet it binds ssDNA with an affinity 155% that of wt XPD 
(3). K84H, a mutation at a residue near the [4Fe4S] cluster decreases helicase activity but does 
not affect ATPase rates. K84H XPD binds ssDNA with an affinity (Kd=80 nM) ~ 58% that of wt 
(3). Currently, there is no crystal structure of XPD bound to DNA, but recently, we have 
employed a variety of techniques to investigate whether XPD is indeed another protein containing 
a [4Fe4S] cluster that exhibits a DNA-bound redox potential conducive to relaying charge to and 
from other proteins (6-10). 
     Using electrochemical methods, we have demonstrated that XPD has a DNA-bound potential 
similar to that of BER enzymes we have examined the past (~ 80 mV vs. NHE) (9).  Moreover, 
we directly observe that the efficiency of DNA CT is enhanced in an ATP-dependent manner (9). 
As ATP is added to XPD bound to DNA on an electrode, the current increases. When we 
substitute ATP with a non-hydrolyzable analogue, XPD is not able to perform DNA CT as 
efficiently. Also, consistent with biochemical studies by Tainer et al. (3), the SaXPD G34R 
mutant described above does not mediate DNA CT as well as wt XPD (9). Thus, we have used 
this assay not only to examine the DNA-bound redox potential of XPD but also to directly 
measure helicase activity. Does the ability of XPD to find lesions correlate with the addition of 
ATP? Does the addition of ATP help XPD “lock in” to the DNA strand to cooperate with other 
proteins in a DNA-mediated search? 
     To test this, we have employed single-molecule atomic force microscopy (AFM) to investigate 
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the ability of XPD to find lesions in strands of DNA (10). In an effort to link the efficiency of 
XPD to perform DNA CT with its biochemical function, here, we induce the helicase activity of 
XPD by incorporating ATP in the experiments, at concentrations comparable to those applied in 
electrochemical studies. Other AFM studies with helicases have established that it is indeed 
possible to track proteins as they unwind DNA (11-16). Notably, as these enzymes separate the 
DNA duplex, strands will appear as “forks” in high-resolution images (11). To this end, we have 
substituted ATP with a caged-ATP analogue, which, importantly, we can trigger with UV-light, 
thereby releasing energy to activate XPD helicase. Upon irradiation, we observe forked DNA 
structures, indicative of XPD helicase activity, yet we are still working to increase the speeds with 
which we gather images. With improved resolution, we hope to observe XPD redistribution and 
helicase activity in “real-time”.  
 
 
 
Materials and Methods All chemicals were purchased from Sigma Aldrich.  All enzymes were 
purchased from New England Biolabs unless otherwise specified. Mica surfaces were purchased 
from SPI supplies.  Silicon AFM probes were purchased from Budget Sensors. Oligonucleotides 
were purchased from IDT or synthesized on a 3400 DNA synthesizer (Applied Biosystems). 
 
Mismatched (C:A) Strand Synthesis Mismatched and matched strands were prepared according 
to the protocol described in Chapter 5. 
 
 
Protein Purification and Expression Protein concentrations were determined using the UV-
visible absorbance of the [4Fe4S] cluster (410 nm, ε = 17,000 M-1cm-1) (17).  XPD was purified 
as previously described (9). 
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AFM Experiments AFM experiments were performed using the protocol similar to that 
reported previously (8, 10). Stock DNA solution contained 50–200 ng of total DNA (~ 6 µM) 
composed of the mixture of ligated 3.8 kbp duplexes and the two unligated duplexes (1.6 and 2.2 
kb) in 6 mM MgCl2/Tris-EDTA buffer. The 1.6 kb overhang complement (60 µM) was added to 
the DNA solution to block the 14 bp single-strand overhangs generated by PCR. This was then 
incubated overnight at 4 °C. XPD protein was dialyzed against the protein buffer (20 mM 
phosphate, 100 mM NaCl, 1 mM EDTA, 5% glycerol, pH 7.5 and filtered prior to use) to remove 
residual DTT.  The concentration of individual proteins were determined by UV/visible 
spectrophotometry (Beckman DU 7400) using ε=17,000 M-1cm-1 at 410 nM for the [4Fe-4S] 
cluster.  After addition of excess 2.2 kb duplex complement (60 µM), XPD (0.6 µM) was added 
to the stock DNA solution. This protein/DNA solution was incubated at 4 °C overnight. Sample 
was then deposited (5–10 µL) onto a freshly cleaved mica surface for 1–2 min, rinsed with 2 mL 
of water, and dried under argon.  
 
AFM Studies of XPD + 2 mM ATP Samples containing 34.25 µL Tris EDTA buffer, 14 µL 20 
mM MgCl2 (to a concentration of 6 mM), 0.75 µL of the appropriate DNA ligation products (6 
µM), and 0.66 µL (60 µM) complementary strand (primer 2 in excess of DNA) were prepared and 
incubated for 24 hours at 4 ºC. The samples were removed from the refrigerator and 
complementary strand (primer 3 for matched primer 4 for mismatched) was added in excess. The 
sample was vortexed and quickly centrifuged to mix the contents, then split into two 25 µL 
aliquots. 1.5 µL of 10 µM XPD protein was added to each aliquot (to a concentration of 0.6 µM) 
and samples were incubated for another 24 hours at 4 ºC. For ‘incubated’ samples, 1 µL of 50 
mM ATP stock was added to each sample (2 mM working concentration) directly after protein 
addition and incubated with the sample for 24 hours. For ‘deposition samples’ ATP was added to 
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the sample (2 mM) immediately before surface deposition.  
 
AFM Studies of XPD + 5 mM ATP Samples containing 34.25 µL Tris EDTA buffer, 12.5 µL 20 
mM MgCl2 (to a concentration of 5 mM), and 0.75 µL of the appropriate DNA ligation products 
(6 µM) were prepared and incubated for 24 hours at 4 ºC. The samples were removed from the 
refrigerator and split into two 25 µL aliquots. 1.5 µL of 10 µM XPD protein was added to each 
aliquot (to a concentration of 0.6 µM) and the samples were incubated for another 24 hours at 4 
ºC. For ‘incubated’ samples, 2.5 µL of 50mM ATP stock (5 mM working concentration) was 
added to each sample directly after protein addition and incubated with the sample for 20 
minutes. For ‘deposition samples’ ATP was added to the sample (5 mM) immediately before 
surface deposition.  
 
Caged ATP studies An initial sample of 34.25 µL Tris EDTA buffer, 14 µL 20 mM MgCl2 (to a 
concentration of 6 mM), and 0.75 µL the appropriate ligation reaction of DNA (6 µM) was prepared 
and incubated for 24 hours at 4 ºC. The sample was then removed from the refrigerator and split 
into two 25 µL aliquots. 1.5 µL of 10 µM XPD protein was added to each aliquot (to a 
concentration of 0.6 µM) and samples were incubated for another 24 hours at 4 ºC. In incubated 
samples, 1 µL of 50 mM NPE-caged ATP (Invitrogen) was added (2 mM) directly following the 
addition of protein and incubated with the sample for 24 hours. As an alternative method, ATP was 
added (2 mM) 20 minutes before deposition onto the surface. The sample was not dried to 
completion. The sample was irradiated either after it was deposited onto the mica surface, or from 
directly above the eppendorf test tube. Prior to activation of caged ATP (355 nm) with a small 
handheld light, the overhead lights were kept off. The imaging procedure is still being optimized.  
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AFM to Probe XPD Helicase Activity 6 mM MgCl2 and 6 µM DNA in Tris-EDTA buffer is 
incubated overnight at 4 °C. 0.6 µM XPD was added, and the sample was incubated overnight once 
again with 5 mM ATP alongside a control that has water added instead of ATP. An aliquot of the 
sample was be imaged at this point. XPD will preferentially bind to the short strand overhangs (14 
bp).  
 
AFM Instrumentation Silicon AFM Probes purchased from Budget Sensors, with a spring 
constant of 3 N/m and a resonance frequency of 75 kHz, were used in a Digital Instruments 
Multimode SPM. Images were captured in air with scan areas of 2 x 2 µm2 or 3 x 3 µm2 in 
tapping mode, at an amplitude of 0.54–2.00 V and at a scan rate of 3.05 Hz.  Scan rates of 3.05 
Hz were used in order to obtain images of higher quality.  
 
Binding Density Ratio Calculations WSxM software was used to measure general DNA contour 
lengths and height profiles of the proteins as described previously (8, 10). For each data set, 
images from at least three independent samples were analyzed, compared, and pooled (> 200 long 
or short strands). Distinguishable strands and protein positions were counted by hand. The 
binding density ratio, r, is defined as the ratio of the proteins bound on long strands divided by 
proteins bound on short strands. The ratio is normalized for length by dividing by 1.9 kbp, which 
is the average length of the short strands. Binding affinities were found by determining the 
number of proteins bound per kilobasepair strand. The uncertainty was determined through the 
total number of proteins observed. 
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Results and Discussion 
 
 
Atomic Force Microscopy of XPD + ATP  We have previously demonstrated with BER proteins 
that the ability of a protein to perform DNA CT directly correlates to its redistribution in the vicinity 
of base lesions or mismatches that inhibit CT (8, 10). We have tested XPD, an NER protein, with 
respect to redistribution promoted through DNA CT by preparing DNA strands containing a single 
C:A mismatch, a modification that we know to inhibit CT (18), alongside DNA strands containing 
no mismatches. Although a C:A mismatch effectively inhibits DNA CT (18), it is not a lesion that is 
preferentially bound by XPD. However, the 14-nucleotide overhangs generated with PCR are 
specific substrates for XPD helicase (Kd~1 µM) (19, 20). To block XPD from binding to the 14 bp 
segment, overhang complements were added to DNA/protein solutions in excess. We found, when 
we blocked the overhangs, no preferential binding to the short strands was observed. Protein 
assignments were verified through analysis of their 3–4 nm heights in the images; without protein, 
features of this dimension were not observed and larger heights (> 7 nm) indicated salt precipitates 
or protein aggregation. Only clearly identifiable long or short strands and bound proteins were 
counted. XPD showed redistribution onto long mismatched strands with a ratio of protein binding 
densities, r (long/short) of 1.54 ± 0.08. If, instead, we examined XPD distribution when long and 
short strands were fully matched, we observed a binding density ratio of 0.94 ± 0.05 (10). 
     Using electrochemical techniques, we have previously observed an increase in the efficiency of 
XPD to perform DNA CT in an ATP-dependent manner. In order to understand whether ATP also 
enhances the propensity of the protein to find lesions in the genome, we have performed AFM 
studies to measure XPD redistribution in the presence of ATP. Here, wild-type (wt) XPD was 
mixed with 2 mM ATP, the energy source for the enzyme, and DNA. Short duplex overhangs were 
blocked with excess complementary single strand. Figure 6.2 shows a representative image of DNA 
strands incubated for 24 hours with XPD and 2 mM ATP. In parallel, XPD and DNA were treated 
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with 2 mM ATP and immediately deposited for imaging. Consistent with XPD redistribution in 
the absence of ATP, as shown in Figure 6.3, we find that XPD with 2 mM ATP redistributes onto 
mismatched strands when the samples are immediately deposited (r = 1.35 ± 0.06), we expect a 
ratio of 1 if there were an equal distribution of proteins on matched and mismatched strands (7). 
However, when the samples are incubated overnight with 2 mM ATP, there is a preference for the 
short strands both when strands are matched and mismatched (r = 0.78 ± 0.05 and r = 0.83 ± 0.04, 
respectively) (Table 6.1), similar to what we would expect if we did not block the overhangs.  
     Importantly, we measured the relative binding affinity of XPD, and in all of the samples 
described, the number of proteins bound per base pair remained constant at ~ 0.20 proteins/kbp 
(Table 6.1). Thus, any changes we see in distribution are not due to differences in binding affinities. 
This result indicates that over the 24-hour incubation, even though we added complementary 
strands to block the overhangs, we have induced XPD helicase activity. Notably, the preference we 
observe in the incubated samples directly reflects the enzyme binding to DNA and beginning to 
unwind at the junction.   
     In order to minimize the bias of XPD toward short strands and increase our chances of observing 
an enhancement in protein redistribution, we decreased the sample incubation time to 20 minutes 
and changed the concentration of ATP to 5 mM. As Figure 6.4 shows, the baseline binding density 
ratios for all of the samples is greater than 1, though in each case we observe a slight increase in 
redistribution onto the mismatched strands.  
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Figure 6.2. Representative AFM image of XPD + 2 mM ATP. Proteins that bind to DNA 
strands are tallied for binding density ratio measurements. Scan size: 3 x 3 µm2, scan rate: 3.05 Hz 
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Figure 6.3. Quantitation of XPD density ratios (< 10% uncertainty) where C:A indicates a 
mismatch is contained in long strands.  Samples were incubated with 2 mM ATP for 24 hours (left) 
or immediately deposited (right). Redistribution only occurs when ATP is added and the samples 
are immediately deposited and imaged by AFM. 
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Table 6.1. Binding Density Ratios for Atomic Force Microscopy Samples XPD + 2 mM ATP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Binding Density Ratio (BDR) is reported as (number of proteins bound on long strands (3.6 
kbp)) /number of long strands) divided by the (number of proteins on short strands (1.9 
kbp))/number of short strands) normalized for length. (CA) represents samples with long 
mismatched strands. 
 
b) These data represent three individual samples with 10–20 images per sample.  
 
c) Error is reported as the (total number of proteins divided by the square root of the total number of 
proteins counted) times 100 for each type of sample. 
 
 
 
 
 
 
 
Sample (2 mM ATP) BDRa,b Long Strands Proteins Short Strands Proteins Error (%)c Prot./Kbp
Incubated 0.78 258 171 246 110 6 0.19
Incubated (CA) 0.83 393 260 433 181 4.8 0.19
Deposited 0.92 410 291 315 128 4.9 0.19
Deposited (CA) 1.35 335 295 435 149 4.8 0.21
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Figure 6.4. Quantitation of XPD density ratios (< 10% uncertainty) where C:A indicates a 
mismatch is contained in long strands.  Samples were incubated with 5 mM ATP for 20 minutes 
(left) or immediately deposited (right). XPD has a preference for the long strands in all of the 
samples. 
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For C:A mismatched samples that were incubated for 20 minutes, r = 1.44 ± 0.07 whereas in the 
fully matched samples r = 1.33 ± 0.08. The difference may be somewhat more pronounced in the 
values when the samples are immediately deposited: r = 1.38 ± 0.06 and r = 1.22 ± 0.07 
mismatched and matched, respectively. Importantly, the number of proteins bound per base pair 
remained constant at ~ 0.20 proteins/kbp (Table 6.2). Notably, there were more features of larger 
heights (> 4 nm) in the samples that had 5 mM ATP. Thus, the high concentration of ATP may 
have inhibited sample deposition, disrupted the quality of the images, or increased DNA/protein 
aggregation, resulting in a biased redistribution ratio. 
 
Caged-ATP Studies AFM studies provide us with a “snapshot” of protein redistribution, giving us 
insight on the first step of lesion detection. Similar to BER proteins that we have examined in the 
past, XPD is a repair protein from the NER pathway that exhibits a DNA-bound redox potential ~ 
80 mV vs. NHE (9). Notably, however, XPD is also a 5ʹ′-3ʹ′ helicase, a property that we can explore 
in ‘real-time.’ Thus, we have employed a strategy to trigger the helicase activity of XPD in the 
presence of ATP. Following the protocol we developed to observe XPD with 2 mM ATP, here we 
replaced ATP with NPE-caged ATP (Figure 6.5), an analogue in which a blocking group is attached 
to the gamma phosphate. Upon irradiation with 355 nm light (UV), the analogue is deprotected and 
released in as native ATP.  
     Based on other AFM studies of helicases (11-16), DNA structures that are forked indicate that 
the protein has begun unwinding the strand. In our studies, we did not add complementary single 
strands, leaving the short strand overhangs free for XPD to bind. The DNA/protein samples were 
incubated for a few minutes and deposited onto a freshly cleaved mica surface. Images of DNA and 
protein complexes were acquired in the dark with a scan size of 2 x 2 µm2 or 3 x 3 µm2 at a scan rate 
of 1–3.05 Hz.  
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Table 6.2. Binding Density Ratios for Atomic Force Microscopy Samples XPD + 5 mM ATP 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) Binding Density Ratio (BDR) is reported as (number of proteins bound on long strands (3.6 
kbp)) /number of long strands) divided by the (number of proteins on short strands (1.9 
kbp))/number of short strands) normalized for length. (CA) represents samples with long 
mismatched strands. 
 
b) These data represent three individual samples with 10–20 images per sample.  
 
c) Error is reported as the (total number of proteins divided by the square root of the total number of 
proteins counted) times 100 for each type of sample. 
 
 
 
 
 
 
 
Sample (5 mM ATP) BDRa,b Long Strands Proteins Short Strands Proteins Error (%)c Prot./Kbp
Incubated 1.33 210 168 256 81 6.3 0.19
Incubated (CA) 1.44 367 334 417 139 4.6 0.22
Deposited 1.22 316 228 289 90 5.6 0.18
Deposited (CA) 1.38 401 348 539 179 4.4 0.21
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Figure 6.5. AFM of XPD/DNA treated with caged-ATP to visualize XPD helicase activity. 
(Top) Picture of AFM instrument with small UV-light to irradiated caged-ATP at 355 nm. 
Irradiation deprotects the compound, releasing ATP that the protein can utilize as an energy source. 
(Bottom) Schematic of XPD bound to duplex with short overhang. AFM images display DNA 
strands that are forked. XPD is bound at the junction. 
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Once we gathered an image of a DNA strand with bound protein, we irradiated the sample with 
a handheld UV-light while quickly scanning the region of interest. With this method, we could not 
detect any changes in DNA structure. In another method, the sample was irradiated in the test tube 
for 10 minutes prior to deposition onto the mica surface.  Interestingly, in this example, we 
observed a large percentage of forked DNA structures.  Significantly, many of the forks exhibited 
XPD bound at the junction (Figure 6.5).  We are now optimizing this strategy so that we can 
observe changes in the DNA structure as a function of helicase activation (sample irradiation).  
 
Visualizing XPD Helicase Activity Complementing AFM studies of XPD with caged-ATP to 
visualize helicase activity, we have imaged XPD in the absence and presence of 5 mM ATP. We 
can compare the percentage of forked DNA structures, which are indicative of DNA unwinding. 
We expect that in the presence of ATP, when XPD is activated, more strands will be forked.  
     Concurrently, we would like to observe XPD redistribution, thus we have increased the scan rate 
in an attempt to visualize the protein association with or dissociating from the DNA strand.  
Here, the short strand overhangs remain unblocked and are accessible to XPD. We find several 
differences between samples that contain ATP and those that do not (Figures 6.6, 6.7, 6.8). 
Although there are not many forked DNA structures overall, we observe curled structures, where 
the DNA turns to meet at junctions in the presence of 5 mM ATP. We have considered including 
other proteins that perform DNA CT to probe whether we observe a shift in redistribution onto 
mismatched strands as we initiate XPD helicase activity.  
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Figure 6.6. AFM images of 6 µM DNA and 0.6 µM XPD with (left) or without (right) 5 mM 
ATP. Scan size: 3 x 3 µm2, scan rate: 3.05 Hz. Arrows highlight proteins bound to DNA strands. 
Short DNA strands contain 14 base single-strand overhangs. Although there are more DNA strands 
that can be visualized in the images on the right, the concentration of the samples is not different. 
The images show that with ATP, more of the strands are forked or curled, structures that we do not 
see as much if ATP is not present. 
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Figure 6.7. AFM images of 6 µM DNA and 0.6 µM XPD with (left) or without (right) 5 mM 
ATP. Scan size: 3 x 3 µm2, scan rate: 3.05 Hz. Arrows highlight proteins bound to DNA strands. 
Short DNA strands contain 14 base single-strand overhangs. Although there are more DNA strands 
that can be visualized in the images on the right, the concentration of the samples is not different. 
The images show that with ATP, more of the strands are forked or curled, structures that we do not 
see as much if ATP is not present. 
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Figure 6.8. AFM images of 6 µM DNA and 0.6 µM XPD with (left) or without (right) 5 mM 
ATP. Scan size: 3 x 3 µm2, scan rate: 3.05 Hz. Arrows highlight DNA forks that have protein 
bound. Short DNA strands contain 14 base single-strand overhangs. Although there are more DNA 
strands that can be visualized in the images on the right, the concentration of the samples is not 
different. The images show that with ATP, more of the strands are forked or curled, structures that 
we do not see as much if ATP is not present. 
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Summary 
     In these studies we demonstrate that XPD, in the presence of 2 mM ATP, redistributes in the 
vicinity of mismatches similar to wild-type protein. Since XPD exhibits helicase and ATPase 
activity, it is not surprising that incubating the samples for 24 hours prior to imaging results in a 
preference of XPD for short strands that contain single-strand overhangs. Upon increasing the 
concentration of ATP to 5 mM, there is a redistribution onto long strands irrespective of a 
mismatch. Thus, our efforts toward enhancing the efficiency of DNA CT with ATP to improve the 
ability of XPD to find lesions were not successful. However, significantly, this early work reveals 
that AFM may be employed to “visualize” XPD helicase activity. When protein and DNA samples 
are treated with caged-ATP and activated with UV-light, forked structures appear in AFM images, 
indicative of DNA unwinding. We observe proteins bound at the junction of the forks, exactly 
where we would expect XPD to bind as it initiates helicase activity. Applying what we have 
learned, in the most recent experiments, we have left short-strand overhangs accessible to XPD. 
When 5 mM ATP is added to these samples, we observe curled DNA strands, forks, and other 
structures with XPD, once again, bound at the junctions. Future studies using AFM to visualize 
XPD redistribution and helicase activity with/without ATP will help us understand the link between 
the ability of a protein to perform DNA CT and its propensity to cooperate with other DNA-bound 
proteins to find and correct lesions. We could then extend our studies to examine XPD mutants 
relevant to disease. 
 
 
 
 
  
217 
REFERENCES 
1. Kuraoka, I., Bender, C., Romieu, A., Cadet, J., Wood, R. D., and Lindahl, T. (2000) Proc. Natl. 
Acad. Sci. USA 97, 3832.   
 
2. Wolski S. C., Kuper, J., Hänzelmann, P., Truglio, J. J., Croteau, D. L., Van Houten, V., and 
Kisker, C. (2008) PLos Biol. 6, 1332. 
 
3. Fan, L., Fuss, J. O., Cheng, Q. J., Arvai, A. A., Hammel, M., Roberts, V. A., Cooper, P. K., and 
Tainer, J. A. (2008) Cell 133, 789. 
4. Liu H., Rudolf, J., Johnson, K. A., McMahon, S. A., Oke, M., Carter, L., McRobbie, A. M., 
Brown, S. E., Naismith, J. H., and White, M. F. (2008) Cell 133, 801. 
 
5. Lukianova, O. A., and David, S. S. (2005) Curr. Opin. Chem. Biol. 9, 145. 
 
6. Gorodetsky, A. A., Boal, A. K., and Barton, J. K. (2006) J. Am. Chem. Soc. 128, 12082. 
 
7. Boal, A. K., Genereux, J. C., Sontz, P. A., Gralnick, J. A., Newman, D.K., and Barton, J. K. 
(2009) Proc. Natl. Acad. Sci. 106, 15237. 
 
8. Romano, C. A., Sontz, P. A., and Barton, J. K. (2011) Biochemistry 50, 6133. 
 
9. Mui, T. P., Fuss, J. O., Ishida, J. P., Tainer, J. A., and Barton, J. K. (2011) J. Am. Chem. Soc. 133, 
16378. 
 
10. Sontz, P. A., Mui, T. P., Fuss, J. O., Tainer, J. A., and Barton, J. K. (2012) Proc. Natl. Acad. Sci. 
USA 109, 1856. 
 
11. Henn, A., Medalia, O., Shi, S. P., Steinberg, M., Franceschi, F., and Sagi, I. (2001) Proc. Natl. 
Acad. Sci. USA 98, 5007. 
 
12. Marsden, S., Nardelli, M., Linder, P., and McCarthy, J. E. G. (2006) J. Mol. Biol. 361, 327. 
 
13. Zhang, W., Dillingham, M. S., Thomas, C. D., Allen, S., Roberts, C. J., and Soultanas, P. (2007) 
J. Mol. Biol. 371, 336. 
 
14. Liu, Y. Y., Wang, P. Y., Dou, S. X., Wang, W. C., Xie, P., Yin, H. W., Lin, Y., Jian, Y. X., 
Fang, X. H., and Xi, X. G. (2005) Sci. Technol. Adv. Mat. 6, 842. 
 
15. Lia, G., Indrieri, M., Owen-Hughes, T., Finzi, L., Podesta, A., Milani, P., and Dunlap, D. (2008) 
J. Biophoton. 1, 280. 
 
16. Yeeles, J. T. P., van Aelst, K., Dillingham, M. S., and Moreno-Herrero, F. (2011) Mol. Cell. 42, 
806. 
 
17. Cunningham, R. P., Asahara, H., Bank, J. F., Scholes, C. P., Salerno, J. C., Surerus, K., Munck, 
E., McCracken, J., Peisach, J., and Emptage, M. H. (1989) Biochemistry 28, 4450.  
  
218 
 
18. Charge Transfer in DNA: From Mechanism to Application (2005), ed. Wagenknecht H. A. 
(Wiley- VCH, Weinheim). 
 
19. Fan, L., Fuss, J. O., Cheng, Q. J., Arvai, A. A., Hammel, M., Roberts, V. A., Cooper, P. K., and 
Tainer, J. A. (2008) Cell 133, 789. 
 
 
20. Rudolf, J. (2006) Thesis submitted for the degree of Doctor of Philosophy, University of St. 
Andrews, Scotland, UK. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
219 
CHAPTER 7 
Charge Photoinjection in Intercalated and Covalently Bound [Re(CO)3(dppz)(py)]+-
DNA Constructs Monitored by Time-Resolved Visible and Infrared Spectroscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Olmon, E. D., Sontz, P. A., Blanco-Rodríguez, A. M., Towrie, M., Clark, I. P., 
Vlček, A. Jr., and Barton, J. K. (2011) J. Am. Chem. Soc. 133, 13718 
E.D.O. and P.A.S. prepared oligonucleotide conjugates and constructs. P.A.S. performed oxidative 
DNA cleavage experiments. E.D.O. performed spectroelectrochemistry and transient absorption 
studies, and A.M.B.R., M.T., I.P.C., and A.V. performed TRIR studies.  
  
220 
INTRODUCTION 
 
     The ability of DNA to mediate charge transport (CT) has been established using a variety of 
redox-active probes and in a great diversity of experimental systems (1-3). The efficiency of DNA-
mediated CT is affected by several factors, including the extent of electronic coupling between the 
probe and the DNA base stack, coupling within the base stack itself, the driving force of the CT 
reaction, and the base sequence. DNA CT has been observed over long molecular distances with 
little attenuation (4-6), suggesting its utility in molecular-scale devices (7-9) and in biological 
systems (2, 10-13). Many of the properties of DNA CT have been elucidated in experiments 
involving the slow accumulation of oxidative damage at low potential guanine sites. While such 
methods remain useful in the investigation of DNA CT, a general probe for direct, time-resolved 
monitoring of these processes remains elusive. 
      Time-resolved infrared (TRIR) spectroscopy offers several advantages over other time-resolved   
methods for the study of CT events (14). With the proper choice of IR-active probe and solvent 
medium, changes in the absorption pattern of well-resolved, transient IR bands provide kinetic 
information on specific photophysical, chemical, and biochemical processes, together with 
structural characterization of the excited states and reaction intermediates involved. One common 
family of probes are coordination complexes of the type [Re(CO)3(N,N)(L)]n, where N,N stands for 
an α-diimine ligand such as 2,2′-bipyridine (bpy), phenanthroline (phen), or dppz (dipyrido[3,2-
a:2′,3′-c]phenazine) and L represents an axial ligand, often Cl (n = 0) or functionalized pyridine (n 
= 1+) (15-23). Photophysical or photochemical reactions involving these Re complexes are 
manifested in TRIR spectra as changes in the intensities and positions (energies) of absorption 
bands due to CO stretching vibrations of the Re(CO)3 group, ν(C≡O). Variation of the N,N and L 
ligands affords fine control over the excited-state characters and energetics (16, 18-20, 22-27). 
These complexes have also proven useful as biochemical probes for fluorescence imaging (28), for 
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monitoring the dynamics of structural fluctuations (29, 30), and especially, for triggering 
photoinduced electron transfer (ET) (31). Information on ET kinetics and intermediates provided by 
TRIR is more direct than that obtained using UV/visible time-resolved spectroscopic methods due 
to their low specificity. Recently, the presence of tryptophan along the ET pathway in Re(CO)3(4,7-
dimethyl-1,10-phenanthroline)-modified azurin was shown to increase the rate of ET (32-34). 
Although other coordination complexes, such as dicarbonyl Ru species, W(CO)5(4-cyanopyridine), 
and [Ru(bpy)(CN)4]2- have been employed as TRIR probes, tricarbonyl Re complexes have been 
studied much more extensively (14, 16, 35). TRIR can also be used to monitor changes in the 
vibrational frequencies and IR band intensities of organic functionalities in ET assemblies (36). Of 
particular interest, TRIR spectra were recorded following the 267 nm excitation of the four 
canonical nucleotides and of poly(dG-dC)·poly(dG-dC) and poly(dA-dT)·poly(dA-dT) (37). In that 
work, the lifetimes of the transient states of the free nucleotides ranged from 2.2 to 4.7 ps, while 
those of the polymers were an order of magnitude longer. Upon 200 nm photoionization of 5′-
dGMP and poly(dG-dC)·poly(dG-dC), evidence for the formation of the guanine radical was 
observed by TRIR as the growth of a transient band at 1702 cm-1 (38). In other experiments, TRIR 
was used to observe the triplet state of thymine and of 2′-dT (39), as well as to unravel the pH-
dependent photophysics of 5′-G, 5′-GMP, and poly(G) (40). Importantly, these studies indicate that 
TRIR can be used to monitor photoinduced changes of DNA and of [Re(CO)3(N,N)(L)]n 
simultaneously, making it possible to investigate both the donor and the acceptor sites of Re-DNA 
CT assemblies. Although interactions between Re complexes and DNA have been studied by 
UV/visible spectroscopy (41, 42), these interactions had not been investigated by vibrational 
methods until very recently (43, 44). 
     Here, TRIR spectroscopy is used in conjunction with other methods to observe the DNA-mediated  
oxidation of guanine in DNA by photoexcited [Re(CO)3(dppz)(py′-OR)]+, where py′-OR 
represents pyridine functionalized at the 4 position (Figure 7.1). The influence of guanine on the 
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photochemical behavior of the Re complex bound to DNA is investigated by comparing 
results obtained in four different DNA contexts, including two in which the complex is covalently 
tethered to specific locations on the duplex. The data presented show that the photoexcited Re 
complex can oxidize guanine at a distance of several bases away by DNA-mediated CT and that 
this process can be monitored on the ps to µs time scale by TRIR. The results of this study, in 
which TRIR is used for the first time to observe DNA-mediated CT between photooxidants and 
guanine in well-defined covalent constructs, shows that the DNA sequence surrounding the metal 
complex binding site has a large influence on the photophysics and photochemistry of the system.  
Materials and Methods Most reagents for metal complex synthesis and coupling were purchased 
from Sigma-Aldrich unless otherwise indicated. 3-(pyridin-4-yl)propanoic acid (py′-OH) was 
purchased from Chess GmbH (Mannheim, Germany). Reagents for DNA synthesis were 
purchased from Glen Research (Sterling, VA). All reagents were used as received.  
Complex and Conjugate Synthesis Preparation of [Re(CO)3(dppz)(py′-OH)](PF6) was adapted 
from previously described methods (41). Following the synthesis, the PF6– counter anion was 
exchanged (QAE Sephadex A-25 resin, GE Healthcare) for chloride ion in order to increase the 
solubility of the complex in aqueous media. Because facile proton loss from the carboxylic acid-
modified pyridine ligand results in an overall neutral zwitterionic species, altering the extent of 
electrostatic repulsion between complex molecules and of electrostatic attraction to DNA, the 
protected ethyl ester version of the complex, [Re(CO)3(dppz)(py′-OEt)]+ (py′-OEt = ethyl 3-
(pyridin-4-yl)propanoate), was used for some experiments. 
 
Oligonucleotide Synthesis and Modification Oligonucleotides were synthesized using standard 
solid-phase phosphoramidite chemistry on an Applied Biosystems 3400 DNA synthesizer. Tethers 
were appended to the 5′-OH termini of resin-bound oligonucleotides: Holmlin et al. (45).  
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Figure 7.1. Schematic illustration of [Re(CO)3(dppz)(py′-OR)]+, the covalent linker, and the 
DNA sequences used for studies of guanine oxidation. Experiments involving AT-30 and GC-30 
were conducted in the presence of the free complex Re′-OH. In the covalent assemblies Re-25(G) 
and Re-25(I), the Re photooxidant is tethered to the 5′ end of one strand via a peptide linkage. 
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The alkyl tether was added to the DNA strand by successive treatment with carbonyldiimidazole 
and diaminononane. Agitation of the resin-bound, amine modified DNA strands in the presence of 
excess (5 mg) [Re(CO)3(dppz)(py′-OH)]Cl, O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate (HBTU), 1-hydroxybenzotriazole hydrate (HOBT), and 
diisopropylethylamine (DIEA) in anhydrous DMF for 24 hrs resulted in covalent attachment of the 
metal complex to the DNA. Cleavage from the resin was effected by incubation in NH4OH at 60 °C 
for 6 h. Oligonucleotides were purified by reversed-phase HPLC and characterized by MALDI-
TOF mass spectrometry. Oligonucleotide concentrations were determined by UV/visible 
spectrophotometry (Beckman DU 7400). Annealing was accomplished by incubating solutions 
containing equimolar amounts of complementary strands in buffer (10 mM NaPi, 50 mM NaCl 
buffer; pH 7.0) at 90 °C for 5 min followed by slow cooling over 90 min to ambient temperature. 
 
Assay for Oxidative DNA Damage Oxidative DNA cleavage experiments were performed using a 
protocol adapted from Zeglis (46) with the following adjustments. Oligonucleotides were labeled at 
the 3′-end by incubating a mixture of 2 µL single-stranded DNA (100 µM), 5 µL [α-32P]-dTTP 
(Perkin Elmer), 2 µL terminal transferase (TdT; New England Biolabs), 5 µL CoCl2 solution 
(included with TdT), and 5 µL terminal transferase reaction buffer (included with TdT) for 2 h at 37 
°C. Before gel purification, strands were incubated at 90 °C for 20 min in 100 µL 10% aqueous 
piperidine to induce cleavage of damaged strands. Following purification and annealing, samples 
(10 µL, 2 µM) were irradiated in parallel for 2 hrs using a solar simulator (Oriel Instruments) fitted 
with a 340 nm internal long pass filter. Samples were then treated with 0.2 units calf thymus DNA 
and 10% piperidine (v/v), heated for 30 min at 90 °C, and dried in vacuo. After gel electrophoresis, 
oxidative damage was quantified by phosphorimagery (ImageQuant). Sample counts are reported as 
% of total counts per lane and were corrected by subtracting the dark control. 
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Spectroelectrochemistry UV/visible spectroelectrochemistry was carried out using a custom-
built, optically transparent, thin-layer electrode (OTTLE) cell (path length = 0.1 mm) consisting 
of vapor-deposited platinum working and pseudoreference electrodes and a Pt-wire auxiliary 
electrode (47). The potential of the cell was controlled by a potentiostat (CH Instruments Model 
650A electrochemical workstation). Samples consisted of saturated solutions of metal complexes 
in dry acetonitrile with 0.1 M Bu4NPF6 electrolyte. Samples were degassed by bubbling argon 
and introduced into the optical cell using a gas-tight syringe prior to measurement. The cell was 
held at a reducing potential, and spectra were acquired on a Hewlett Packard 8452A diode array 
spectrophotometer every 4 s until the sample was fully reduced. 
 
UV/Visible Emission and Transient Absorption Spectroscopy Steady-state emission spectra 
were recorded on a Fluorolog-3 spectrofluorometer (Jobin Yvon) using 2 mm slits. Scattered 
excitation light was rejected from the detector by appropriate filters. Reported spectra are 
averages of at least five consecutive measurements. 
     All time-resolved UV/visible spectroscopic measurements were carried out at the Beckman 
Institute Laser Resource Center. Nanosecond luminescence decay measurements and transient 
absorption (TA) measurements were performed using the third harmonic (355 nm) of a 10 Hz, Q-
switched Nd:YAG laser (Spectra-Physics Quanta-Ray PRO-Series) as the excitation source (8 ns 
pulse width, 5 mJ/pulse). Probe light was provided by a synchronized, pulsed 75 W Hg-Xe arc 
lamp (PTI model A 1010), and detection was accomplished using a photomultiplier tube 
(Hamamatsu R928) following wavelength selection by a double monochromator (Instruments SA 
DH-10). Scattered light was rejected using suitable filters. The samples were held in 1 cm path 
length quartz cuvettes (Starna) equipped with stir bars. TA measurements were made with and 
without excitation, and were corrected for background light, scattering, and fluorescence.  
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Picosecond emission decay measurements (48-51) were performed using the third harmonic 
of a regeneratively amplified mode-locked Nd:YAG laser (355 nm, 1 ps pulse width after 
amplification) as the excitation source and a picosecond streak camera (Hamamatsu C5680, 
photon-counting mode) as the detector. Emission was observed under magic angle conditions 
using a 550 nm long-pass cutoff filter. 
 
TRIR Spectroscopy The ULTRA instrument at the STFC Rutherford Appleton Laboratory has 
been used. It is described in detail elsewhere (52). In brief, a titanium sapphire laser-based 
regenerative amplifier (Thales) produces 800 nm, ~ 50 fs pulses at a 10 kHz repetition rate. The 
laser output is split in two parts, one of which is either frequency doubled or used to drive an 
OPA (Light Conversion, TOPAS) equipped with SHG and SFG units to produce a pump beam at 
400 or 355 nm, respectively. The second pumps a TOPAS OPA, yielding signal and idler beams 
that are difference frequency mixed to generate ~ 400 cm-1 broad mid IR probe pulses. An optical 
delay line is used to introduce a delay between the pump and probe beams, and the mid IR probe 
spectrum is recorded at a given time delay using two 128 element HgCdTe detectors (Infrared 
Associates). For ns-µs measurements, the sample was pumped with 355 nm, 0.7 ns FWHM 
pulses (AOT, AOT-YVO-20QSP/MOPO), and probed with electronically synchronized 50 fs IR 
pulses (53). The sample solutions were placed in a round dip ca. 0.75 mm deep, drilled into a 
CaF2 plate and tightly covered with a polished CaF2 window. The cell was scanned-rastered 
across the area of the dip in two dimensions to prevent laser heating and decomposition of the 
sample. FTIR spectra measured before and after the experiment demonstrated sample stability. 
 
Fitting Methods TRIR data were simulated at each time delay as a series of Gaussian terms in 
order to extract kinetic data from overlapping transient bands. The area of each Gaussian was 
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calculated, and kinetic decays were constructed as the change in area with delay time. 
Nanosecond time-resolved emission, TRIR, and TA data were fit by nonlinear least-squares 
analysis using IGOR Pro software (Wavemetrics). Model functions consisted of a linear series of 
exponential terms of the form y(t) = Σ ai exp[-t/τi], where ai and τi are the pre-exponential factor 
and lifetime, respectively, of the ith term. Up to three exponential terms were included until 
reasonable fits were obtained. For time-resolved emission data, the percent relative contribution 
reported in Table 7.1 represents the number of photons emitted at the probe wavelength by each 
emissive population, and is calculated as anτn/Σaiτi (the area under the decay for the nth 
exponential term normalized to the total area under the decay curve). For TRIR and TA data, the 
percent relative contribution represents the change in absorbance of species n extrapolated to time 
t = 0, and is calculated as an/Σai. 
     Picosecond emission data were collected at 1 ns, 5 ns, and 50 ns time ranges and spliced 
together before fitting. Data were compressed logarithmically in time prior to fitting in order to 
decrease the bias of long time data on the fit. These data could not be fit well to a series of 
exponential terms and were instead analyzed by the maximum entropy method using a MATLAB 
(MathWorks) routine written at Caltech (48-51). 
 
Results 
Research Strategy and Design of Re-DNA CT Assemblies With the aim to establish DNA 
oxidation by electronically excited rhenium tricarbonyl-diimine complexes, we have employed a 
newly developed Re sensitizer, [Re(CO)3(dppz)(py′-OR)]+ (R = H, Re′-OH; or R = CH2CH3, Re′-
OEt), which can be covalently linked to DNA (Figure 7.1). Three design elements make this a 
promising probe for the study of DNA-mediated CT. 
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Table 7.1. Decay Lifetimes from Least-Squares Fits (λex = 355 nm) 
 
 
Technique Detail Sample Lifetimes, seconds
 (% Relative Contributiona) 
10-9 10-8 10-7 10-6 10-5 >10-5 b 
TRIRc 
Re(CO)3 Bleach 
Recovery 
AT-30 + Re'-OH  1.4 (28) 3.0 (31)  2.5 (41)  
GC-30 + Re'-OH  6.3 (43) 5.5 (49)  1.1 (8)  
Re-25(I)  2.6 (16) 4.8 (30)  2.8 (54)  
Re-25(G) 4.8d  2.9 (65) 9.1 (35)   
MLCT (2071 cm-1) 
AT-30 + Re'-OH 8.8 (38)  5.6 (38)   Long (23) 
Re-25(I)  3.2 (36) 8.9 (44)   Long (20) 
IL (2030 cm-1) 
AT-30 + Re'-OH   1.5 (31)  2.4 (69)  
GC-30 + Re'-OH   1.8 (51) 1.0 (42) 2.2 (7)  
Re-25(I)    3.0 (34)  Long (66) 
Re-25(G) 4.0d  3.0 (58) 9.2 (42)   
G●+/G● (1702 cm-1) GC-30 + Re'-OH   2.1d 5.8   
DNA Bleach 
Recovery 
AT-30 + Re'-OH   1.4 (48) 5.0 (18)  Long (35) 
GC-30 + Re'-OH  5.9 (31) 9.6 (69)    
Re-25(I)   3.1 (88)   Long (12) 
Re-25(G)  2.9d 8.4 (53) 1.0 (47)   
NS Visible TAe λprobe = 475 nm 
AT-30 + Re'-OH   4.9 (17)  2.7 (83)  
GC-30 + Re'-OH   2.7 (42) 2.0 (58)   
Re-25(I)   9.6 (42)  2.0 (58)  
Re-25(G)   4.4 (37)  1.4 (63)  
NS Emissione,f λprobe = 570 nm 
AT-30 + Re'-OH 2.9 (34) 2.4 (23) 5.7 (43)    
GC-30 + Re'-OH 3.2 (39) 2.7 (35) 2.4 (26)    
Re-25(I) 5.3 (17) 2.6 (21) 5.4 (62)    
Re-25(G) 3.9 (42) 2.1 (30) 4.5 (28)    
 
 
 
a Determined by different methods for absorption and emission; see Experimental Section. b “Long” indicates 
incomplete decay. c Uncertainty estimated at 20%. d These values reflect an increase in intensity. e Uncertainty 
estimated at 10%. f Processes faster than 8 ns are convoluted with instrument response. 
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The first is the incorporation of TRIR-active carbonyl ligands. Re carbonyl-diimine complexes 
are useful probes in TRIR spectroscopic experiments due to the intense and well-resolved bands 
corresponding to carbonyl stretching modes. These modes are extremely sensitive to changes in 
electron density distribution, molecular structure and environment (17, 24, 30, 32, 54, 55). The 
second design element is the inclusion of the planar dppz ligand. By incorporating dppz on the 
metal center, we ensure effective electronic coupling with the DNA base stack. Indeed, the binding 
constants for intercalating dppz complexes such as [Ru(bpy)2(dppz)]2+ and [Ru(phen)2(dppz)]2+ are 
greater than 106 M-1 (56). While the binding of complexes like [Re(CO)3(dppz)(py′-OR)]+ is weaker 
(105 M-1) (41, 42, 57) due to its lower electrostatic charge, the decrease of the molar absorptivity of 
its near-UV absorption band (i.e., hypochromicity) upon incubation with DNA, as well as an 
increase in the melting temperature of the bound DNA duplex by approximately 5 °C (depending 
on the sequence), indicate that this Re complex indeed binds by intercalation. The third design 
element is the ability to covalently attach the complex to DNA via carboxyalkyl-modified pyridine 
incorporated at the axial coordination site. The covalent link between the complex and the DNA 
strand, while flexible, restricts diffusion of the unbound complex, ensuring a higher percentage 
bound than if the complex were allowed to diffuse freely. In addition, the covalent link enables us to 
define the DNA sequence at the binding region, eliminating sequence effects as a variable. Physical 
models suggest that in the equilibrium geometry (disregarding frayed end effects) tethering restricts 
binding to the region within three base pairs from the end of the duplex. 
     The DNA duplexes used were designed to test for the effect of the DNA sequence on the 
efficiency of DNA oxidation. For systems in which guanine, an effective hole trap, is placed near 
the expected binding site of the Re complex, charge injection may be followed by facile back 
electron transfer (BET). Such nonproductive reactions are competitive with permanent charge 
trapping at guanine sites (58-60). The frequency of nonproductive events can be reduced by 
replacing guanine at the Re binding site with inosine (I), a base analog that has a higher oxidation 
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potential than guanine [E°(I●+/I) ≈1.5 V vs. NHE; E°(G●+/G) = 1.29 V vs. NHE] (60-64). With 
these considerations in mind, four DNA sequences were designed (Figure 7.1). Two of them 
contain only adenine and thymine (AT-30) or guanine and cytosine (GC-30) and are expected to 
reveal the effect of the absence or presence, respectively, of strong guanine thermodynamic hole 
traps on DNA oxidation by noncovalently bound Re′-OH. Two DNA sequences were also designed 
to test for the effect of neighboring guanine on the efficiency of long range DNA oxidation by 
covalently-bound Re. These are Re-25(G), which contains guanine next to the Re binding site, and 
Re-25(I), in which guanine is replaced by inosine. 
 
Sensitizer Characterization The photophysics of [Re(CO)3(dppz)(py′-OH)]+ and 
[Re(CO)3(dppz)(py′-OEt)]+ are very similar, suggesting that modification at the py′ carbonyl has 
little effect on the energetics of the complex. For example, each complex exhibits absorption 
maxima at 364 and 382 nm (ε ≈ 11,000 M-1 cm-1) (41, 65), with a tail that extends into the visible 
region (66). The emission spectra of both complexes show maxima at 554 and 595 nm. At 570 nm, 
Re′-OH and Re′-OEt each show a biexponential emission decay in acetonitrile, with lifetimes on the 
order of 200 ns (~ 10%) and 10 µs (~ 90%), tentatively attributed to emission from different types 
of 3IL states (66). Tethering the Re species to DNA, therefore, is expected to have negligible 
influence on the energetics of the complex. 
     The reduction potential of the emissive 3IL state(s), E°(*Re+/Re0), of the Re label can be estimated  
as the sum of the ground-state reduction potential, E°(Re+/Re0), and the zero-zero excited-state 
energy, (E0,0) (67).The exact value of E0,0 is unknown, but it is estimated to lie between the energy 
at which the excitation and emission spectra coincide (480 nm, 2.58 eV) and the energy of the 
emission maximum in aqueous solution (570 nm, 2.18 eV). For Re′-OEt in acetonitrile, E°(Re+/Re0) 
was reported as –850 mV vs. NHE (66), predicting the excited-state reduction potential to lie 
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between 1.33 and 1.73 eV. As an oxidant, electronically excited Re′-OEt is clearly strong 
enough to oxidize guanine, and it may be strong enough to oxidize adenine [E°(A●+/A) = 1.42 V vs. 
NHE] (68). The latter reaction, however, is expected to be slower due to the lower driving force. 
 Hole injection into the DNA base stack must coincide with reduction of the metal complex. In order  
to characterize this reduced state independently, IR spectroelectrochemical reduction of saturated 
Re′-OEt in acetonitrile was carried out (Figure 7.2). Before reduction, the spectrum exhibits a band 
at 2036 cm-1 assigned to the totally symmetric in-phase ν(C≡O) vibration A′(1), and a band at 1932 
cm-1 due to quasidegenerate totally symmetric out-of-phase A′(2) and equatorial antisymmetric A′′ 
ν(C≡O) vibrations (17, 54, 69). Reduction results in a bathochromic shift of these bands to 2029 
cm-1 and 1922 cm-1, respectively. This shift is similar to that observed previously (23) upon 
reduction of [ReCl(CO)3(dppz)] and its small magnitude is consistent with occupation of the 
phenazine π* orbital of the dppz ligand in the [ReI(CO)3(dppz●−)(py′-OEt)] reduction product (24). 
Subsequent regeneration of the initial species via reoxidation was 95% complete, suggesting partial 
irreversible decomposition of the electrogenerated product; however, these decomposition products 
are not expected to interfere in time-resolved spectroscopic experiments employing fast 
photocycles. An attempt was made to duplicate the experiment in D2O buffer (10 mM NaPi, 50 mM 
NaCl, pD 7.0) in order to generate spectra that would be more directly comparable to TRIR 
measurements conducted in D2O buffer. Although the low solubility of the complex and the strong 
background absorbance of the solvent in this energy region prevented precise analysis, band 
positions, widths, and relative intensities were similar to those observed in acetonitrile solutions. 
 
Oxidative Damage Pattern of Re-25(G) and Re-25(I) Observed by PAGE Figures 7.3 and 7.4 
show DNA-mediated oxidative damage in 2 µM solutions of Re-25(G) and Re-25(I) observed after 
2 hours of broadband (λ > 340 nm) irradiation and 20% PAGE analysis.  
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Figure 7.2. Steady-state FTIR spectra (bottom) of saturated Re′-OEt in acetonitrile recorded 
during bulk reduction using an OTTLE cell. Arrows indicate spectral changes that occur upon 
reduction. The difference in absorbance between the fully reduced species and the initial species is 
also shown (top). 
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Figure 7.3. (Left) Oxidative damage with Re(CO)3(dppz)(py)+ photooxidant in Re-25(I) 
assemblies. 20% PAGE after irradiation of functionalized 3ʹ′-dTTP-32P-labeled DNA assemblies (2 
µM). A+G and C+T are Maxam-Gilbert sequencing lanes. Following 2 hour irradiation with a solar 
simulator, samples were treated with 10% piperidine (v/v), heated for 30 min at 90 °C, and dried. 
Lane 3 shows background damage in the absence of photooxidant and irradiation. LC indicates the 
light control, which is nonfunctionalized assembly with irradiation. DC indicates the dark control, 
which is the functionalized assembly without irradiation but with subsequent piperidine treatment. 
Re25IA refers to the assembly with inosine near the complex binding site. DNA-mediated oxidative 
damage at the double guanine site and other guanine positions is indicated with an arrow. (Right) 
Oxidative damage with Re(CO)3(dppz)(py)+ photooxidant 20% PAGE gel analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guanine Oxidation Re-25(I)!
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Figure 7.4. Quantification of oxidative damage observed for Re-25(I) (X = I; red) or Re-25(G) 
(X = G; blue) by PAGE analysis. Aqueous samples containing 3′-[α-32P]-radiolabelled (indicated by 
*) Re-DNA constructs (2 µM) were irradiated for 2 h and treated with piperidine to induce cleavage 
at damaged bases. Cleavage products were separated by 20% PAGE and imaged by 
phosphorimagery. Quantitation was accomplished by normalizing counts at each site to total counts 
per lane. Traces were corrected for false positives by subtracting the dark control (DC). The arrow 
indicates the 5′-guanine of a 5′-GG-3′ doublet. Re is expected to bind 2–3 bases in from the 5′-end 
of the duplex. 
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Damage occurs as base radicals, formed following hole injection by the excited Re complex, 
react with solution species such as H2O or O2 to form irreversible products (70, 71). Subsequent 
treatment of the 3′-[32P]-labeled DNA with piperidine induces cleavage at damage sites. For both 
Re-25(G) and Re-25(I), damage is observed primarily at the 5′-G site of the 5′-GG-3′ doublet, 
several bases distant from the Re complex binding site predicted from physical models. 
Importantly, the low concentrations used in these experiments preclude interstrand damage (i.e., it is 
unlikely that the Re moiety of one construct will intercalate into the base stack of another). The 
observation of damage at the 5′-GG-3′ site indicates that long-range photoinduced hole injection 
from the Re label to DNA indeed occurs, consistent with results obtained for a similar Re-DNA 
conjugate (66). However, the extent of damage is consistently greater in the case of Re-25(I) than 
Re-25(G). 
 
Emission Measurements Many Re tricarbonyl complexes of dppz behave as DNA light switches 
(18-23, 41, 42), much like their Ru counterparts (72), and the complexes studied here are no 
exception. In the absence of DNA, negligible emission is observed from an aqueous solution of Re′-
OH or Re′-OEt; however, in the presence of AT-30 and in the Re-25(I) sample, a prominent 
emission band is observed that exhibits a maximum at 570 nm and a shoulder near 600 nm, 
resembling the emission spectrum seen for similar Re complexes in organic solvents (19, 21, 22, 41, 
42, 57, 65). By comparison with the emission of [Ru(bpy)3]2+ in deaerated acetonitrile, the emission 
quantum yield of Re′-OEt in the presence of AT-30 in buffer is 0.008 (as compared to 0.062 for 
[Ru(bpy)3]2+ (73). In the presence of GC-30 and in the Re-25(G) sample, the emission is much less 
intense, the maxima are shifted to 585 nm, and no shoulder is observed. Steady-state emission 
spectra of AT-30 alone and in the presence of Re′-OEt are shown in Figure 7.5. Interestingly, the 
DNA oligomers used in this study are themselves emissive under 355 nm excitation, giving rise to a 
broad band near 450 nm that tails into the visible region.  
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Figure 7.5. Steady-state emission spectra of 20 µM Re′-OEt in the presence of 0.5 mM (base 
pairs) AT-30 (red), and of 0.5 mM (base pairs) AT-30 (black) alone following excitation at 355 nm. 
Samples were prepared in D2O buffer (10 mM NaPi, 50 mM NaCl; pD 7.0). 
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All efforts were made to ensure that this is not an effect of the instrument, solvent, scattering, or 
impurities. Such emission, ascribed to excitons or charge transfer excited states, has previously been 
observed in DNA oligomers but not in calf thymus DNA (74-76). The Re-loaded AT-30 sample 
shows overlapping DNA and Re′-OEt emission. By scaling and subtracting the emission band due 
to DNA alone, it is possible to isolate emission from only the intercalated complexes. Significantly, 
emission from Re′-OEt becomes strongly quenched on going from AT-30 to GC-30 (Figure 7.6). A 
similar decrease is observed for Re-25(G) compared to Re-25(I). The concentrations of DNA and of 
the Re complex are the same in all of the samples, but the intensity of emission decreases as AT-30 
≈ Re-25(I) > Re-25(G) ≈ GC-30. 
     Differences in emission intensity are also observed in time-resolved measurements carried out on 
the nanosecond timescale with a PMT detector (response time 8 ns) and on the picosecond 
timescale using a streak camera (response time 55 ps). On the nanosecond timescale, the time-
integrated emission intensity of Re-25(G) at 570 nm is 14% that of Re-25(I), and the intensity of 
GC-30 is 12% that of AT-30, following the trend observed in stationary spectra. Even on the 
picosecond timescale, the instantaneous emission intensity extrapolated to t=0 is lower in the GC-30 
and Re-25(G) samples than in the AT-30 and Re-25(I) samples, respectively. In addition, on this 
time scale, the time-integrated emission intensity of Re-25(G) is 79% that of Re-25(I), and the 
intensity of GC-30 is 69% that of AT-30. These observations clearly indicate reaction(s) between 
electronically excited Re complex and DNA occurring on the picosecond to nanosecond timescale. 
On the basis of results of the PAGE experiment, hole transfer from *Re to G is most likely a 
prominent contributing reaction pathway. 
     The emission decay of the four DNA samples is highly multiexponential, with lifetimes varying 
over four orders of magnitude, from ~ 100 ps to ~ 500 ns. The present data do not allow us to 
attribute individual emission decay components to particular species present in the solution, 
although steady-state results suggest that DNA excimer emission contributes significantly (~ 20 %) 
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to the total decay. After accounting for DNA excimer emission, which decays with a lifetime of 
only a few ns (75), about half of the Re emission decays within 50 ns, and the remainder persists for 
hundreds of ns. Maximum entropy fitting of the emission decays yields several distributions of rate 
constants (Figure 7.7) that vary only slightly between samples, and in every sample, the majority 
component has a lifetime of less than 1 ns. Notably, while most of the lifetimes are shortened 
slightly on going from AT-30 to GC-30 and from Re-25(I) to Re-25(G), no decay component is 
observed that corresponds to quenching of the excited Re sensitizer by guanine. Considering the 
significant quenching in steady-state measurements of the GC-30 and Re-25(G) samples, it seems 
that quenching at the reactive binding site(s) is ultrafast, probably tens of picoseconds or faster, but 
involves only a fraction of the excited population. 
 
Time-Resolved Infrared (TRIR) Spectra Whereas emission spectra provide evidence for ultrafast 
hole injection from electronically excited Re into the GC-30 and Re-25(G) samples, TRIR has the 
potential to characterize the reacting state(s) of the Re complex and to detect products and 
intermediates. To this effect, TRIR spectra were investigated in the picosecond (1–100 ps) and 
nanosecond-to-microsecond time domains in the regions of the Re(CO)3 ν(C≡O) and DNA organic 
carbonyl vibrations. 
     Typical picosecond TRIR spectra obtained in the ν(C≡O) region after 355 nm excitation are 
shown in Figure 7.8 for AT-30 and GC-30. The spectra measured 1 ps after excitation show 
negative bands due to bleaching of the ground-state absorption (2036 and 1939 cm–1) and broad 
transient bands at 2026 and 1908 cm–1. Over the course of time, both features decay in intensity 
while a sharp band grows in at 2031 cm–1 (overlapping with the 2036 cm–1 bleach) together with a 
broad band between 1915 and 1935 cm–1.  
 
  
239 
Figure 7.6. Steady-state emission spectra of 20 µM Re′-OEt and 0.5 mM DNA (base pairs) in 
D2O buffer (10 mM NaPi, 50 mM NaCl; pD 7.0) solution following excitation at 355 nm. Emission 
spectra of Re′-OEt with AT-30 (red) or GC-30 (black) have been corrected for emission from DNA 
alone. 
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Figure 7.7. Lifetime distributions from maximum entropy analysis of emission from (64 µM) 
Re′-OH in the presence of 1.6 mM (base pairs) DNA and of 64 µM Re-25(I) or Re-25(G) measured 
on the picosecond timescale (λex = 355 nm, 1 ps pulse width). Samples were prepared in D2O buffer 
(10 mM NaPi, 50 mM NaCl; pD 7.0) and were irradiated at 355 nm. Probability P is plotted as a 
function of rate k. Large distributions at k = 1011-1012 s-1 are caused by convolution of the 
measurement signal with instrumental noise. The emission decay from Re′-OH in buffer is expected 
to be monoexponential; the complex distribution of rates observed here may be due to the formation 
of aggregates (solubility is quite low) or it may simply be an effect of the low emission intensity 
observed for this sample. 
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Figure 7.8. Picosecond-timescale TRIR difference spectra of 4.8 mM (base pairs) AT-30 
(top) or GC-30 (bottom) with 0.5 mM Re′-OH measured at specified time delays after 355 nm, 50 
fs excitation. Each probe data point is separated by ca. 2.1 cm–1. Arrows indicate changes in the 
spectra with time. Delay times displayed are a subset of the data collected. (Similar TRIR spectra 
of Re-25(I) and Re-25(G) are shown in Figure 7.10.) 
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These new transients partially overlap with the parent bleaches at 2036 and 1939 cm–1; hence, 
the growth of the transients is accompanied by a decrease in the intensities of both bleaches and a 
distortion of the band shape of the 1939 cm–1 bleach. The down-shift in the energies of the transient 
bands from the ground-state positions is typical of ππ* 3IL(dppz) excited states (19-32, 26, 27, 54). 
Tentatively, we attribute the initially formed 2026 and 1908 cm-1 transient bands to a hot 3IL state 
localized at the phen part of the dppz ligand, 3IL(phen). Subsequent electron density reorganization 
and cooling produce another 3IL state localized predominantly at the phenazine part, 3IL(phz), 
manifested as the sharp 2036 cm-1 band. The 3IL(phz) IR spectrum is more similar to that of the 
ground states than the 3IL(phen) spectrum since the electronic changes in 3IL(phz) occur further 
away from the Re center. The excited-state conversion is largely completed in the first 100 ps. The 
spectra measured at 100 and 500 ps also show a shoulder at ~ 2020 cm–1 that probably corresponds 
to a residual population of the IL(phen) state. The ps spectra do not show any bands attributable to 
Re→dppz MLCT states, which are expected to occur at higher energies. 
     The GC-30 sample shows very similar behavior (Figure 7.8, bottom); however, there is one 
important difference: the ~ 2031 cm–1 3IL(phz) feature at longer time delays (> 50 ps) is much 
weaker relative to the initially formed transient than in the case of AT-30. In accordance with the 
ultrafast GC-30 emission intensity quenching, we attribute this deficiency to a partial picosecond 
quenching of the 3IL state(s) by CT with guanine to produce [ReI(CO)3(dppz●−)(py′-OH)] and G●+. 
The lack of IR features in the TRIR spectra due to the reduced Re complex is likely caused by two 
factors. The first is very close similarity with the spectrum of the 3IL(phz) state (compare with 
Figure 7.2); the second is very fast BET that regenerates the ground state and keeps the 
concentration of the reduced state low. The persistence of the 2031 cm–1 band of GC-30 into the 
nanosecond-to-microsecond domain (see below) demonstrates that the relaxed 3IL(phz) state of Re′-
OH shows little reactivity, if any. This spectral feature could also correspond to a population of Re 
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complexes that are protected from solvent quenching by DNA binding but are not well coupled 
to the base stack. 
     The picosecond TRIR spectrum of AT-30 in the DNA region is very similar to that measured in 
the nanosecond time domain (Figure 7.9). The spectra show instantaneous formation of bleach 
bands at ca. 1618 (weak), 1635, 1660, and 1690 (weak) cm–1 that are not accompanied by the 
formation of transients. These bleaches originate from a decrease in the intensity of the nucleobase 
carbonyl IR bands upon excitation, rather than band shifts, and they compare well with bleaches 
observed upon direct 267 nm photoexcitation of nucleic acid polymers (37). The GC-30 sample 
shows strong bleaches at about 1577, 1619 (weak), 1648 and 1679 cm–1, again without the 
formation of transients. Notably, on the picosecond timescale there is no evidence of a transient due 
to oxidized G●+ or G●, which would be expected at ~ 1700 cm–1 (38, 43, 44). The absence of such a 
transient is consistent with the ultrafast BET proposed above. 
     Picosecond TRIR spectra (Figure 7.10) of the Re-25(I) and Re-25(G) samples in both the 
Re(CO)3 ν(C≡O) and the DNA carbonyl regions closely resemble those of the AT-30 and GC-30 
samples, respectively. Importantly, the 3IL(phz) band intensity at 100−500 ps is much lower for Re-
25(G) than Re-25(I) relative to the initial transient, again indicating ultrafast *Re→G CT. Absence 
of any [ReI(CO)3(dppz●−)(py′-OH)] or G●+/G● IR features suggests ultrafast BET, as in the case of 
GC-30. 
     TRIR spectra recorded between 1 ns and 10 µs after photoexcitation are shown in Figure 7.9. 
The spectral patterns are very similar to those obtained in picosecond experiments at 100 ps and 
longer: The IL(phz) bands, as well as the bleaches in the DNA region, appear prominently in all 
four samples. Despite these similarities, closer examination reveals several important spectral 
differences. The AT-30 and Re-25(I) samples both show a weak isolated positive band at 2070 cm-1 
and a broad, positive absorbance near 1980 cm-1.  
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Figure 7.9. Nanosecond-timescale TRIR difference spectra showing changes in the IR 
absorbance of systems containing 0.5 mM [Re(CO)3(dppz)(py′-OR)]+ and 4.8 mM DNA (base 
pairs) following 355 nm excitation. Both the Re(CO)3 ν(C≡O) (1860–2150 cm-1) and the DNA 
C=O stretching (1550–1850 cm-1) regions are shown. Arrows indicate changes in the spectra with 
time. Delay times displayed are a subset of the data collected. The growth of the signal at ~ 1700 
cm-1 in the GC-30 sample is shown in the inset. 
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Figure 7.10. Picosecond-timescale TRIR difference spectra of 100 µM Re-25(I) (top) and Re-
25(G) (bottom) measured at the indicated delay times after 355 nm, 50 fs excitation. Each probe 
data point is separated by ca. 2.1 cm-1. Arrows indicate changes in the spectra with time. Delay 
times displayed are a subset of the data collected. 
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The 2070 cm-1 band can be assigned definitively to the MLCT excited state based on analyses 
of related complexes (19-23, 35-37, 54, 69, 77). This assignment predicts two additional low-
intensity absorption bands near 2015 cm-1 and 1960 cm-1 due to hypsochromic shift of the A′(2) and 
A′′ modes upon excitation of the complex into the MLCT state. These features are probably 
encompassed by the broad unresolved absorption between 1960 cm-1 and 1990 cm-1 and eclipsed by 
the much stronger absorption of IL states at higher energies. The MLCT features are absent in the 
GC-30 and Re-25(G) spectra. The AT-30 and Re-25(I) samples also exhibit a pronounced shoulder 
near 2020 cm-1 that is weaker for GC-30 and nearly absent in the Re-25(G) sample. This shoulder 
grows in intensity with increasing sample irradiation during the experiment, so it is in part related to 
transient absorption of a side photoproduct. However, its greater intensity in the AT-30 and Re-
25(I) samples may be due to the presence of an underlying MLCT band or residual population of 
the 3IL(phen) state, as observed in the picosecond experiments (see above). Importantly, on the 
nanosecond timescale, TRIR spectra of GC-30 in the DNA region show a growing band at ~ 1700 
cm–1 attributable to the oxidized guanine radical, G●+ or G●. This transient is very similar to that 
observed at 1702 cm-1 in both 5′-dGMP and poly(dG-dC)·poly(dG-dC) upon 200 nm 
photoionization, which was assigned to oxidized guanine (although the particular ionic state of this 
radical was not determined) (38, 43, 44). 
     The nanosecond kinetic behavior of the four samples differs substantially in several ways (Table 
7.1): (i) The bleach recoveries and 3IL(phz) decays of the AT-30 and Re-25(I) are largely composed 
of long-lived components (≥ 20 µs) with smaller contributions on the time scale of tens to hundreds 
of nanoseconds. The occurrence of such slow microsecond processes, which have no counterparts 
in emission decays, indicates the presence of long-lived, non-emissive 3IL excited states or transient 
species. (ii) The AT-30 and Re-25(I) MLCT band at ~ 2070 cm-1 is fully formed in the 1 ns spectra 
and decays monotonically over time (9 and 32 ns, respectively). In general, the lifetimes of the 
MLCT bands are significantly different than those of the IL bands, showing that the 3IL and 3MLCT 
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states are not equilibrated. Importantly, the 2070 cm–1 MLCT band is completely absent in the 
spectra of the GC-30 and Re-25(G) samples, probably due to very fast quenching of the 3MLCT 
excited state by guanine. (iii) As compared to AT-30 and Re-25(I), both GC-30 and Re-25(G) show 
faster 3IL decay and bleach recovery. (iv) Direct IR evidence for G●+/G● formation was obtained for 
the GC-30 sample, where a band appears with a lifetime of 210 ns in the DNA spectral region at ~ 
1700 cm-1 and then decays over ~ 20 µs with a lifetime estimated roughly as 6 µs, Figure 7.11. 
     As in the picosecond TRIR spectra, we do not see any distinct signals attributable to the reduced 
Re sensitizer [ReI(CO)3(dppz●−)(py′-OH)]. This again is because its IR spectrum is nearly identical 
with that of the 3IL(phz) state; moreover, the yield of reduced Re species is low due to efficient 
BET. 
 
Visible TA Transient absorption decay in the visible spectral range at 475 nm was investigated in 
order to compare the TRIR kinetics specific to the Re(CO)3 moiety with those of the dppz part of 
the chromophore. A single exponential term was a poor model for the transient decay, indicating 
that more than one transient species exists during the course of the measurement. Biexponential fit 
parameters for the transient decays are shown in Table 7.1. It should be noted that the TA 
experiments were performed with a time resolution of about 10 ns, so they only provide information 
on the slower kinetics and longer-lived intermediates. Still, the TA decay lifetimes for each sample 
are comparable to the decay of the TRIR band near 2030 cm-1, including the lifetime shortening 
upon guanine incorporation near the Re binding site. It follows that the same states and processes 
are monitored by both methods. In a similar system, the TA spectrum of the reduced state following 
355 nm excitation of a Re-DNA conjugate could not be distinguished from the spectrum of the 
excited state, presumably due to the greater concentration of the excited state and the strong 
similarity between the two spectra (66).  
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Figure 7.11. Nanosecond-timescale TRIR difference spectra showing changes in the IR 
absorbance of 4.8 mM (base pairs) GC-30 in the presence of 0.5 mM Re′-OH following excitation 
at 355 nm. Arrows indicate changes in the spectra with time. The increase in absorbance at ~ 1700 
cm-1 is clearly displayed. 
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However, a change in the lifetime of the transient upon DNA binding suggested that DNA-
mediated quenching by guanine was taking place. A similar effect is expected for the conjugates 
studied here.  
 
Discussion 
Interactions Between [Re(CO)3(dppz)(py′-OR)]+ and DNA Strong interactions between 
intercalating metal complexes and DNA are well known. As observed with several other dppz-
bearing cationic metal complexes, incubation with DNA results in hypochromicity of the electronic 
spectrum and increased luminescence of the complex (78-80). Certainly, the light switch effect is a 
strong indicator of intercalative binding. Biexponential emission decays observed for other light 
switch complexes bound to DNA, such as dppz complexes of Ru, have been attributed to the 
existence of two different intercalative binding modes: a perpendicular mode, in which the metal-
phenazine axis of the dppz ligand lies along the DNA dyad axis, and a side-on mode, in which the 
metal-phenazine axis lies along the long axis of the base pairs (81). In a similar way, the 
multiexponential emission decays observed for the Re complexes are probably due in part to the 
existence of several binding modes. Emission decay lifetimes of intercalated complexes are also 
affected by the DNA sequence to which they are bound (82-84). Although the range of DNA 
binding sites in the tethered complexes is limited, the tether is flexible enough to allow for binding 
at any of several locations, each of which may have a different effect on the luminescence lifetime. 
Similarly, for non-tethered samples, slight variations in the sequence at the binding site may 
contribute differently to the overall decay. DNA sequence effects, therefore, also contribute to the 
multiexponential emission decay kinetics of bound complexes. 
     The bleaches observed in the organic carbonyl stretching region (1600 cm-1 to 1700 cm-1) of the 
TRIR spectra could be another indication of the strong interaction between the complexes and 
DNA. It is possible that such bleach signals arise from direct photoexcitation of DNA, but excited 
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states thus generated are expected to persist for only a few nanoseconds (76). On the contrary, 
the microsecond DNA bleach recovery lifetimes, commensurate with Re excited-state lifetimes 
observed herein, indicate that the bleached signals originate from perturbation of the bases upon 
photoexcitation of electronically coupled Re chromophore. A similar effect was observed 
previously upon 400 nm photoexcitation of [Ru(dppz)(tap)2]2+ intercalated nonspecifically into 
poly(dG-dC)·poly(dG-dC) (85). In that work, a series of overlapping bleach and transient signals in 
the organic carbonyl stretching region at short times (2 ps to 2 ns) was attributed to guanine 
oxidation by excited Ru via a proton-coupled electron transfer (PCET) mechanism. Such a 
mechanism seems unlikely in our system because of the absence of TRIR transients that could be 
assigned to changes in cytosine carbonyl stretching frequency.  
 
Guanine Oxidation by *[Re(CO)3(dppz)(py′-OR)]+ Previous work has shown that extended 
irradiation of mixtures of [Re(CO)3(dppz)(py)]+ and supercoiled plasmid DNA at λ > 350 nm 
results in nicks in the DNA backbone (42). In that work, the yield of cleavage did not depend on the 
concentration of singlet oxygen, suggesting that cleavage is the result of direct oxidation of guanine 
by the excited complex. The experimental results described here provide further evidence for the 
oxidation of guanine in DNA duplexes by photoexcited [Re(CO)3(dppz)(py′-OR)]+. In PAGE 
experiments, oxidation was observed preferentially at the 5′-guanine of the 5′-GG-3′ doublet. 
Importantly, the observation of oxidation at this site, at least three base pairs removed from the Re 
binding site, indicates that long-range DNA-mediated CT has occurred. The preferential oxidation 
of the 5′-guanine of the doublet is typical for long-range DNA-mediated CT processes (86, 87). 
This pattern is due to localization of the injected hole at guanine, the site of lowest oxidation 
potential (68). Once localized on guanine, proton transfer with base-paired cytosine results in the 
formation of the neutral guanine radical (k ≈ 107 s-1) (38). In this state, the radical is quite stable, and 
can persist for > 1 ms (88). In the present study, a greater yield of guanine damage was observed by 
  
251 
PAGE at the guanine doublet in Re-25(I) than in Re-25(G). This result can be attributed to the 
effect of the flanking guanines in Re-25(G). For each photon absorbed, CT may occur to any low 
potential guanine site that is well-coupled to the probe. Statistically, transfer to and trapping at the 
guanine doublet is more probable in Re-25(I) than in Re-25(G) since CT to inosine is expected to be 
thermodynamically less favorable. The long-range DNA-mediated oxidation of guanine observed in 
the gel experiment is not surprising, given the favorable driving force and strong electronic coupling 
between the complex and DNA. 
     The spectroscopic data are also consistent with guanine oxidation. By both steady-state and time-
resolved emission, the luminescence intensity of each AT-30 and Re-25(I) is greater than that for 
GC-30 and Re-25(G), respectively. In early work, a similar disparity in the emission intensity of 
[Re(CO)3(dppz)(py)]+, a known DNA light-switch complex, bound to poly(dA)·poly(dT) versus 
poly(dG)·poly(dC) was ascribed to steric inhibition of binding to the latter duplex (42). Such an 
interpretation falls short on several accounts. First, it cannot explain the difference in emission 
intensity observed between Re-25(I) and Re-25(G); exchanging guanine for inosine at the Re 
binding site is expected to present a negligible change in steric interactions between the complex 
and the duplex. Second, it is not consistent with the equal degree of hypochromicity observed in the 
electronic spectrum of a similar Re complex when bound to either poly(dG-dC)·poly(dG-dC) or 
poly(dA-dT)·poly(dA-dT) (57). Finally, it contradicts the strong luminescence observed from the 
bulkier light switch complex [Ru(bpy)2(dppz)]2+ bound to poly(dG-dC)·poly(dG-dC) (72, 89). A 
more consistent explanation involves facile quenching of the Re excited state by guanine (43, 44, 
57). CT from excited Re to guanine accounts well for our observation that the Re-25(G) and GC-30 
samples, in which guanine neighbors the intercalation site, show less emission than the Re-25(I) and 
AT-30 samples, in which direct interaction between the complex and guanine is prevented.  
     TRIR spectra reported above provide further information on the rate and mechanism of guanine 
oxidation in GC-30 and Re-25(G). The reduced yield of the IL(phz) state relative to AT-30 and Re-
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25(I) suggests that *Re→G CT involves the IL(phen) state and occurs on a comparable time 
scale as the IL(phen)→IL(phz) conversion, namely a few tens of picoseconds. In addition, the 
absence of MLCT features in spectra observed on the nanosecond timescale shows that parallel CT 
involving the MLCT state occurs with a sub-nanosecond lifetime. Under some circumstances, 
IL(phz) could be reactive as well, but we have no direct evidence for a process involving this state. 
The rate of *Re→G CT cannot be determined exactly by TRIR because the spectral patterns of the 
IL-excited and reduced states cannot be distinguished. Nevertheless, the picosecond-timescale CT 
rates are further corroborated by comparison of the instantaneous (t = 0) emission intensity between 
samples. On the nanosecond timescale, the four samples give similar emission decay rates, although 
the integrated emission intensity is much less for Re-25(G) and GC-30 than for Re-25(I) and AT-
30. 
     The reason for the absence of a guanine oxidation signal in TRIR spectra of Re-25(G) and Re-25(I)  
is unclear, but it may be an effect of the mixed base sequence used in these constructs. In previous 
studies of guanine oxidation by [RuIII(phen)2(dppz)]3+, a strong transient was observed in the visible 
region that was attributed to the neutral guanine radical when the complex was intercalated in 
poly(dG)·poly(dG) or poly(dG-dA)·poly(dC-dT), but no signal was seen when the complex was 
intercalated in poly(dG-dT)·poly(dC-dA) (88). This difference was attributed to sequence dependent 
variations in the redox potential of guanine or structural variations, which would alter the coupling 
in the system.  
 
Long-Lived Transient States In addition to the reactive Re states, TRIR and TA measurements 
indicate that one or more non-emissive transient states persists long after the emissive species has 
been depleted. We have established that the long-lived transients are composed primarily of 
mixtures of Re in the 3IL(phz) excited state and in the reduced state,  [Re(CO)3(dppz●−)(py′-OR)]. 
The long-lifetime decay processes observed by these absorption methods therefore contain 
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contributions from the decay of these two states. From the 3IL(phz) state, the decay is likely due 
to internal conversion to the ground state. From the reduced state, the decay is caused by charge 
recombination, i.e., BET. The observation of long-lived transients in the AT-30 sample and the 
possibility for the oxidation of by excited Re indicate that some amount of charge injection may be 
possible in the absence of guanine. However, the lack of evidence for the formation of A●+ and the 
relatively strong emission observed in the AT-30 system suggest that if CT with adenine occurs, it 
is slow, minimally competitive with emission, and followed by fast BET. 
 
Suggested Mechanism of DNA-Mediated Guanine Oxidation Based on spectroscopic evidence, a 
model can be generated for the oxidation of guanine by excited [Re(CO)3(dppz)(py′-OR)]+ (Figure 
7.12). Photoexcitation of the complex populates a mixture of close lying IL(phen), IL(phz) and 
MLCT excited states, presumably spin-triplets, that are clearly observed by TRIR. (Such mixture of 
states also has been observed experimentally in analogous rhenium tricarbonyl complexes, and has 
been verified in computational models (16, 17, 19, 21-23, 26, 27, 41, 90). On the basis of our TRIR 
results, it appears that different excited states are more or less likely to participate in DNA-mediated 
CT. The MLCT state in particular, which is not observed in samples where the excited complex is 
in direct contact with guanine, seems to be more easily quenched than the IL states. The CT 
reactivity appears to decrease in the order MLCT > IL(phen) > IL(phz). It is also possible that 
conversion between excited states affects the apparent rates and yields observed for charge injection 
or emission. The reaction pathways from the excited state are also governed by the extent of 
electronic coupling in the system, which itself is determined by the dynamics of the probe and of 
the bases themselves (66). At the instant of excitation, two major populations exist. The first 
involves complexes which are poorly bound or which are bound to DNA in orientations that are not 
conducive to electron transfer. In this population, the mechanism of relaxation involves either 
quenching by water, observed for Ru-dppz complexes in polar, protic solvents (56, 91), or emission.  
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Figure 7.12. The proposed model for the oxidation of guanine by photoexcited 
[Re(CO)3(dppz)(py′-OR)]+. Photoexcitation in the poorly coupled system results in emission (hν′) or 
nonradiative decay to the ground state. Photoexcitation in the well-coupled system results in charge 
injection over an arbitrary distance to form reduced [Re(CO)3(dppz)(py′-OR)]0 (Rered) and the 
guanine radical cation (G●+). During the excited state lifetime of the complex, the poorly coupled 
system may undergo reorientation, allowing charge injection. From the charge-separated state, 
facile back electron transfer (BET) competes with charge migration and trapping, resulting either in 
no reaction or the formation of permanent oxidation products. Base motions may result in isolation 
of the injected charge, favoring the trapping pathway. 
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Emission is expected to occur primarily from the 3IL state, as reported for [Re(CO)3(dppz)(py)]+ 
in acetonitrile (19). In the second population, the excited complex is well coupled to the DNA. 
Here, excited state quenching via positive charge (i.e., hole) injection into the DNA duplex is the 
preferred reaction pathway. Indeed, primarily coherent CT at a distance of ten base pairs was 
observed in systems utilizing 2-aminopurine as a hole donor (60). Such processes are rapid. In 
systems involving DNA-bound ethidium, DNA-mediated CT over distances of several bases was 
observed to occur in 5 ps (92). Further, emission quenching is not limited to the population that 
exists in a CT-active configuration at the moment of excitation; reorientation of the bound oxidant 
to generate such a configuration may occur within the lifetime of the excited state. The rate of 
reorientation for DNA-bound ethidium is 75 ps (92), although for a larger molecule such as 
[Re(CO)3(dppz)(py′-OR)]+, this rate may be slower. Following charge separation, charge 
recombination (BET) may occur. After all, the ground-state oxidation of [ReI(CO)3(dppz●−)(py′-
OH)]0 [E°(Re+/Re0) = -0.85 V vs. NHE] by G●+ [E°(G●+/G) = 1.29 V vs. NHE] (68) is 
thermodynamically favorable, and immediately after charge separation, the system exists in a CT-
active state. Back reaction along this pathway is consistent with the absence of a guanine signal at 
short times in TRIR experiments. While this non-productive reaction pathway can be invoked to 
explain some of the experimental observations, additional pathways must be operative; quantitative 
deactivation of the charge separated state via short-range BET would prevent the eventual 
formation of permanent oxidative damage. A third population, then, involves molecules that are 
well coupled during charge injection, but that lose coupling before BET can take place due to 
reorientational motion of either the probe or the bases. The holes thus isolated within the base stack 
are quite stable and can migrate away from the site of injection, further reducing the probability for 
BET to occur and increasing the yield of permanent oxidative damage (60). Charge migration is 
limited in rate by stacking and destacking motions of the duplex, which form transient delocalized 
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electronic domains (93, 94). The 210 ns rate of formation for the guanine radical signal 
observed at ~ 1700 cm-1 by TRIR in the GC-30 sample may therefore reflect the rate of this 
conformational gating. 
 
Concluding Remarks 
      Complexes that contain IR-active moieties show promise as probes for the study of DNA CT. In  
this work, we have used PAGE and time-resolved spectroscopy to observe the oxidation of guanine 
in DNA by photoexcited [Re(CO)3(dppz)(py′-OR)]+. Although no direct evidence for this reaction 
is afforded by UV/visible methods, fast excited-state quenching by guanine provides indirect 
evidence that oxidation is taking place. Direct evidence for the formation of guanine oxidation 
products is observed biochemically by PAGE analysis and spectroscopically by TRIR following 
photoexcitation of Re′-OH in the presence of GC-30. Similarities between the spectral features and 
kinetics of this system with those of other DNA sequences containing guanine allow us to conclude 
that the photochemical processes observed in the GC-30 sample are general. In these systems, the 
rate of guanine oxidation (herein 210 ns) is dictated largely by motions of the bases, which allow 
for long-range charge separation and prevent BET, rather than by the intrinsic photophysics of the 
photosensitizer complex. In this respect, the role of Re′-OH is similar to that of other photooxidants 
that have been used in DNA CT studies (60, 93, 94). 
      Unlike the well-known [Ru(phen)2(dppz)]2+ DNA “light-switch”, rhenium(I) tricarbonyl-dppz  
complexes are strong enough photooxidants to inject positive charge into DNA directly from their 
electronically excited state(s), i.e., without the use of an external quencher and involvement of 
diffusion-controlled steps. This allows for ultrafast charge injection, with possible applications in 
mechanistic studies of DNA-mediated CT and in development of DNA-based photonic devices. 
However, the present study indicates that charge injection by [Re(CO)3(dppz)(py′-OR)]+ 
preferentially involves the initially populated IL(phen) and the minor MLCT states, with the long-
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lived 3IL(phz) state showing little reactivity, if any. This, together with fast BET, limits the 
reaction yield. From the experimental point of view, Re tricarbonyl-diimines have the advantage of 
being both ET phototriggers and probes by virtue of their sensitive IR spectral responses to changes 
in the electron density distribution (32, 34). However, in the particular case of dppz complexes, the 
TRIR spectral analysis is complicated by the close resemblance of 3IL(phz) and reduced-state 
spectral patterns that renders the two species indistinguishable. It is suggested that optimization of 
the Re-photooxidant structure will improve both the charge injection efficiency and the IR spectral 
response.  
     A complete picture of DNA CT requires the observation of processes on very different time 
scales. At the instant of photoexcitation, the extent of coupling between the probe and the base 
stack, and between the bases themselves, defines two populations of DNA: one that is CT-active 
and one that is CT-inactive. The outcomes of fast processes, such as fluorescence and charge 
injection, are determined based on the relative sizes of these populations. At longer times, base 
motions change the energetic landscape, offering alternative reaction pathways, such as charge 
migration and trapping, that were not available immediately after excitation. TRIR allows for the 
observation of processes at all of these time scales, making it a valuable addition to the methods 
employed for the study of DNA-mediated CT. 
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     DNA is an exquisite biomolecule that stores genetic information to encode proteins and 
regulate pathways, but even more remarkable, its unique structure imparts unprecedented function 
that allows it to mediate charge transport over long molecular distances, and potentially relay 
signals within the cell (1-4). DNA is composed of a sugar-phosphate backbone that encloses 
nucleotide base pairs layered on top of one other. The π-stacked bases of the DNA duplex make it 
identical to other conductive molecular wires, such as graphite (1-4). Using a variety of 
spectroscopic, electrochemical, biochemical techniques, we have investigated the fundamental 
properties of DNA CT (1-11). Importantly, the redox probes that we employ to monitor CT must be 
well-coupled to the DNA base pair stack, thus, for our studies, we are limited to molecules that we 
can design and build in the laboratory. Yet, Nature has already evolved incredible redox probes of 
its own: metalloproteins. Significantly, we are discovering that proteins from a variety of organisms 
and pathways incorporate redox-active cofactors, which are specialized “engines” that allow them 
to “tap-into” DNA CT. Therefore, just as a gold electrode can be used to send charge through DNA 
to a distally bound redox acceptor (4), it is possible that proteins take on both of these roles, 
simultaneously, within the cell. 
      One major repair pathway of the cell, base excision repair (BER), involves many proteins, some 
of which are in very low copy number (~ 30 copies), to scan the entire genome for damage (12-15). 
A subset of BER proteins contain a [4Fe4S] cluster that is not required for structure or folding; we 
then asked, why is the [4Fe4S] cluster present in these proteins? Our initial electrochemical 
experiments revealed that MutY and EndoIII, BER proteins, exhibit DNA-bound redox potentials 
of ~ 100 mV vs. NHE (15-18), which is relevant to the potentials found inside a cell.  From these 
studies, we found that as MutY or EndoIII binds DNA, the [4Fe4S] cluster is activated toward 
oxidation 3+, and thus necessarily, has a > 1000 higher affinity (Kd) for DNA (15). Notably, BER 
proteins must search through thousands of bases to find damage, and assuming facilitated diffusion 
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and instant interrogation, the copy number of these proteins is not sufficient to locate lesions 
before the cell divides (15). We have proposed a model, however, in which bound proteins utilize 
DNA-mediated CT to efficiently scan regions of the genome, allowing them to reduce the 
population of sites to search by a localization of protein in the vicinity of lesions. In this model, 
there are four fundamental requirements: i) DNA CT occurs over distances of 100−500 bp; ii) 
lesions attenuate DNA CT; iii) repair proteins exhibit DNA-bound redox potentials of ~ 80−100 
mV vs. NHE and are able to efficiently perform CT; iv) there is a balance of reduced and oxidized 
protein (15). We have previously, and are currently, performing experiments to investigate each 
requirement we propose for the DNA-mediated search. In a complementary way, the studies 
described here are directed toward monitoring the entire coordination process that occurs among 
repair proteins for lesion detection. 
     In the second chapter, we detail an assay we have developed to determine whether repair 
proteins could cooperate in a DNA-mediated search for damage. Atomic force microscopy (AFM) 
is employed to obtain a “snapshot” of the search for lesions, which is reported as a redistribution 
ratio. We have incorporated a C:A lesion that inhibits DNA CT but is not a specific substrate for the 
repair protein in the assay into a long DNA strand (3.8 kbp). In this assay, strands and proteins are 
visualized and tallied from multiple samples and images based on height (nm). When EndoIII 
protein is incubated with long mismatched strands and short matched duplexes, we observe a higher 
density of proteins bound to the mismatched strands. Consistent with the model, this observation 
correlates with the ability of EndoIII to perform DNA CT, which has been characterized 
electrochemically. Alternatively, in the fully matched controls, there is no lesion to “home-in on”, 
and the distribution ratio is ~ 1, indicating there is an equal number of proteins bound to long and 
short strands. Importantly, the model depends on the percentage of protein in the oxidized/reduced 
states. To this end, we add small concentrations of peroxide to the protein/DNA samples and 
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examine them with AFM. Only in the mismatched samples, we find the binding density ratio 
increases proportional to the peroxide treatment, indicating that indeed, when more protein is 
oxidized, it is bound in the vicinity of the lesion. From these experiments, AFM emerges as a tool, 
complementary to other methods we have developed in the lab, that we can apply to investigate 
whether proteins coordinate to find damage (15).  
     We then wondered: which residues are involved in mediating charge between the DNA and the 
[4Fe4S] cluster? Chapter three discusses a number of EndoIII mutants that we have characterized 
based on their ability to perform DNA CT and their propensity to redistribute in AFM studies (19). 
We find that the ability of a protein to localize in the vicinity of a lesion correlates with its ability to 
send and receive charge. Importantly, we note that the Y82A EndoIII mutant, which is deficient in 
CT, has been associated with colorectal cancer in humans (15), thus we must consider the 
implications of a DNA-mediated search process in vivo. 
     Applying genetic techniques, we have begun exploring this model in E. coli cells (15). The assay 
has been designed to measure the ability of MutY, a BER protein to repair oxidative damage in 
vivo.  Our search model benefits from cooperation among metalloproteins that exhibit similar DNA-
bound potentials. Thus we have asked whether eliminating one of these “helper” proteins disrupts 
the search partner left behind. We find that indeed this is the case, as we observe a decrease in the 
ability of MutY to fix damage when EndoIII is knocked out genetically. In chapter four, we 
describe methods designed to improve the signal output of this assay and ultimately reduce error in 
the measurements. Additionally, we present efforts toward developing a high-throughput screen, 
based on the helper function assay, to identify other proteins that may cooperate with MutY in a 
DNA-mediated search for damage.  
      Could the DNA-mediated search also occur among metalloproteins from different repair 
pathways? Excitingly, XPD, an archaeal protein from the nucleotide excision repair (NER) 
pathway, incorporates a [4Fe4S] cluster (20, 21). Similar to the [4Fe4S] cluster found within BER 
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proteins, the cluster is not required for XPD to fold and, additionally, is labile. XPD is a 5ʹ′-3ʹ′ 
helicase, one component of the transcription factor IIH machinery involved in binding near bulky 
lesions and exposing them for repair (20, 21). Significantly, XPD has a similar DNA-bound redox 
potential to EndoIII (~ 80 mV vs. NHE) (22). Notably, the efficiency of DNA CT increases upon 
the addition of ATP, as its helicase activity is activated (22). Might XPD also participate in the 
search process? AFM results, presented in chapter five, establish that XPD redistributes onto long 
mismatched strands. In these studies, the short strand overhangs are blocked with complementary 
single strand, so that XPD does not have a bias toward the short strands. Expanding upon these 
observations, we then utilized AFM to investigate whether proteins from different pathways (BER 
vs. NER) could cooperate with one another. To this end, we mixed XPD and EndoIII, proteins from 
distinct organisms as well as pathways, and discovered that they localize in the vicinity of lesions 
(23)! If, instead, we introduced a mutant either of EndoIII or XPD, defective at CT, we did not 
observe this redistribution (23). This result is exciting, considering these two proteins are from two 
different organisms. DNA signaling appears to depend only upon the [4Fe4S] clusters in the DNA 
binding proteins and this ability to couple through CT. 
      Probing the model further, we use AFM in an attempt to observe XPD helicase activity in 
conjunction with redistribution. In chapter 6, we find no difference in redistribution when we add 
ATP to XPD/DNA samples. In an effort to activate helicase activity, and observe unwinding in 
‘real-time’, we have substituted ATP with a caged-analogue that is deprotected with UV-light. Post-
irradiation, we observe forked DNA structures, indicative of XPD helicase activity. We are now in 
the process of expanding these studies using different concentrations of ATP and scanning speeds. 
     We have also probed DNA CT using time-resolved IR (TRIR) spectroscopy. In the first step of 
the search model, a reduced metalloprotein binds DNA, and consequently, gets oxidized. Since the 
guanine base is the most susceptible to oxidation, we have considered that guanine oxidation may 
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trigger the metalloprotein to bind DNA, initiating the search process. We have designed a Re-
based metal complex, a photooxidant, to initiate this process. Significantly, we observe guanine 
oxidation via spectroscopic and biochemical techniques (24).  
     As we identify the metalloprotein players in the DNA-mediated search damage, it is clear that 
many pieces of this puzzle are interchangeable. In order to participate, proteins must bind DNA and 
simply have the means (i.e., redox-active moiety) to harness DNA-mediated CT. We have the 
methods and tools to characterize the DNA-bound redox potentials of proteins from a variety of 
pathways. Described here, AFM and in vivo assays will help us establish whether there is signaling 
between the proteins we identify in the future. Metalloproteins containing [4Fe4S] clusters are 
emerging rapidly: polymerases, primases, and transcription factors (25). We can even consider 
proteins from other organisms. 
      Pathogenic actinobacteria such as Mycobacterium tuberculosis, Cornebacterium diphtheria, and 
Streptomyces coelicolor, possess specific mechanisms that help them survive and thrive under 
extreme cellular conditions including oxidative stress (26). Recently, WhiB-like (Wbl) proteins 
have been identified as major components of redox control in actinobacteria (27-29).  What is the 
biochemical role of these proteins?  Importantly, these proteins bind DNA, act as transcription 
factors, and incorporate a [FeS] cluster cofactor that is stable under anaerobic conditions (30).  
What is the role of these [FeS] clusters in sensing redox conditions? Might Wbl proteins also be 
involved in DNA-mediated signaling?  
     We now move toward identifying and understanding the players in this search model. Just as 
nature takes advantage of the resources it has, so will we employ the tools we have designed to 
probe DNA-mediated CT in a biological context.  
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